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Summary 
Hepatocyte Growth Factor (HGF) is a pleiotropic factor that affects many aspects of 
biological functions through activation of its transmembrane tyrosine kinase receptor 
c-Met. This ligand/receptor pair has been shown to be essential for the development 
of several epithelial organs in mouse. However, many aspects of its function as well 
as the mechanisms of action are still unclear due to the early embryonic lethality of 
the knockout mice. In this study, we used zebrafish as a vertebrate model to study the 
developmental role of hgf and its receptor c-met. Full length cDNA of the two hgf 
genes hgfa, hgfb and the receptor c-met were cloned by PCR and their Expression 
analyzed by qRT-PCR as well as whole mount in situ hybridization. hgfa is mainly 
expressed in the somite during somitogenesis stage, indicating its role in 
somitogenesis. hgfb is expressed in liver mesenchyme while c-met was detected in 
hepatocytes, indicating their paracrine signaling in liver development. The co-
expression of hgfa and c-met in pectoral fin, hgfb and c-met in proneprhic duct also 
indicate their paracrine signaling in the development of these organs in zebrafish. 
 
Knockdown hgfa by morpholino antisense oligonucleotides resulted in curved truck 
and altered myoD, fgf8 and aldh1a2 expression patterns in somites, indicating roles of 
hgfa in zebrafish somitogenesis and myogenesis. In addition, the intersegmental 
vessel sprouting, especially the dorsal part is also affected in the hgfa morphants. 
Although hgfa is not expressed in liver or pancreas, knockdown of hgfa expression 
caused the left-right positional shift of these two organs and this shift is correlated 
with the curved trunk phenotype.  
 
Knockdown of hgfb or c-met caused reduction in liver size which are dependent on 
xi 
the extent of gene expression knockdown. Smaller liver correlated with lower level of 
endogenous hgfb or c-met expression in the hgfb morphants. Since the reduced liver 
size in hgfb or c-met morphants is only discernable after 4 dpf, and there is no change 
in the hepatocyte proliferation rate in morphants, it is likely that accelerated liver cell 
apoptosis is responsible.  
 
These results indicate distinct expression and function of the two hgfs in zebrafish 
most likely through a shared receptor c-Met. The distinct function is mainly generated 
through differential gene expression both temporally as well as spatially. These 
studies expanded our understanding of HGF/c-Met in vertebrate development and 
established the foundation for further studies of their molecular mechanisms of action 
in various organs as well as their regulation of expression. 
 
1 
Chapter 1. Introduction 
1.1 Discovery of HGF and its receptor c-met 
1.1.1. Discovery of HGF 
Hepatocyte growth factor (HGF) and scatter factor (SF) were originally identified as 
distinct cytokines that promote the growth or motility of epithelial cells, respectively. 
HGF was identified in the serum of partially hepatectomized rats as a potent mitogen 
for cultured rat hepatocytes (Michalopoulos et al., 1984; Nakamura et al., 1984). It 
was isolated from rat platelets (Nakamura et al., 1986), human plasma (Gohda et al., 
1988), human serum (Zarnegar and Michalopoulos, 1989), and rat liver (Asami et al., 
1991). The HGF cDNA has been cloned and sequenced (Miyazawa et al., 1989; 
Nakamura et al., 1989; Rubin et al., 1991; Tashiro et al., 1990). Scatter factor was 
originally described as a secretory product of fibroblasts that dissociate normal and 
malignant epithelial cells in vitro, increasing their motility and invasiveness (Gherardi 
et al., 1989; Stoker et al., 1987; Weidner et al., 1990). Sequence analysis (Gherardi 
and Stoker, 1990) and cDNA cloning from fibroblasts, placenta, and liver showed that 
HGF and scatter factor are identical (Naldini et al., 1991; Weidner et al., 1991). The 
molecular identity of the two cytokines has been further proven by their 
interchangeable activities in promoting hepatocyte growth, epithelial cell dissociation, 
and matrix invasion (Furlong et al., 1991; Naldini et al., 1991; Weidner et al., 1991). 
Nowdays people often name this protein as HGF/SF. 
2 
 
1.1.2. Discovery of c-met and identification of c-met as the receptor of 
HGF 
 
In 1984, c-met was originally identified as a transforming gene from a chemically 
transformed human osteosarcoma-derived cell line (Cooper et al., 1984). In 1986, its 
cloning revealed that the oncogene encoded a truncated tyrosine kinase due to 
chromosomal rearrangement (Park et al., 1986). Although the oncogene product is 
predominantly a cytosolic kinase, the proto-oncogene product was identified as a 
transmembrane receptor-like protein (Park et al., 1987). In 1991, a 145kD tyrosyl 
phosphoprotein observed in rapid response to HGF treatment of intact target cells was 
identified by immunoblot analysis as the β subunit of the c-met proto-oncogene 
product, a membrane-spanning tyrosine kinsase (Bottaro et al., 1991). Covalent  
cross-linking of 125I-labeled ligand to the cellular proteins of appropriate size 
recognized by c-met antibody established the c-met product as the cell-surface 
receptor for HGF (Bottaro et al., 1991). 
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1.2. Structure of HGF and c-met 
 
1.2.1. Structure of HGF 
 
HGF is a member of the plasminogen-related growth factor (PRGFs) family, thus is 
sometimes also referred as PRGF-1. Human HGF gene spans 70 kb on chromosome 
7q21.1 and is initially produced as pro-HGF, a single chain precursor, which is 
subsequently cleaved by a protease to produce HGF which forms a two-chain 
heterodimer (Mars et al., 1993; Seki et al., 1991). The larger α chain (residues 1–494) 
contains a typical signal peptide, cleaved during secretion, followed by five distinct 
domains: an N-terminal (N) hairpin loop homologous to the activation peptide of 
plasminogen and four kringle (K) domains. The smaller β chain (residues 495–728) 
resembles a typical serine protease domain (Fig1.1).  
 
1.2.2 Structure of c-met 
 
The human MET gene is located on chromosome 7 band 7q21–q31 and spans more 
than 120 kb in length (Duh et al., 1997; Liu, 1998). In wild-type cells, the primary 
MET transcript produces a 150 kDa polypeptide that is partially glycosylated to 
produce a 170 kDa precursor protein. This 170 kDa precursor is further glycosylated 
and then cleaved into a 50 kDa α chain and a 140 kDa β chain, which are linked via 
disulfide bonds. The mature MET heterodimer thus consists of a highly glycosylated 
extracellular α subunit and a β subunit with a large extracellular region, a membrane 




Fig.1.1 Schematic representation of proHGF/SF, HGF/SF and the c-Met receptor. 
Proteolytic cleavage of proHGF/SF generates the heavy (H) and light (L) chain of the 
active factor and is accompanied by a major conformational change. Active HGF/SF 
binds to c-Met, inducing receptor dimerization and activation.(from Birchmeier and 
Gherardi, 1998) (PAN-AP domain, divergent subfamily of APPLE domains, TK 
domain, Tyrosine kinase, catalytic domain) 
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1.3 HGF regulation by HGF activator (HGFA) and HGFA inhibitor 
(HAIs)  
 
HGF/SF is a heparin-binding glycoprotein secreted by mesenchymal cells as an 
inactive single-chain precursor (also known as pro-HGF) with a molecular weight of 
around 94 kD. HGF/SF remains in this precursor single-chain form, probably 
associated with ECM in the producing tissue and/or with cellular surface 
proteoglycans (Matsumoto and Nakamura, 1996; Naldini et al., 1992). To generate 
biologically active HGF, the conversion of an inactive single-chain precursor form to 
a two-chain heterodimeric active form by a single proteolytic cleavage between 
Arg494 and Val495 is essential (Naka et al., 1992; Naldini et al., 1992). Activation of 
the inactive HGF is a highly regulated process that requires orchestration of a number 
of enzymes. One of the most powerful activators is the HGF activator, HGFA 
(Miyazawa et al., 1993; Shimomura et al., 1995). Other activators include urokinase-
type plasminogen activator (Mars et al., 1993; Mars et al., 1996; Naldini et al., 1992); 
injurin, an inducer of expression of the gene for hepatocyte growth factor (Matsumoto 
et al., 1992); blood coagulation factor XIIa (Shimomura et al., 1995); membrane-type 
serine protease-1 (MT-SP1) (Lee et al., 2000); hepsin, a cell surface serine protease 
(Herter et al., 2005; Kirchhofer et al., 2005). 
 
HGFA is a member of the Kringle-serine proteinase superfamily, and its molecular 
structure resembles that of the coagulation factor XII (Miyazawa et al., 1993). It is 
secreted mainly by the liver and circulates in the plasma as an inactive single-chain 
96-kDa proform (proHGFA) (Miyazawa et al., 1993). Therefore, activation of 
proHGFA and efficient localization of mature HGFA to the desired tissue and cells 
6 
would be a prerequisite to utilize this potent enzyme in the pericellular activation of 
HGF. It has been shown that thrombin is responsible for the activation of proHGFA 
by cleavage at Arg407 in the presence of a negatively charged substance, resulting in 
an active two-chain heterodimeric form (Shimomura et al., 1993). 
 
Mature HGFA is not inhibited by major serum proteinase inhibitors, and HGFA is, in 
fact, active in serum (Shimomura et al., 1992; Shimomura et al., 1995). Indeed, 
HGFA activity was initially identified in and purified from bovine serum (Shimomura 
et al., 1992). This evidence strongly suggests the existence of a regulatory system of 
HGFA activity in local tissue. This assumption led to the subsequent discovery of the 
HGFA inhibitor (HAI). The first endogenous HAI was purified from the culture-
conditioned medium of an MKN45 gastric carcinoma cell line (Shimomura et al., 
1997). Subsequently, a second type of HAI was purified from the same sample 
(Kawaguchi et al., 1997). These inhibitors were designated as HGFA inhibitor type 1 
(HAI-1) and type 2 (HAI-2), respectively. Both HAI-1 and HAI-2 are Kunitz-type 
serine proteinase inhibitors. They have two Kunitz-type inhibitor domains that share a 
high degree of amino acid sequence identity. It is important to note that each HAI has 
a presumed transmembrane domain near the C-terminal end, suggesting that HAIs are 
type I transmembrane proteins. This unique structure would ensure their biological 
activities at the cellular surface in local tissues (Kataoka et al., 2002a). HAIs are also 
inhibitory against a number of other serine proteinases. Of particular interest is the 
observation in a study by Lin et al. (Lin et al., 1999) in which a secreted form of MT-
SP1/matriptase was found to be complexed with HAI-1 in human milk. Therefore, 
MT-SP1/matriptase is a target proteinase of HAI-1 in vivo. HAI-1 also potently 
inhibits trypsin and plasmin in vitro (Denda et al., 2002; Kataoka et al., 2002a). HAI-2, 
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which appears to have broader inhibitory spectra against serine proteinases than HAI-
1, inhibits plasma and tissue kallikreins, trypsin, plasmin and factor XIa very 
efficiently (Delaria et al., 1997).  
. 
Both HAI-1 and HAI-2 are synthesized as type I transmembrane proteins. However, 
only HAI-1 is a specific cellular inhibitor of active HGFA, which acts on the cell 
surface (Kataoka et al., 2000). Although the membrane-form HAI-2 is not acting as an 
HGFA inhibitor on the cell surface, the secreted-form HAI-2/PB generated by 
ectodomain shedding potently inhibits HGFA (Kataoka et al., 2002b; Kawaguchi et 
al., 1997; Qin et al., 1998). 
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1.4 HGF signaling pathways 
HGF is known to be a paracrine factor that is produced by stromal and mesenchymal 
cells and acts on Met-expressing cells, mainly epithelial cells (Hayashi et al., 1996; 
Iwazawa et al., 1996; Nakashiro et al., 2000; Stella and Comoglio, 1999; Takai et al., 
1997; Weimar et al., 1998; Yi et al., 1998). HGF/c-Met autocrine activation which 
lead to promotion of hepatocarcinogenesis has also been reported in HGF-transgenic 
mice (Horiguchi et al., 2002). A summary of HGF signaling pathway is shown in 
Fig.1.2. 
c-Met signal transduction and regulation 
c-Met is expressed by a variety of normal and malignant cells (Comoglio, 1993). 
Upon ligand binding, c-Met undergoes autophosphorylation of specific tyrosine 
residues within the intracellular region, which leads to the activation of the HGF/c-
Met signaling pathway. Phosphorylation of Y1230, Y1234 and Y1235 located within 
the activation loop of the tyrosine kinase domain activates the intrinsic kinase activity 
of c-Met, whereas phosphorylated Y1313 is important in binding to PI3 kinase (PI3K) 
(with the YXXM motif). Phosphorylation of Y1349 and Y1356 in the C-terminus of 
c-Met activates the multisubstrate signal transducer docking site 
(Y1349VHVX3Y1356VNV) that can bind Src homology-2 (SH2) domains, 
phosphotyrosine binding (PTB) domains, and Met binding domains (MBD) of signal 
transducers and adapter proteins. Chimeric receptors containing this amino acid 
sequence can mediate cellular responses that are similar to those of Met, suggesting 
that this site is responsible for much of Met-mediated signal transduction. Mutational 
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analysis of the multisubstrate docking site suggests that Y1349 and Y1356 mediate 
the interactions with SHC, Src, and Gab1 while recruitment of Grb2, PI3-K, PLC-γ, 
and SHP2 is mediated by Y1356 (Furge et al., 2000). Regulation of morphogenesis of 
lung small cell carcinoma cell line is mediated via Y1365 (Maulik et al., 2002b). 
Within the juxtamembrane domain, the Y1003 residue has important role in binding 
to proteins such as c-Cbl, a protein binding to several activated tyrosine kinase 
receptors, acting either as a transducer or as a ubiquitin ligase, and thus has a role in 
receptor downregulation (Levkowitz et al., 1999; Thien and Langdon, 2001). Cbl 
binds and ubiquinates activated c-Met, promotes c-Met degredation. Moreover, by 
recruiting the endophilin-CIN85 complex, Cbl also regulates c-Met internalization.  
Internalization and subsequent degradation is a principal process regulating the 
duration and propagation of the signal initiated by c-Met, thereby preventing over-
stimulation that could potentially lead to cellular transformation (Petrelli et al., 2002).   
GAB1 pathway in c-Met mediated cell adhesion and migration 
One of the major substrates of the activated c-Met is the adaptor protein GAB1 
(GRB2-Associated Binding Protein-1). Phosphorylated GAB1 binds signal-relay 
molecules, such as the SH2-domain-containing proteins: SHP2 (Tyrosine 
Phosphatase-2), PI3K (Phosphatidylinositol-3 Kinase), PLC- γ (Phospholipase-C- γ), 
STAT3 (Signal Transducer and Activator of Transcription-3) and CrkL, through their 
SH2 domains. GAB1 interacts with CrkL, a protein with SH2 and SH3 protein 
interaction domains that couples to signaling further downstream (Fan et al., 2001). 
The actions of HGF on Pxn (Paxillin), DOCK1 (Dedicator of Cytokinesis-1) and 
Rap1 which alter cell motility are also mediated through GAB1. Through its SH3 
domains, CrkL can associate with, and activate multiple effector proteins, like 
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DOCK1 C3G (Guanine Nucleotide Releasing Protein C3G), a GDP GTP exchange 
factor for Rap1. C3G is implicated in the activation of Rap1, which further activates 
FAK (Focal Adhesion Kinase) and Pxn, associated with Itg (Integrin). The activation 
of FAK induces the formation of focal adhesions, a preliminary step to increased cell 
motility and tissue invasion by transformed cells Paxillin phosphorylation may also 
alter cell adhesion of Met transformed cells (Birchmeier et al., 2003).  
 
GRB2 pathway in c-Met mediated cytoskeletal regulation and motility 
Activated Met can also recruit GRB2 (Growth Factor Receptor-Bound Protein-2), an 
adaptor protein that couples activated receptor tyrosine kinases to SOS (Son of 
Sevenless), promoting Ras activation (Schaeper et al., 2000).  The activation and 
inactivation of Ras are regulated by GEPs (Guanine Exchange Proteins) and GAPs 
(GTPase-Activating Proteins). The major human GEP for Ras is SOS, which is 
constitutively associated with GRB2. Activation of Ras by HGF results in activation 
of Raf1, followed by the subsequent threonine and tyrosine phosphorylation of 
cytoplasmic dual specificity kinases, MEK1 (MAPK/ERK Kinase-1) and MEK2 
(MAPK/ERK Kinase-2). The MEKs in turn activate the extracellular signal-regulated 
kinases: ERK1 and ERK2. The activation of these MAPKs is required for HGF-
elicited cell scattering and tubulogenesis (Delehedde et al., 2001). Major substrates 
for ERKs are the transcription factors Elk1 and Ets, which upon activation, up-
regulate the expression of immediate early response genes, such as c-Fos. The ERKs 
also stimulate the stress-responsive transcription factors: c-Jun and c-Fos, important 
for HGF-mediated survival. Regulation of Rac1 and CDC42 pathways in response to 
HGF contribute to cytoskeletal rearrangement and the subsequent changes in cellular 
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motility. HGF functions as a scattering factor for epithelial cells, and this ability is 
mediated through the activation of STAT3. Phosphorylation of STAT3 alters cellular 
transcription in addition to altering cell adhesion, proliferation and cell motility 
required for triggering differentiation for branching morphogenesis. Rac1 and CDC42, 
both are activated by phosphorylated Ras. DOCK1 also lies upstream of the Rac1 
pathway (Gao and Vande Woude, 2005; Schaeper et al., 2000). Activation of the Rac1 
pathway and the CDC42 pathway contributes to the regulation of cytoskeleton, thus 
culminating in cell polarity and cell motility.  
 
PI3K in Met mediated cell survival and scattering 
Protection of cells against DNA damage by HGF is mediated by a pathway from its 
receptor c-Met to PI3K through GAB1 to Akt and PAK1 (p21-Activated Kinase), 
resulting in enhanced DNA repair and decreased apoptosis (Xiao et al., 2001). 
Activation of PAK1 also inhibits Anoikis, a form of apoptosis which is induce by 
anchorage-dependent cells detaching from the surrouding extracellular matrix. The 
PI3K pathway is responsible for cell scattering by inducing the loss of intercellular 
junctions and cell migration. Akt, the downstream target of PI3K, exerts its anti-
apoptotic effects in a variety of ways, including phosphorylation and activation of 
IKKs (I-KappaB Kinases). This results in I-KappaB degradation and allows NF-
KappaB to enter the nucleus and activate transcription of anti-apoptotic genes. 
Another mechanism whereby Akt functions to promote survival is through 
phosphorylation of BAD. Akt also phosphorylates Procaspase9 and inhibits its 
protease activity, thus suppressing activation of Procaspase3 and promoting cell 
survival as Caspase3 activity has a reverse correlation with Akt activity (Delehedde et 
al., 2001). Activation of the Met receptor also results in an increase in receptor-
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mediated activation of PLC-Gamma which catalyzes the generation of IP3 (Inositol 
1,4,5-Trisphosphate) and DAG (Diacylglycerol) from PIP2 (Phosphatidylinositol 4,5-
Bisphosphate), which act as second messenger molecules to mobilize intracellular 
Calcium and activate PKC (Protein Kinase-C) respectively. These signaling pathways 
act as important components of the cell survival and cell migratory response (Aoki et 
al., 2001).  
 
Activation of transcription factors and cell cycle progresion 
Activation of various transcription factors by HGF induces expression of several 
genes, involved in cell survival and cell cycle progression (Xiao et al., 2001). For 
example, CDK6 (Cyclin-Dependent Kinase-6), Rb (Retinoblastoma) and 
p27/p27(KIP1) (Cyclin Dependent Kinase Inhibitor-p27) are expressed, which act as 
positive regulators of cell cycle progression. The anti-apoptotic gene COX2 
(Cyclooxygenase-2) is also induced by HGF in a c-Jun- and c-Fos-dependent manner 
(Ref.9). COX2 expression by HGF inhibits the process of Anoikis (also known as 
Suspension-Induced Apoptosis), is a term used to describe apoptosis of epithelial cells 
induced by loss of matrix attachment. This process is important for maintaining 




Fig.1.2 HGF signaling pathway. Active HGF/SF binds to c-Met, inducing receptor 
dimerization and activation. The multidocking site at the C-terminus of the c-Met is 
generated by phosphorylation of tyrosine residues (Tyr1349 and Tyr1356) upon 
HGF/SF binding. The multidocking site binds to various adaptor molecules that 
transmit the signals, which are essential for cell survival, cell scattering, cell cycle 
progression, cell polarity and cell motility. (from proteinlounge.com)  
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1.5 Biological functions of HGF and c-Met 
 
1.5.1 Cell proliferation  
HGF/c-Met signaling has been shown to promote proliferation of tumor cells derived 
from ovarian, gastric, glioma, lung adenocacinoma and squamous cell carcinoma, 
pancreatic, colorectal, prostate, and breast cancer patients. Activation of NF-kB has 
been shown to be essential for HGF-mediated proliferation and tubulogenesis in 
MLP29 liver cell line (Muller et al., 2002) and hepatic stem cells (Yao et al., 2004).  
 
1.5.2 Cell survival 
Dose-specific anti-apoptotic effects of HGF have been observed and, interestingly, 
high doses of HGF may be pro-apoptotic via a mechanism by which Met directly 
binds to and sequesters the death receptor Fas in hepatocytes. This interaction 
prevents Fas self-aggregation and Fas ligand binding, thus inhibiting Fas mediated 
apoptosis (Wang et al., 2002). c-Met activation by HGF induces tyrosine 
phosphorylation of focal adhesion kinase (p125FAK) at pY397 (autophosphorylation 
site, with binding to Src family SH2 and the p85 subunit of PI3-K) and pY861 (the 
major Src phosphorylation site) (Maulik et al., 2002a). p125FAK activation can be 
stimulated by integrin clustering as a result of integrin binding to extracellular matrix 
(ECM) ligands. Interestingly, p125FAK activation has been shown to promote cell 
proliferation, cell survival and migration. This anti-apoptotic effect would be 
important for tumor cells to survive during invasion and migration through ECM and 
distal tissues. Targets of FAK signaling implicated in the pro-survival pathways 




Under physiological conditions, the HGF-Met signaling program activates a 
coordinated biological responses resulting in ‘invasive growth’ and ‘branched 
morphogenesis’. The coordinated genetic control of the invasive program is believed 
to be essential in early embryonic development. Knock-out of either HGF or c-Met 
resulted in embryonic lethality in mice due to the severe defects in liver and placenta 
development in-utero (Birchmeier and Gherardi, 1998; Maina et al., 1996). A role of 
HGF in the nervous system development has also been suggested in these experiments, 
which have also been verified by other investigators and has been reviewed recently 
(Maina and Klein, 1999). More detailed information of developmental roles of HGF is 
reviewed in section 1.6. 
 
1.5.4 Scattering 
Scattering of adherent cells is a property of a variety of different cell types. The 
process of cell scattering can be divided into three phases, namely cell spreading, cell-
cell dissociation, and cell migration. In order for epithelial cells to ‘scatter’, the 
attenuation of cell-cell adhesions is a prerequisite. Under physiological conditions, the 
assembly and maintenance of intercellular junctions is tightly regulated. Disassembly 
of these junctions occurs during normal development as well as tumor cell 
invasion/metastasis (Weisberg et al., 1997). HGF was discovered as a secreted 
product of fibroblasts and smooth muscle cells that induced dissociation and motility 
of epithelial cells (scatter factor). HGF is able to induce cell dissociation and mutual 
repulsion in a manner similar to semaphorins (Stella and Comoglio, 1999).   
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Cytoskeleton and focal adhesion regulation is required for scattering activity. The 
cytoskeleton is composed of a network of fibrous proteins within the cytoplasm of 
eukaryotic cells that plays pivotal structural and regulatory roles in the maintenance of 
cell structure and strength, cell division, proliferation, cell motility and invasion, as 
well as signaling functions. Cytoskeletal functions are mediated by a host of 
cytoskeletal proteins, the actin filament being the most abundant one. Other accessory 
proteins include cell surface adhesion receptor integrins, focal adhesion proteins, 
adapter proteins such as Crk and CRKL, non-receptor tyrosine kinases such as PI3-K, 
and cadherin/catenin complexes (Sattler et al., 2000; Sattler and Salgia, 1998). 
Receptor tyrosine kinase-generated signals can cause modification of phosphorylation 
of key cytoskeletal regulatory and structural proteins, as seen in the catalytically 
active p125FAK, SH2-containing tensin, and the multifunctional LIM domain-
containing paxillin (Weisberg et al., 1997). The interactions of focal adhesion proteins, 
with each other and other proteins, may be altered after cellular transformation. 
Paxillin is a 68 kDa adapter protein containing several protein binding motifs for 
Srchomology2 (SH2) and SH3 domain-containing proteins such as Crk/CRKL and 
Src, five leucineand aspartate-rich (LD) domains, and four tandem-repeat double-zinc 
finger LIM domains that are employed to recruit signaling complexes to focal 
adhesions (Salgia et al., 1995; Sattler et al., 2000). Paxillin integrates adhesion- and 
growth factor-dependent signals with alterations in gene expression and actin 
reorganization. The ECM, β1- and β2-Integrin cross-linking, growth factor 
stimulation, and neuropeptide stimulation can induce tyrosine phosphorylation of 
paxillin. HGF/c-Met signaling has been shown to induce tyrosine phosphorylation of 
paxillin (Parr et al., 2001), and specifically at the tyrosine residue pY31 (the first 
CRKL bindingsite) but not pY118 or pY181 (Maulik et al., 2002a). Paxillin is known 
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to bind directly to focal adhesion kinase (p125FAK), as well as other molecules such 
as vinculin, clathrin and the tyrosine-phosphatase PEST (Turner, 2000a; Turner, 
2000b). Paxillin signaling also converges with the Rho-dependent signaling pathway 
in the regulation of cell motility. Interestingly, paxillin has recently been shown to 
bind directly with schwannomin, the NF-2 gene product, at residue 50–70 (exon 2) 
where in-frame deletions and missense mutations have been identified, in mediating 
the dominant genetic disorder Neurofibromatosis type 2 (Fernandez-Valle et al., 
2002). This interaction mediates the membrane localization of schwannomin to the 
plasma membrane, where it associates with β1-integrin and erbB2. p125FAK (focal 
adhesion kinase) is a 125 kDa protein, consisting of a N-terminus integrin-binding site, 
a central kinase domain, and a C-terminus focal adhesion targeting and paxillin-
binding domains (Schaller and Sasaki, 1997). p125FAK family members include 
proteins such as PYK2 and FAK-B. p125FAK can interact with 
integrins, paxillin, PI3-K, SH3 domain-containing adapter proteins, and other tyrosine 
kinases via an autophosphorylation site at tyrosine residue 397 (pY397). Its activation 
most likely occurs via tyrosine phosphorylation, which has been shown to be induced 
by HGF in SCLC (Maulik et al., 2002a). p125FAK was phosphorylated on pY397 
(autophosphorylation site) and pY861 (the major Src phosphorylation site) in 
response to HGF. Overexpression of p125FAK in MDCK cells enhances the cell 
migration component of the HGF-induced cell scattering. Chan et al. has reported 
synergistic effect of FAK overexpression and HGF stimulation on cellular 
transformation in MDCK cells (Chan et al., 2002). Similarly, PYK2 was 
phosphorylated on pY402 (autophosphorylation site) and pY881 (Grb2 bindingsite) in 
response to HGF (Maulik et al., 2002a). The phosphorylation of the Grb2 binding site 
on PYK2 suggests a means to differentially activate the Ras/MAP kinase pathway. 
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1.5.5 Cell motility 
Many studies have shown that HGF/c-Met signaling increases the motility of 
epithelial cells. Motility of small cell lung cancer (SCLC) cells is increased with HGF 
stimulation (Maulik et al., 2002a). Constitutively active c-Met induces the motility of 
Madin-Darby canine kidney cells (Jeffers et al., 1998). Cell motility comprises 
formation and retraction of filopodia/lamellipodia as well as uropod alteration in actin 
filament formation and cell migration (Weisberg et al., 1997). Cell motility is tightly 
controlled by the lipid kinase PI3-K and p21GTPases including Ras, Rac and Rho 
(Nobes and Hall, 1995a; Nobes and Hall, 1995b). PI3-K appears to be an important 
molecule in HGF-induced mito-, moto- and morpho-genesis, since inhibition of PI3-K 
by wortmannin leads to decreased branching formation on collagen matrix and 
chemotaxis of renal cells (Derman et al., 1995; Derman et al., 1996).  In a recent study, 
HGF was found to induce transactivation of the EGFR in epithelial cells, and this is a 
prerequisite for induction of full motility (Spix et al., 2007).  
 
1.5.6 Tumor invasion and metastasis 
The concept of tumor invasion as a result of dysregulation of cell motility has gained 
much attention in recent years. Experimental evidence suggests that tumor invasion 
can be a distinct characteristic of tumor progression. In order for primary tumor cells 
to invade a tissue boundary and metastasize, they must degrade or remodel the 
surrounding extracellular matrix (ECM), which allows the tumor cells to eventually 
migrate through the ECM tissue boundary. Positive regulation of invasion and 
proteases by HGF/c-Met signaling has been shown. Mechanisms of the regulation 
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include upregulation of urokinase-type plasminogen activator (uPA), plasminogen 
activator inhibitor-1 (PAI-1), and matrix metalloproteases (MMPs) in tumor cells 
(Besser et al., 1997; Dunsmore et al., 1996; Wojta et al., 1994). In addition, consensus 
has been growing to believe that the rate-limiting step in invasion is cell migration. 
Reorganization of cytoskeletal scaffolds in the cell contributes to motility and 
migration. Both integrins (adhesion receptors) and growth factors/cytokines can 
modulate tumor cell motility, migration and hence invasion. Activation of PLCg, 
mobilizing actin-modifying proteins, was initially described as necessary for motility 
induced by EGF, PDGF, and IGF-1 (Gilmore and Burridge, 1996). Cell motility, as 
reflected by formation of membrane ruffles and filopodia, is well regulated by small 
GTPase and PI3-K. The actin cytoskeleton needs to be very dynamic for rapid 
alterations of cell shape, adhesion and de-adhesion during cell motility and migration. 
Ras-like GTPases of the Rho family, which includes Rho, Rac, and Cdc42, can 
reorganize actin. 
 
The mechanism whereby HGF stimulation of c-Met leads to increased motility, 
migration and invasion is not well understood. c-Met signaling was first shown to be 
important in invasion when it was found that in mutant mice nullizygous for Met, 
muscles originating from dermomyotome cells that migrate to the limb, diaphragm 
and tip of the tongue fail to develop (Bladt et al., 1995). HGF/c-Met signaling is now 
known to be the main pathway mediating normal and malignant invasive growth. In 
addition, recent emerging data also point to the potential importance of other signaling 
molecules structurally related to c-Met, i.e. semaphorins and their receptors plexins. 
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With increased invasion, there is also increased metastasis seen in a variety of solid 
tumors (Maulik et al., 2002c). As an example, neoplastic cells harboring somatic 
activating mutations of c-Met, namely Y1230C and Y1235D, have been found to be 
selected, via clonal expansion, duringthe metastatic spread of head and neck 
squamous-cell carcinomas (Di Renzo et al., 2000). This is the first report providing 
evidence of a direct involvement of c-Met driving tumor cells metastasis in human 
malignancy. Moreover, a recent molecular profilingof metastatic murine squamous 
carcinoma cells by differential display and cDNA microarray revealed altered 
expression of multiple genes, notably including the RTK c-Met (up-regulated 
expression), during tumor progression (Dong et al., 2001). c-Met has been associated 
with metastatic progression in various tumors (Comoglio and Boccaccio, 2001; Jeffers 
et al., 1996). HGF/c-Met autocrine loop have been reported in various human primary 
and metastatic tumors, including breast cancer, osteosarcoma, glioblastoma and 
melanoma (Ferracini et al., 1995; Koochekpour et al., 1997; Li et al., 2001; Tuck et al., 
1996). Using Tpr/Met as the oncogenic model, Giordano et al. (Giordano et al., 1997) 
reported a point mutation H1351N, located within the signal transducer docking site 
of Met, dissociated neoplastic transformation (increased) from metastasis (abrogated), 
implying the importance of this multifunctional docking site in mediating the 
metastatic potential of the oncogene. Bardelli et al. (Bardelli et al., 1999) have 
demonstrated concomitant activation of pathways downstream of Grb2 and PI3-K is a 
requirement for Met-mediated metastasis. More recently, Saucier et al. (Saucier et al., 
2002) used Tpr/Met oncoprotein model and generated variant forms of the 
oncoprotein with ability to bind individually to the PI3-K-p85, PLCg, or to the Grb2 
or Shc adapter proteins. They found that variants that recruit the Shc or Grb2 
generated transformed fibroblast cells foci, induced anchorage-independent growth, 
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scattering and also experimental nude mice metastasis; which was not seen in cells 
expressing the PI3-K variant. This suggests that pathways downstream from Grb2 or 
Shc are sufficient for cell transformation and metastasis. cDNA microarrays analysis 
has been used to explore the transcriptional response to HGF of MLP-29 mouse 
embryo liver cells. The RGD-containing secreted matrix glycoprotein osteopontin 
(OPN) was identified as a major HGF transcriptional target, mediating HGF-induced 
invasive growth as an autocrine mediator (Medico et al., 2001). 
 
Under physiological conditions, c-Met expressed on epithelial cells is activated in a 
paracrine fashion by mesenchymally derived HGF. Yu and Merlino (Yu and Merlino, 
2002) have reported in a transgenic transplantation mice model that pulmonary 
metastasis of c-Met overexpressing tumor cells is stimulated when introduced into 
transgenic mice overexpressing either HGF or its variant NK2, and that the metastatic 
potential of the resultant heterotypic c-Met signaling was equivalent to that of the 
HGF/c-Met autocrine signaling loop. Wanget al. (Wang et al., 2001) have showed that 
overexpression of c-Met allows activation of the RTK by cell attachment/adherence in 
a ligandin dependent fashion, with tumorigenic capacity. Transgenic mice 
overexpressing c-Met in hepatocytes developed hepatocellular carcinoma (HCC). 
They further showed full regression of the hepatic tumors elicited by transgenic c-Met, 
with reconsititution of normal tissue architecture, is possible when the transgene was 
inactivated, even in the case of advanced stages of tumor progression. This study 
provides strong support for an important role of overexpression of c-Met in sustaining 
HCC in addition to its pathogenesis. More importantly, it offers convincing evidence 
that therapeutic inhibition targeting against the oncogene in c-Met overexpressing 
tumors would have very promising potential. 
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1.5.7 Angiogenesis  
Angiogenesis is defined as the formation of new blood vessels from an existing 
vascular bed (reviewed by Risau, 1997). It is a key step in physiological processes 
such as wound healing and the menstrual cycle. In contrast, multiple pathological 
conditions such as cancer, atherosclerosis, arthritis, diabetic retinopathy, and psoriasis 
are characterized by overt angiogenesis (reviewed by Griffioen and Molema, 2000). 
The fine balance between physiological and pathological angiogeneses is mediated by 
the interplay of multiple endogenous angiogenic and antiangiogenic modulators. 
 
Numerous in vitro studies have shown that c-Met receptors are also expressed by 
cultured vascular endothelial cells (Bussolino et al., 1992; Ding et al., 2003; 
Nakamura et al., 1995). SF/HGF is expressed and secreted by vascular smooth muscle 
cells, pericytes, and fibroblasts (Hayashi et al., 1996; Martin et al., 1999; Rosen et al., 
1990) to activate endothelial c-Met receptors in a paracrine fashion. Conditioned 
media from these cells activate c-Met and lead to functional changes in co-incubated 
vascular endothelial cells. One report also described SF/HGF expression in vascular 
endothelial cells, raising the possibility of autocrine stimulation of endothelial c-Met 
receptors (Nakamura et al., 1995).  
 
Angiogenic property of HGF has been first implicated by Bussolino et al: they 
showed that HGF induces repairs of a wound in endothelial cell monolayer, stimulates 
the scatter of endothelial cells grown on three-dimensional collagen gels, inducing an 
elongated phenotype; in the rabbit cornea, highly purified HGF promotes 
neovascularization at sub-nanomolar concentrations (Bussolino et al., 1992). Using 
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two different in vivo assays, Grant et al. showed that physiologic quantities of purified 
native mouse SF/HGF and recombinant human SF/HGF induce in vivo angiogenesis. 
The angiogenic activity was blocked by specific anti-SF/HGF antibodies (Grant et al., 
1993). Lamszus K et al demonstrated that HGF/SF conferred a growth advantage to 
human breast cancer xenotransplants, linked with a higher microvessel density 
(Lamszus et al., 1997). HGF/SF was also shown to be an angiogenic factor in 
proliferative diabetic retinopathy (Grierson et al., 2000) and in rheumatoid and osteo 
arthritis (Nagashima et al., 2001). Kuba et al. showed that inhibiting SF/HGF leads to 
a dramatic decrease in microvessel density in mammary carcinoma xenografts (Kuba 
et al., 2000). 
 
SF/HGF is a potent motility factor for vascular endothelial cells. Recombinant 
SF/HGF stimulates the chemotactic migration of neuromicrovascular endothelial cells 
(Lamszus et al., 1998). Fibroblasts have been shown to induce the migration of human 
large-vessel endothelial cells in an SF/HGF-dependent manner (Martin et al., 1999). 
SF/HGF also increases the dissociation and migration of human umbilical vascular 
endothelial cells (HUVECs). Such action of HGF/SF on HUVECs was achieved by 
regulation of the endothelial cell-specific cadherin, vascular endothelial (VE)-
cadherin (Martin et al., 2001). SF/HGF-induction of endothelial cell migration in 
endothelial cells derived from the human saphenous vein is mediated by iNOS, a 
well-described endothelial cell motility factor (Purdie et al., 2002). 
 
SF/HGF strongly induces DNA synthesis and proliferation in vascular endothelial 
cells of various origins, including neuromicrovascular endothelial cells and human 
aortic endothelial cells (Hayashi et al., 1996; Lamszus et al., 1998; Nakagami et al., 
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2001). Recombinant HGF/SF as well as conditioned media from vascular smooth 
muscle cells stimulates vascular endothelial cells to grow in an SF/HGF-dependent 
manner. HGF/SF stimulates cell proliferation through the ERK-STAT3 pathway 
(Nakagami et al., 2001). In addition to its proliferative effects, SF/HGF also enhances 
endothelial cell survival and apoptosis resistance. HGF had an anti-apoptotic action 
through the PI3K-Akt pathway in human aortic endothelial cells (Nakagami et al., 
2001). HGF/SF-induced survival of human umbilical endothelial cells is mediated by 
MAPK/ERK and AKT (Ma H et al., 2002). SF/HGF prevents human aortic 
endothelial cell death induced by hypoxia in a Bcl-2, but not a Bcl-xL or Bax 
dependent fashion (Yamamoto et al., 2001). Hepatocyte growth factor prevents 
endothelial cell death under high D-glucose conditions through inhibition of bax 
translocation from cytosol to mitochondrial membrane (Nakagami et al., 2002). 
Protection of hypoxia-induced apoptosis in mouse lung endothelial cells was 
associated with inhibition of p38 MAPK and Bid/Bax as well as increased expression 
of Bcl-xL (Wang et al., 2004). 
 
SF/HGF can also affect angiogenesis by regulating the expression levels of other 
well-known proangiogenic and anti-angiogenic factors such as vascular endothelial 
growth factor (VEGF) and thrombospondin 1. SF/HGF has been shown to induce 
VEGF mRNA and protein expression in normal and neoplastic cells (Moriyama et al., 
1998; Wojta et al., 1999). SF/HGF was also found to induce the expression of the 
VEGF receptor flk-1 in an endothelial cell line (Wojta et al., 1999). Induction of 
VEGF by SF/HGF was shown to be mediated by MAPK, PI3K, PKC-zeta and 
phosphorylation of Sp1, a regulator of the VEGF promoter (Reisinger et al., 2003; 
Zhang et al., 2003). 
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In another human endothelial cell line, VEGF induction by SF/HGF was dependent on 
the upregulation of essential transcription factor ets-1 (Tomita et al., 2003). Hashiya N 
et al. demonstrated that ets-1 regulated angiogenesis through the induction of 
angiogenic growth factors (VEGF and HGF) (Hashiya et al., 2004). The contribution 
of VEGF to SF/HGF-induced angiogenesis was found to be either additive or 
synergistic, depending on the cells/tissues examined. For instance, SF/HGF and 
VEGF had additive effects on HUVEC proliferation and synergistic effects on 
HUVEC migration (Van et al., 1998). In other studies, SF/HGF was found to act in 
concert with VEGF to promote human vascular endothelial cell survival and 
tubulogenesis in 3-D type I collagen gels, a response that did not occur with either 
growth factor alone. The synergistic effects of combining VEGF and SF/HGF on 
endothelial survival correlated with the greatly augmented expression of the anti-
apoptotic genes Bcl-2 and A1 (Xin et al., 2001). HGF/SF and VEGF have also been 
shown to promote angiogenesis in a co-culture assay by inducing distinguishable 
patterns of vascular structures. VEGF increases the length, area and branch point 
number of induced vessels whereas HGF mediates exclusively vascular area growth 
resulting in vascular structures of enlarged diameter. Moreover, the combination of 
both cytokines results in an additive increase of vascular diameter (Beilmann et al., 
2004). Consistent with these findings, the genes significantly up- and down-regulated 
by VEGF versus HGF in endothelial cells exhibit very little overlap, indicating 
distinct signal transduction (Gerritsen et al., 2003). These data show that the 
combination of SF/HGF and VEGF results in the cooperative up-regulation of a 
number of different molecular pathways, leading to a more robust proliferative and 
angiogenic response. In addition to up-regulating VEGF, SF/HGF was shown to 
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simultaneously downregulate the expression of thrombospondin 1, a negative 
regulator of angiogenesis (Zhang et al., 2003). Besides its cooperation with VEGF, 
HGF/SF can induce angiogenesis independently of VEGF (Sengupta et al., 2003). 
27 
 
1.6 Developmental roles of HGF and c-met 
 
1.6.1 Nervous system development 
Possible functions of HGF/SF in the development of the nervous system were first 
suggested by Claudio Stern and colleagues in 1990, who observed that ectopic 
application of HGF/SF to the early chick embryo can generate local supernumerary 
axial structures resembling primitive streak and/or neural plate (Stern et al., 1990). 
Inductive interactions during development are governed not only by the properties of 
the inducing cells, but also largely by the responsive capacity, or competence, of the 
tissue receiving the inducing signals (reviewed by Gurdon, 1987). The epiblast of the 
chick embryo loses its capacity to respond to neural induction by the organizer 
(Hensen's node) between stages 4 and 4+. At the primitive streak stage, HGF/SF is 
expressed specifically in Hensen's node (Streit et al., 1995). After implanting HGF/SF 
secreting cells, the competence to respond to Hensen's node grafts is retained by 
checking the glycoprotein L5-220, a marker for competent cells (Streit et al., 1997). 
Therefore HGF/SF plays a role in maintaining the competence of the epiblast to 
respond to neural inducing signals during the early steps of neural induction. 
Both HGF/SF and c-Met are expressed in the developing nervous system, supporting 
the view that they function in neuronal development. In accordance with this, various 
types of glial cells and neurons respond to HGF/SF in vitro. HGF/SF stimulates 
Schwann cell growth (Krasnoselsky et al., 1994), promotes axon outgrowth of P19 
embryonal carcinoma cells (Yang and Park, 1993), enhances neurite outgrowth in 
neocortical explants (Hamanoue et al., 1996) and promotes the proliferation of 
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neurospheres and neuronal differentiation of neural stem cells (Kato et al., 2004; 
Kokuzawa et al., 2003) . The various effects of sensory neurons are only observed in 
the presence of an additional neural growth factor, NGF, which synergizes with 
HGF/SF in culture (Maina et al., 1997). The level of Met expression in these neurons 
(as in sympathetic neurons) is, however, very low; the protein can be detected using 
anti-Met antibody staining, but the level of Met mRNA is almost undetectable by in 
situ hybridization. This low level of Met expression might explain why HGF cannot 
act alone in these cells but can only potentiate the effects of NGF, whereas in other 
cell types it is able to induce biological responses by itself. The motogenic activity, 
the stimulation of undirected cell movement away from their original position, of 
HGF/SF has been proved in neuron system with the evidence that HGF/SF is a key 
molecular constituent in guiding interneuron migration from the ganglionic eminence 
to the cerebral cortex (Powell et al., 2001). 
Migrating motor axons are guided to their target muscles by both repellent and 
attractant chemotropic factors. For instance, the mesenchyme and the sclerotome, but 
not the dermamyotome, induce axonal outgrowth from spinal cord cultures. In a 
search for diffusible guidance factors for developing spinal motor axons, HGF was 
found to be a limb-mesenchyme-derived chemoattractant (Ebens et al., 1996). 
Furthermore, c-met and HGF/SF genes are expressed in patterns that are consistent 
with a role in axon guidance of motor neurons – that is, HGF/SF in limb bud 
mesenchyme and c-met in a subpopulation of motor neurons that are more abundant 
in limb-innervating than in trunk-innervating segments (Ebens et al., 1996; 
Yamamoto et al., 1997). In addition to its role as a chemoattractant, HGF can also 
induce the survival of a subpopulation of motor neurons during development. In 
cultures of purified embryonic rat motor neurons, HGF promotes short-term survival, 
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with an efficiency comparable to that of other neurotrophic factors such as brain-
derived neurotrophic factor (BDNF) and ciliary neurotrophic factor (CNTF) (Ebens et 
al., 1996; Wong et al., 1997; Yamamoto et al., 1997). Consistent with the pattern of 
Met expression in vivo, motor neurons from limb-innervating brachial segments show 
a more potent survival response to HGF than do thoracic motor neurons (Yamamoto 
et al., 1997). Treatment of embryos with exogenous HGF/SF rescues lumbar but not 
other somatic motor neurons from cell death (Novak et al., 2000). Thus HGF secreted 
by limb mesenchyme could selectively support the survival of motor neurons in the 
limb-innervating segment. HGF and CNTF seem to act in synergy, because a 
combination of the two factors can rescue neurons that are not rescued by saturating 
concentrations of either factor alone (Wong et al., 1997). Motor neurons in the spinal 
cord are grouped into motor pools, each of which innervates a single muscle. 
Transcription factor PEA3 is a marker of a few such motor pools. Signaling by Met, 
the HGF receptor, is required for the rostral expansion of the pea3 domain, while the 
onset of pea3 expression is independent of met function. met expression is observed in 




1.6.2 Muscle and limb development 
Another of the interesting developmental functions of c-Met and HGF/SF is a decisive 
role in the generation of skeletal muscle that derives from long-range migrating 
precursor cells. Migrating muscle precursor cells emigrate from the dermomyotome, 
an epithelial structure that develops from somites, and finally generate a subset of the 
hypaxial muscle groups. These long-range migrating cells are already destined to 
form skeletal muscle, even though lack of expression of myogenic determination 
factors such as myogenin or MyoD. These factors are expressed only after the 
migrating cells reach their final targets. Migrating precursors are generated from the 
dermomyotome of specific somite only, i.e. occipitally, cervically, and on the levels 
of the fore and hind limbs. They express the homeobox gene Lbx1, which provides a 
useful marker for their visualization. In mice, migrating precursor cells give rise to 
muscles of the extremities, the hypoglossal chord, and the diaphragm. 
 
Prerequisite of the migration of muscle precursor cells into the limb buds is the 
delamination of cells. It has been shown that de-epithelialization and subsequent 
migration of dermomyotomal cells can be induced ectopically by grafting of proximal 
limb bud mesoderm to the flank level (Hayashi and Ozawa, 1995). The underlying 
molecular mechanism is an interaction between the transmembrane tyrosine kinase 
receptor c-met expressed by the dermomyotome cells and its ligand scatter 
factor/hepatocyte growth factor (SF/HGF) that is produced by somatopleural cells of 
the limb buds. In mice carrying met null mutations myogenic precursor cells fail to 
migrate, preventing the normal development of limb and body wall muscle, whereas 
axial muscle is unaffected (Bladt et al., 1995). Migrating myogenic progenitors are 
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generated from the dermomyotome by an epithelial–mesenchymal transition. The 
migrating cells cannot be observed in HGF/SF- or c-met-null mutant mouse embryos, 
conversely, an ectopic application of exogenous SF/HGF leads to de-epithelialization 
of the dermomyotomal edges even at interlimb level and emigration of 
dermomyotomal cells (Bladt et al., 1995; Brand-Saberi et al., 1996; Heymann et al., 
1996). Thus, HGF/SF and c-met seem to regulate the detachment and emigration of 
myogenic precursor cells from the dermomyotome in vivo, resembling the cellular 
response that leads to the identification of HGF/SF as ‘scatter factor’ in cell culture 
(Stoker et al., 1987). Since migrating precursors are generated on particular axial 
levels only, the tight spatio-temporal control of the emigration might be regulated by 
restricted expression of HGF/SF, although additional signals could participate. 
 
The important role of tightly regulated HGF/SF expression for the ordered 
development of skeletal muscle also became apparent from the analysis of transgenic 
mice that over expresses HGF/SF under the control of the metallothionein promoter 
(Takayama et al., 1996). In these embryos, ectopic expression of HGF/SF in the 
adjacent neural tube induces inappropriate formation of skeletal muscle in the central 
neural system (CNS), supporting the notion that in normal development HGF/SF 
plays an important role in regulating migration of Met-containg myogenic precursor 
cells. The vertebrate neural crest is another migratory cell population that are able to 
give rise to a wide variety of derivatives. Interestingly, melanocyte precursors, one 
neural crest derivative, are also found within such transgenic adult in a number of 
abnormal ectopic sites, including the CNS. Moreover, melanocytes are produced in 
excess, indicating that not only migration but also growth and/or survival of the cells 
are affected (Takayama et al., 1996). 
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Gene targetting of either HGF or c-met results in the absence of muscle in the limbs. 
The resulting phenotype of c-met and HGF/SF knockout mice resembles the 
phenotype of a naturally occurring mutation in the Pax3 gene called splotch (Bober et 
al., 1994; Franz et al., 1993). Pax-3 and c-met show similar expression patterns in the 
early development of the myogenic compartment – both genes are expressed in 
migrating myogenic precursor cells and in the ventral dermomyotome, where 
migratory cells are located prior to emigration (Bladt et al., 1995; Yang et al., 1996). 
Pax-3 has been shown to regulate the expression of c-met (Daston et al., 1996; 
Epstein et al., 1996; Tajbakhsh et al., 1997; Yang et al., 1996). Consistent with this, c-
met promoter contains a Pax3 binding site, and Pax3 can drive reporter gene 
expression from the c-met promoter in vitro (Daston et al., 1996; Epstein et al., 1996; 
Yang et al., 1996). Therefore, it can be concluded that Pax3 controls the release of 
migrating muscle precursors in vivo by activating c-met. It should be noted, however, 
that the Pax-3 mutation causes severe additional changes in the dermomyotome, 
suggesting that Pax-3 also controls other genes important in dermomyotome 
development (Daston et al., 1996). 
 
Skeletal muscle development involves several waves of myofibre formation. In the 
mouse, primary fibres form from myoblasts at around embryonic day 13 (E13), 
secondary fibres start to form on E16 in the same basal lamina, and, in the adult, 
fibres can be regenerated from stem cells of the adult muscle, the satellite cells. The c-
Met receptor might not only function in formation of migratory myogenic precursor 
cells that generate hypaxial muscle groups but also in subsequent stages of the 
development of all skeletal muscle. Targeted disruption of either the hgf or the met 
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locus in mice confirmed the importance of HGF signaling in development; mice 
lacking either HGF or its receptor die during embryogenesis, with defects in placenta, 
liver and muscle (Bladt et al., 1995; Schmidt et al., 1995; Uehara et al., 1995). This 
early lethality has made it difficult to study the role of HGF in later stages of 
development. Rescue of the placental defect by aggregation of tetraploid (wild type) 
and diploid (c-Met-/-) morulae allows development of c-Met mutant animals to term. 
They lack muscle groups that derive from migratory precursor cells, but display 
otherwise normal skeletal musculature (Dietrich et al., 1999). Taking the advantage of 
zebrafish model, loss-of-function experiments reveal that Met and its ligand, 
hepatocyte growth factor, are required for the correct morphogenesis of the hypaxial 
muscles in which met is expressed (Haines et al., 2004). In another study, the 
placental defect was bypassed by replacing the endogenous met gene with a signaling 
mutant of met, thereby revealing a requirement for Met in late myogenesis for 
secondary muscle fiber formation (Maina et al., 1996). Finally, satellite cells respond 
to HGF/SF in cell culture with increased proliferation and delayed differentiation 
(Allen et al., 1995; Anastasi et al., 1997). Taken together, these results indicate that 
HGF/SF and c-Met might play independent roles in skeletal muscle development, that 
is in generation of hypaxial skeletal muscle that derives from migrating precursor 
cells and in formation of secondary fibres. It is possible that HGF/SF and c-Met also 
participate in fibre regeneration in the adult organism, but this has not been 
established in vivo. 
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1.6.3 Tubulogenesis and angiogenesis 
 
Epithelial tubulogenesis, the organization of epithelial cells into tubular structures, 
forms the basis for the intricate organization of functional units of parenchymal 
organs. Tubules can arise in vertebrates through two main mechanisms: the 
invagination of cells from an epithelial sheet, as occurs in the formation of the neural 
tube or through the organization of initially unpolarized cells into cord-like structures 
that invade the surrounding mesenchyme, forming branched hollow tubules lined by 
polarized cells (reviewed by Hogan and Kolodziej, 2002). The latter mechanism is 
involved in the formation of organs such as the mammary gland and pancreas and 
during angiogenesis. HGF/SF plays an important role in the development of tubular 
organs through this mechanism. 
 
HGF/SF was found to stimulate epithelial cells derived from a variety of different 
organs to form tubule-like extensions when seeded in three-dimensional matrices (so-
called ‘branching morphogenesis’) (Brinkmann et al., 1995; Montesano et al., 1991; 
Weidner et al., 1993). During this HGF/SF induced tubulogenesis, cell-cell adhesive 
contacts are differentially regulated while the polarity and specialization of plasma 
membrane subdomains reorganize, enabling cells to remain in contact as they 
rearrange into new structures (Pollack et al., 1998). 
 
In vivo, HGF/SF stimulates tubulogenesis in the adult liver and kidney during organ 
regeneration after partial hepatectomy or kidney damage, respectively (Bell et al., 
1999; Kawaida et al., 1994). Additionally, anti-HGF/SF antibodies perturbed 
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branching morphogenesis of the ureteric bud in organ cultures (Woolf et al., 1995). In 
the developing kidney, HGF/SF was expressed in the mesenchyme, while met was 
expressed in both the ureteric bud and the mesenchyme (Woolf et al., 1995). 
Interestingly, a renal serine protease HGF/SF activator (HGFA), which cleaves and 
therefore activates the HGF/SF zymogen, is expressed around the tips of the invading 
ureteric bud, suggesting a gradient of HGF activity created by HGFA in the 
developing kidney (van et al., 2001). Inhibition of HGFA activity reduced ureteric 
bud branching, an effect that can be rescued by active HGF/SF (van et al., 2001). 
 
In the mammary gland, elevated expression of endogenous Met and HGF/SF 
correlates with stages of active tubulogenesis, expression being high through early 
pregnancy but virtually absent during late pregnancy and lactation when 
alveologenesis and gland differentiation take place (Yang et al., 1995). Indeed, 
overexpression of HGF/SF in reconstituted mouse mammary glands in vivo induces 
hyperplastic branching morphogenesis (Yant et al., 1998), and specific antisense HGF 
oligonucleotides prevent branching morphogenesis in whole mammary gland cultures 
(Yang et al., 1995). 
 
Two phosphorylated tyrosine residues (Y1349 and Y1356) located at the C-terminal 
end of the Met β chain, together with the surrounding amino acids, constitute a unique 
multisubstrate docking site which is both necessary and sufficient to mediate Met 
signal transduction and biological functions, including tubulogenesis (Ponzetto et al., 
1994; Sachs et al., 1996). Signaling mediators recruited to Met include enzymes such 
as Src tyrosine kinase and phosphoinositide 3-kinase (PI3K), as well as several 
adaptor proteins such as Grb2, Gab1, Shc and c-Cbl. Gab1 associates with Met both 
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by direct binding to the docking site on Met and through association with Grb2 (Lock 
et al., 2002; Nguyen et al., 1997). Expression of Gab1 in epithelial cells is sufficient 
to induce the c-Met-specific activities, including branching morphogenesis (Weidner 
et al., 1996). Met receptor mutants with impaired ability to bind to Gab1 fail to induce 
branching morphogenesis, which can be rescued by overexpression of Gab1 (Nguyen 
et al., 1997; Schaeper et al., 2000). Association of Gab1 with SHP2, but not PI3K, 
CrkL, or Shc was essential to induce branching morphogenesis (Maroun et al., 2000; 
Schaeper et al., 2000). SHP2 regulates the kinetics of activation of at least two 
pathways that are required for branching morphogenesis: the PI3K and MAP kinase 
pathways. PI3K is critical for c-met-mediated tubulogenesis and cellular motility 
(Derman et al., 1995; Royal and Park, 1995). Activated PI3K causes branching tubule 
formation similar to that seen with HGF/SF treatment (Khwaja et al., 1998). The PI3K 
pathway might also be important for the stimulation of anchorage-independent growth 
and cytoskeletal reorganization during tubulogenesis (Potempa and Ridley, 1998; 
Royal and Park, 1995). The duration of Met signaling and of ERK MAP kinase 
activation has been shown to determine biological outcome: sustained activation of 
ERK is required for branching morphogenesis (Boccaccio et al., 2002; Maroun et al., 
2000). Different from other Gab family members, Gab1 can bind directly to Met 
through sequences unique to Gab1 (reviewed by Gu and Neel, 2003) which may result 
in a more stable interaction with Met and thus prolonged Gab1 phosphorylation. This 
prolonged Gab1 phosphorylation, which correlates with sustained activation of the 
ERK mitogen-activated protein (MAP) kinase and protein kinase B (PKB)/Akt 
pathways, is required for HGF-induced branching tubulogenesis but not for cellular 
motility (Gual et al., 2000). While activation of ERK is necessary and sufficient for 
the initial stage of tubulogenesis, during which cells depolarize and migrate, ERK 
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becomes dispensable for the latter stage, during which cells repolarize and 
differentiate; conversely, the activity of matrix metalloproteases (MMPs) is essential 
for the late stage but not the initial stage (O'Brien et al., 2004). 
 
During HGF/SF-stimulated branching morphogenesis, cell polarity is transiently lost 
and subsequently regained and cells move without losing cell–cell contact (Pollack et 
al., 1998). Similarly HGF can induce certain cell lines to move as coherent cell sheets 
(Nabeshima et al., 1998). Thus, careful regulation of adherens junction structure is 
thus required. During HGF/SF-stimulated branching morphogenesis, components of 
cell-cell junctional complexes undergo profound rearrangements: E-cadherin is 
randomly distributed around the cell surface, desmoplakins I/II accumulate 
intracellularly, and the tight junction protein ZO-1 remains localized at sites of cell-
cell contact (Pollack et al., 1998). HGF/SF stimulation leads to the selective 
upregulation of both ECM proteins and integrin molecules (Chiu et al., 2002). 
Inhibition of integrin α2 function or of fibronectin expression blocks HGF/SF-
stimulated branching morphogenesis in MDCK cells (Jiang et al., 2000a; Saelman et 
al., 1995). A similar requirement for integrin β1 has been reported for both in vivo 
mammary duct formation and in vitro HGF/SF-stimulated branching morphogenesis 




During organogenesis, epithelial-mesenchymal interactions play crucial roles in cell 
fate determination (or specification), growth, migration, survival, and morphogenesis. 
Epithelial cells form complex branched tubular structures during development of a 
variety of organs, including kidney, mammary gland, lung, salivary gland, and liver. 
In tissue explant experiments, it has been demonstrated that these morphogenic 
processes depend on mesenchymal factors (Grobstein, 1967; Saxen and Sariola, 1987), 
and identification of external signaling molecules exchanged between epithelium and 
mesenchyme hold much interest. 
 
During murine development, the c-Met/HGF receptor gene is expressed in epithelia, 
while the HGF gene in mesenchymal cells in close vicinity in various organs such as 
the kidney, lung, pancreas, liver, intestine, stomach, salivary gland, limb bud, tooth, 
etc (Defrances et al., 1992; Noji et al., 1990; Sonnenberg et al., 1993; Tabata et al., 
1996). These expression patterns indicate that HGF is a mesenchymal-derived factor 
which predominantly acts on neighboring developing epithelia, and in these 
developing organs, mesenchymal factors are involved in growth and morphogenesis 
of epithelia. During epithelial development, one particular function of HGF is in 
duction of epithelial morphogenesis. HGF induces branching tubulogenesis in vitro in 
several types of cells originating from distinct epithelial tissues, including renal 
tubules, mammary gland, and hepatic epithelium (Johnson et al., 1993; Montesano et 




Essential roles of HGF in the organogenesis were defined by targeted distruption of 
HGF or its receptor c-met (Bladt et al., 1995; Maina et al., 1996; Schmidt et al., 1995; 
Uehara et al., 1995). These knockout mice are embryonic lethal due to impaired 
organogensis of the liver and placenta. The embryonic liver is reduced in size and 
shows extensive loss of hepatocytes, due to apoptotic cell death (Schmidt et al., 1995). 
In the placenta, the number of labyrinthine trophoblasts is markedly reduced (Schmidt 
et al., 1995; Uehara et al., 1995). Role of HGF for liver development is highly 
conserved from amphibian to mammalian species (Aoki et al., 1997). When tyrosine 
kinase-negative Met mRNA was microinjected into two-cell to eight-cell stages 
Xenopus embryos, liver development was mostly impaired and structures of 
pronephros and the gut were grossly underdeveloped in the restricted, late stage of 
development (Aoki et al., 1997) 
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1.6.5 Hematopoiesis and Lymphopoiesis 
Hematopoiesis 
Several elements of HGF’s biology provide clues to suggest that it may be an 
important player in the hematopoietic system. First, the receptor for HGF/SF is c-Met, 
a prototypic receptor tyrosine kinase that is structurally similar to c-kit and FLT3/Flk2, 
receptor tyrosine kinases with vital roles in hematopoiesis. Second, HGF/SF is 
produced by marrow stromal cells and some hematopoietic cell lines, and c-Met is 
expressed by hematopoietic progenitor cells and bone marrow stromal cells (Matsuda-
Hashii et al., 2004). Indeed, HGF signaling on marrow stroma has been reported to 
provide important trophic effects and to induce secretion of IL-11, SDF-1, and SCF 
(Matsuda-Hashii et al., 2004). Third, HGF/SF is structurally similar to plasminogen, 
although it has a mutated serine protease domain that prevents it from exerting 
proteolytic activity. Fourth, functional studies have consistently demonstrated that 
HGF/SF can induce proliferation of early hematopoietic progenitors (Zarnegar and 
Michalopoulos, 1995), although its effects are consistently augmented by coculture 
with other cytokines. For instance, HGF/SF synergizes with IL-3 or GM-CSF for 
expansion of myeloid cell lines and normal hematopoietic progenitors (Kmiecik et al., 
1992; Nishino et al., 1995; Weimar et al., 1998). 
 
The first clue indicating that HGF may be involved in hematopoiesis came from 
studies on progenitor-enriched murine bone marrow cells and on several murine 
myeloid progenitor tumor cell lines blocked in the early stages of myeloid 
differentiation. Such investigations revealed, first, that these cells express c-met, and 
second, that HGF synergizes with IL-3 or GM-CSF to support the growth of these 
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cells in culture (Kmiecik et al., 1992; Mizuno et al., 1993). Conflicting results, 
however, were obtained by these two investigations with regard to whether HGF 
alone stimulates mitogenesis in myeloid progenitor cell lines. Although HGF 
synergized with other factors to stimulate growth of progenitor cells, it apparently did 
not influence the pattern of myeloid differentiation since the ratio of macrophages to 
granulocytes in resultant colonies remained similar to those obtained with IL-3 or 
GM-CSF alone (Kmiecik et al., 1992). Later in 1994, Galimi et al. reported that the 
HGF receptor is present in a small fraction of highly-enriched hematopoietic 
progenitor cells from human bone marrow and peripheral blood, and further showed 
that, in the presence of erythropoietin, HGF induces the formation of erythroid lineage 
colonies when cultured in vitro. However, in the presence of erythropoietin and stem 
cell factor, it was demonstrated that HGF supported the growth of multipotent 
colonies (granulocyte-erythroid-megakaryocyte) rather than recruiting erythroid 
precursors (Galimi et al., 1994). HGF is constitutively produced by BM stromal cells 
and it enhances hematopoiesis, probably through an autocrine mechanism (Takai et al., 
1997). 
 
In Xenopus, strong signals of HGF as well as c-met are detected early in the 
developing ventral mesoderm, which later gives rise to the ventral blood island 
(Koibuchi et al., 2004). In all vertebrate development, blood cell formation occurs in 
two successive waves, which are termed primitive and definitive hematopoiesis, based 
on the time of initiation, site of development, cell morphology, globin content, and 
potential to differentiate (Zon, 1995). Primitive hematopoiesis occurs first and gives 
rise to predominantly erythrocytes (primitive red blood cells). This phenomenon is 
then followed by definitive hematopoiesis, which leads to the production of all the 
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blood lineages that are required throughout the life span of a vertebrate. Blocking of 
HGF signaling pathway in Xenopus embryos resulted in a marked decrease in the 
number of circulating blood cells and a significant reduction (or absence) of stem cell 
leukemia (SCL), α-globin, and GATA-1 expression, but not GATA-2 expression, in 
the ventral blood island (VBI) where primitive red blood cells are exclusively 
produced. In contrast, no significant difference was observed in the levels of 
expression of early definitive blood markers, SCL, GATA-2, and GATA-3 in the 
dorsolateral plate (DLP) where definitive blood cells arise predominantly (Koibuchi et 
al., 2004). This study demonstrated that HGF is a specific regulator of primitive 
hematopoiesis rather than definitive hematopoiesis, which is different from mouse 




HGF has been reported to regulate hematopoiesis in mouse fetal liver and adult bone 
marrow, where it apparently can substitute for the stem cell factor (SCF) and c-kit 
system (Nishino et al., 1995; Yu et al., 1998). However, its role in the regulation of 
lymphopoiesis has not been well characterized. c-met is predominantly expressed on 
CD38(+)CD77(+) tonsillar B cells while HGF/SF is produced at high levels by 
tonsillar stromal cells thus providing signals for the regulation of adhesion and 
migration within the lymphoid microenvironment. Stimulation of c-Met lead to 
enhanced integrin-mediated adhesion of B cells to both VCAM-1 and fibronectin (van, 
V et al., 1997). Another study showed that c-Met is expressed in the thymus during 
early ontogeny, and that c-Met/HGF signals can promote T-cell development (Tamura 
et al., 1998). 
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Interleukin-7 (IL-7), originally described as a pre-B cell growth factor, is a 
nonredundant cytokine that has diverse effects on the hematopoietic and immunologic 
systems (Komschlies et al., 1995; Namen et al., 1988b; Namen et al., 1988a). In 1998, 
Lai and coworkers identified an IL-7–associated molecular complex that primed 
differentiating B cells for subsequent proliferation to IL-7 alone (Lai et al., 1998; 
McKenna et al., 1998). They named the molecule pre–pro–B cell growth stimulating 
factor (PPBSF) and reported that it was a self-assembling heterodimer that could be 
generated by adding IL-7 to stromal cell-conditioned media from IL-7-/- mice. 
Subsequently, this group discovered that the molecule that partnered with IL-7 in 
PPBSF was a variant β chain of HGF. Remarkably, this resulted from postsecretion 
processing, wherein the presence of heparin sulfate-derived oligosaccharides in the 
microenvironment induced IL-7–HGFβ pairing into a bioactive heterodimer (Lai and 
Goldschneider, 2001). 
 
Because full characterization of this novel hybrid cytokine could not be performed 
with the small amounts generated naturally, Lai and colleagues produced a 
recombinant version of the hybrid cytokine by fusing a signal sequence with IL-7 
combined by a linker to HGF β chain (Lai et al., 2006). The resulting single-chain 
molecule shows potent and unique activity on primitive hematopoietic cells and 
developing B-cell subsets. Mechanistically, the data suggest that the hybrid cytokine 
signals through both the high-affinity IL-7R and c-Met and that the pairing of the 
chains leads to IL-7R and c-Met aggregation and capping on the surface of stimulated 
cells. This work provides a novel insight into yet another mechanism by which 
cytokines can mediate specificity in vivo. In this case, postsecretion processing leads 
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to selective pairing of genetically unrelated molecules, rendering the resultant signal 
distinct and greater than the sum of its parts. 
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1.7 Zebrafish as a model organism in developmental biology 
One of the most promising experimental models for study of developmental biology 
emerged in recent years is the zebrafish (Danio rerio), a small tropical freshwater 
teleost fish. A combination of various features makes zebrafish a versatile model 
organism in vertebrate genetics and developmental biology. The zebrafish offers 
several distinct advantages for genetic and embryological studies including the 
external fertilization, rapid development and optical clarity of its embryos. 
 
The versatility of the zebrafish as a model for developmental biology is particularly 
apparent due to the array of cellular, molecular and genetic techniques available. It is 
technically easy to introduce DNA into zebrafish embryos using various methods like 
microinjection, electroporation and microprojectiles. Microinjection, in particular, is 
the most popular method due to the transparency and easy manipulation of the 
embryos. Creation of various transgenic lines of the zebrafish carrying the green 
fluorescent protein (GFP) gene or/and red fluorescent protein (RFP) under the control 
of various promoters have been extremely helpful in various studies including cell 
lineage tracing experiments, promoter studies and tissue-specific transgene expression 
(reviewed by Gong et al., 2001; Wan et al., 2002).  
 
Besides gain-of-function analyses by transgenic approaches, loss-of-function analyses 
are also important to fully determine the function of a gene in vivo. The powerful 
reverse genetics approach, gene knock-out used in transgenic mice, is lacking in 
zebrafish. The advent of translation-blocking or splicing-interfering morpholino 
oligonucleotides has led to a method of sequence specific gene inactivation or 
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modification in zebrafish (Ekker and Larson, 2001; Nasevicius and Ekker, 2000) thus 
improving the prospects of a comprehensive large-scale and genome-wide gene 
analysis in the zebrafish. Morpholinos have been shown to effectively and specifically 
induce phenotypes similar to that of induced loss-of-function of genes (Nasevicius 
and Ekker, 2000).  
 
The availability of large repertoire of mutagenesis tools, breeding strategies and 
screening methods (Malicki et al., 2002) helped to establish the zebrafish as a 
vertebrate of choice for random, genome-wide, large-scale mutagenesis of genes 
crucial for development (Driever et al., 1996; Haffter et al., 1996; Malicki et al., 2002; 
Schulte-Merker, 2000; Talbot and Hopkins, 2000). Today a large number of zebrafish 
mutants affecting early development and organogenesis, generated by various 
mutagenesis techniques are available (Chen et al., 2002; Driever et al., 1996; Golling 
et al., 2002; Haffter et al., 1996; Knapik, 2000; Schulte-Merker, 2000). A variant of a 
reverse genetic screen, large-scale whole mount in situ hybridization screens are 
feasible in the zebrafish owning to the transparency of the embryos.  
 
The efficient identification of genes disrupted by mutation in zebrafish requires dense 
maps of the genome. This has been possible because of the availability of large-insert 
genomic libraries (Amemiya et al., 1999; Zhong et al., 1998) and several genetic 
linkage maps, which essentially cover the entire zebrafish genome (Gates et al., 1999; 
Kelly et al., 2000; Postlethwait et al., 1998; Talbot and Hopkins, 2000; Woods et al., 
2000). Radiation hybrid (RH) maps with markers, which include simple sequence 
length polymorphisms (SSLPs), cloned genes and ESTs, have been developed for 
zebrafish (Geisler et al., 1999; Hukriede et al., 2001; Hukriede et al., 1999; Kwok et 
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al., 1998). The two zebrafish RH maps, Ekker LN54 and Goodfellow T51, together 
cover >90% of the zebrafish genome (Talbot and Hopkins, 2000). Efforts were also 
initiated to obtain the complete sequence of the zebrafish genome, and the draft 
sequence has been released in mid 2003. To cope with the phenomenal rate of 
increase of information, Zebrafish Information Network (ZFIN) (http://zfin.org) was 
established. This is a centralized database for zebrafish researchers, providing links 
and information about zebrafish genes, mutations, genetic maps etc. (Westerfield et al., 
1999a; Westerfield et al., 1999b). In February 2001 the Sanger Institute started 
sequencing the genome of zebrafish. These assemblies of the genome are accessible in 
Ensembl (http://www.ensembl.org/Danio_rerio). Besides facilitating the identification 
of mutants, the genetic maps have been useful in comparative studies between the 
zebrafish and other vertebrate genomes. In spite of the 450 million years of 
evolutionary distance between zebrafish and human (Kumar and Hedges, 1998), 
comparisons of zebrafish and mammalian gene maps have revealed extensive 
conservation of syntenic relationships among vertebrates (Amores et al., 1998; 
Barbazuk et al., 2000; Gates et al., 1999; Postlethwait et al., 1998; Postlethwait and 
Talbot, 1997; Woods et al., 2000; Woods et al., 2005). Identification of conservation 
of synteny between the zebrafish and human genome has been valuable in defining 
candidate genes for zebrafish mutants (Karlstrom et al., 1999; Schmid et al., 2000) 
and in prediction of orthologous gene relationships (Barbazuk et al., 2000). In 
addition, the human-zebrafish comparative maps can help the understanding of the 
vertebrate genome. The zebrafish represents a valuable outgroup of vertebrates, 
distinguishing shared features of mammalian genomes and those derived from 
ancestral genomes (Gates et al., 1999; Postlethwait et al., 1998; Postlethwait et al., 
2000; Woods et al., 2000; Woods et al., 2005).  
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In addition to the advantages it offers to developmental biologists, zebrafish has a 
great potential to serve as a model for human disease (reviewed by Barut and Zon, 
2000; reviewed by Dooley and Zon, 2000; reviewed by Ward and Lieschke, 2002). 
For instance, the zebrafish gridlock mutant has a defect similar to coarctation of the 
aorta in humans (Weinstein et al., 1995). In addition, there are zebrafish mutants with 
cystic kidneys that may represent polycystic kidney disease of humans (Drummond et 
al., 1998). Comparative analysis of microarray data from zebrafish liver tumors with 
those from four human tumor types revealed molecular conservation at various levels 
between fish and human tumors (Lam et al., 2006). Hence, the zebrafish has definitely 
evolved not only as an ideal model organism for vertebrate developmental biology 
and genetics but also as a valid animal model for medical research. 
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1.8 vertebrate liver development   
 
The liver provides many essential functions. It is the largest exocrine gland in the 
body, producing bile, metabolizing lipids, and is the primary site for detoxification 
and elimination of body wastes. The liver also performs important endocrine 
functions by secreting blood proteins such as albumin that maintain homeostasis, as 
well as regulating blood glucose levels through glycogen storage.  
 
Based on descriptive and experimental embryology in mouse and chicken, liver 
development can be conceptualized in a series of steps (Zaret, 2002) and from 
preliminary experiments these appear to be largely conserved in Xenopus (Chalmers 
and Slack, 2000; Zorn and Mason, 2001). First the endoderm germ layer forms during 
gastrulation and eventually gives rise in the adult to the liver, pancreas, lung, thyroid 
and epithelial cells of the gastrointestinal and respiratory systems (Wells and Melton, 
1999). The endoderm is then patterned into broad domains along the anterior-
posterior axis and anterior endoderm (AE) becomes competent to give rise to foregut 
derivatives. Around the 4-8 somite stage of development a combination of positive 
inductive signals from the cardiogenic mesoderm and repressive signals from the 
trunk mesoderm specifies a group of cells in the ventral foregut endoderm to adopt a 
hepatic fate (Fukuda-Taira, 1981; Gualdi et al., 1996; Le Douarin et al., 1975). The 
hepatic endoderm epithelium thickens, delaminates and invades the surrounding 
mesenchyme to form the liver bud. Continued epithelial/mesenchymal interactions 
stimulate cell proliferation and morphogenesis as the embryonic organ grows. The 
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undifferentiated cells in the liver bud, known as hepatoblasts, are bi-potential, giving 
rise to hepatocytes and biliary epithelium.  
 
Promoter studies examining the transcriptional regulation of liver specific genes in 
tissue culture, such as transthyretin, α-fetoprotein and albumin have provided 
extensive molecular information on terminal hepatocyte differentiation (Costa et al., 
2003). At the other end of the developmental spectrum, work in Xenopus and 
zebrafish has begun to elucidate the molecular details of how the endoderm is formed 
in the first place (Stainier, 2002). Finally genetic analysis in the mouse has identified 
many of the genes, such as Hex, Prox1, c-jun, Hlx, HGF, c-Met, Smad2/3 Kras, Sek1, 
CERB and Xbp1 that are required for maintenance, proliferation, morphogenesis and 
survival of the liver bud once the hepatic lineage is specified (Zaret, 2002).  
 
Classical transplantation experiments in avian embryos and in vitro mouse embryos 
explant cultures, indicate that the cardiogenic mesoderm (CM) induces liver 
development in the adjacent ventral foregut endoderm between the 4-8 somite stages 
of development (Fukuda-Taira, 1981; Gualdi et al., 1996; Le Douarin et al., 1975). 
Only the CM, which includes the precardiac and septum transversum mesenchyme, 
had this activity and mesoderm from other regions of the embryo could not stimulate 
hepatic development in foregut endoderm (Fukuda-Taira, 1981; Gualdi et al., 1996; 
Le Douarin et al., 1975). Furthermore, in vivo only the foregut endoderm was 
competent to initiate hepatogenesis. Zaret and colleagues have shown that FGF and 




In vivo transplantation experiments in chick found that only the foregut endoderm 
was "competent" to differentiate into liver and CM could not induce hepatic 
development in posterior endoderm (Fukuda-Taira, 1981; Le Douarin et al., 1975). 
However, mouse explant studies found that posterior endoderm could express liver 
markers once isolated from its adjacent dorsal/posterior mesoderm and cultured in 
vitro. Furthermore, this dorsal mesoderm could repress hepatic induction in foregut 
co-cultures (Gualdi et al., 1996). This suggests that hepatic potential is normally 
repressed in the hindgut by dorsal mesodermal signals, while the anterior endoderm is 
somehow protected. And a model was proposed where Wnt ligands secreted from the 
trunk mesoderm repress hepatic development in the posterior endoderm, while Wnt-
antagonists expressed in the anterior endoderm make the developing foregut 
refractory to these repressive Wnts and competent to respond to hepatic induction. 
This model is supported by the fact that Wnt promots biliary differentiation by 
enhancing stem cell specification, hepatocyte trans-differentiation and promoting 
biliary survival (Hussain et al., 2004). 
 
In this study, we use zebrafish as the animal model to study liver development. 
Zebrafish liver development can be divided into two phases: budding and growth. 
Budding stage (Figure 1.2) can be further divided into three stages based on distinct 
liver morphology: anterior thickening of intestinal rod between 24 to 28 hours post 
fertilization (hpf) (Figure 1.2 A, B), leftward bend and a smooth thickening on the 
outer curvature of the intestinal bulb primordium at 30 hpf (Figure 1.2 C), and a 
furrow formation between the liver bud and the adjacent oesophagus at 34hpf (Figure 
1.2 D). By 50hpf, cells connecting the liver and the intestinal bulb primordium have 
formed the hepatic duct, which marks the end of budding process. From end of the 
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budding to 96hpf, the liver is in growth phase. At this phase, the liver is a well-
defined strucuture and increases in size and modifies its shape and placement. By 
72hpf, the size of the liver has increased moderately but the shape has not changed. 
By 96hpf, the liver has extends from the left side of the embryo all the way across the 
midline ventral to the oesophagus, which marks the end of growth phase (Field et al., 
2003). In zebrafish model, several genes were identified to be involved in liver 
development and disease. For instance, uhrf1 gene, a cell cycle regulator and 
transcriptional activator of top2a expression, is required for hepatic outgrowth and 
embryonic survival in zebrafish (Sadler et al., 2007). A genetic screen in zebrafish 




Fig.1.3 Time course of zebrafish liver budding. (A–F) Two-dimensional projections 
of confocal stacks showing ventral views of the gutGFP line, anterior to the top. Scale 
bar, 100 μm. Embryos were fixed and imaged at (A) 24, (B) 28, (C) 30, (D) 34, (E) 36, 
and (F) 46 hpf. (A, B) The liver (arrowhead) starts budding from the intestinal rod 
between 24 and 28 hpf. (C) At 30 hpf, the liver is a smooth thickening on the outer 
curvature of the intestinal bulb primordium, which at this time has a clear leftward 
bend. (D) A furrow (open arrow) begins to form between the medial anterior edge of 
the liver and the adjacent oesophagus and continues to expand posteriorly (E, F) to 
separate the liver from the intestinal bulb primordium. The pancreas (asterisk) and 
endodermal lining of the swim bladder (arrow) can also be seen developing from the 
intestinal bulb primordium over time. (From Field et al., 2003) 
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1.9 Somitogenesis and myogenesis 
In the vertebrate embryo, the most obviously symmetric embryonic structures are the 
left and right somitic columns. During somitogenesis, the cells lying on either side of 
the organizer in the marginal zone mesoderm, will segment into are epithelial spheres 
of somites that flank the neural tube. The process occurs sequentially from anterior to 
posterior as the embryo grows posteriorly. The somites subsequently differentiate to 
give rise to the vertebrate, ribs and skeletal muscles of the body. 
 
Somitogenesis has been shown to be regulated by two mechanisms: 1) the 
segmentation clock (reviewed by Bessho and Kageyama, 2003) and 2) a continuously 
regressing posterior-to-anterior gradient of fibroblast growth factor 8 (fgf8) (Dubrulle 
and Pourquie, 2004) and Wnt signalling in the presomitic mesoderm (PSM) (reviewed 
by Aulehla and Herrmann, 2004). The clock, a molecular oscillator that involves 
Notch (Dale et al., 2003; Jiang et al., 2000b) and Wnt signalling (Hofmann et al., 
2004) pathways, ensures a regular timing of somite formation by generating cyclic 
waves of gene expressions along the PSM. The gradient gives rise to a determination 
front – a concentration threshold below which somite formation can occur (Aulehla et 
al., 2003; Dubrulle et al., 2001). Both the segmentation clock oscillations and 
determination front regression occur synchronously on the embryo’s left and right 
sides, resulting in simultaneous, bilateral somitogenesis. 
 
Myogenesis begins during embryonic segmentation and lasts until birth (reviewed by 
Buckingham et al., 2003). Myogenesis requires the coordination of several processes: 
the specification of muscle precursors and the control of their proliferation, migration 
and differentiation (reviewed by Buckingham et al., 2003; reviewed by Parker et al., 
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2003). During somitogenesis, the segmentation boundary demarcates a posterior 
domain, where somite maturation is repressed and an anterior domain, where 
differentiation begins (reviewed by Iulianella et al., 2003; reviewed by Pourquie, 
2003). 
 
Myogenesis is under the influence of numerous signals arising from neighbouring 
structures, i.e. surface ectoderm, neural tube and notochord. During zebrafish 
myogenesis, two distinct cell populations give rise to slow and fast muscle fibres 
(Stickney et al., 2000). The slow muscle derives from the medially located adaxial 
cells and requires Hedgehog (Hh) signals from the notochord (Barresi et al., 2000; 
Blagden et al., 1997; Du et al., 1997; Wolff et al., 2003). Slow fibres segregate into 
two subpopulations: the superficial slow fibres (SSF), which migrate to the lateral 
somite surface; and the muscle pioneers (MPs) that remain medial. The remaining 
myotome differentiates into fast muscle fibres (Devoto et al., 1996; Wolff et al., 2003). 
How the cells of the lateral somites are specified to differentiate into fast muscle is 
unknown. 
 
The zebrafish has long been recognized as an ideal organism for cellular and 
histological studies of somite patterning. The overall process of somite development 
in zebrafish is similar to that in amphibians, birds, and mammals (Kimmel et al., 
1995). In zebrafish, gastrulation is first visible when the shield is established on the 
dorsal side of the embryo. Shield cells are functionally equivalent to the organizer of 
amphibians and Hensen’s node cells in chick (Shih and Fraser, 1996). These cells give 
rise to the notochord and prechordal plate, and they exert profound patterning 
influences on surrounding tissues (Mullins, 1999). The paraxial mesoderm develops 
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from cells around the margin of the early gastrula, which converge toward the dorsal 
side, forming paraxial mesoderm adjacent to the axial mesoderm that is derived from 
the shield. This convergence of cells toward the future notochord contributes to the 
anteroposterior extension of the embryo (Kimmel et al., 1990). During this convergent 
extension the notochord precursors begin to express signaling molecules such as sonic 
hedgehog, which exert patterning influences on the paraxial mesoderm. The first 
somite forms shortly after the end of gastrulation. As somitogenesis continues, the 
trunk begins to lift off of the yolk and the tail extends. At the end of the first day of 
development, somite formation is complete and somite patterning nearly so. The most 
obvious differences between zebrafish and the amniote somite are anatomical: in 
zebrafish the large myotome is adjacent to the notochord, whereas in chick the large 
sclerotome is adjacent to the notochord. In addition, myogenesis begins before somite 
formation in fish whereas in chick it likely begins after somite formation. 
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1.10 Hypotheses 
Since HGF was first discovered as a mitogene for hepatocyte, our study is fisrt 
focused on the role of HGF in zebrafish liver development. Motogenic and 
morphogenic outcome of the ligand/receptor would be responsible for Hgf’s role in 
liver budding while apoptotic and proliferative outcome would be responsible for 
Hgf’s role in liver growth. However, from previous literature, we know that HGF has 
pleotrophic roles in embryonic development, working as mitogene, motogene and 
morphogene. Due to this, many aspects of Hgf’s character would be investigated to 
reveal its pleotrophic roles in different aspects of zebrafish development. Hgf’s role in 
somitogenesis, hematopoiesis and angiogenesis would reflect HGF as mtiogene, 
motogene and morphogene. 
 
1.11 Aim of this study 
In this study, zebrafish model will be used to study the function of hgf and c-met and 
achive the goals as following: 
 Molecular cloning of zebrafish hgf and c-met 
 Expression analysis of the zebrafish hgf and c-met 





Chapter 2. Materials and methods 
2.1 Cloning 
2.1.1 DNA isolation 
Isolation and purification of plasmid DNA 
Small-scale preparation of plasmid DNA was carried out using Qiagen Plasmid 
Purification kit (Qiagen, USA). The protocol involved alkaline lysis followed by 
binding of plasmid DNA to a silica-based resin. DNA was eluted in low salt buffer or 
water. Normally, about 10-20 µg of high copy number plasmid DNA can be isolated 
from 4 ml of overnight bacterial culture in Luria-Bertani (LB) medium. 
 
Firstly, the bacteria in LB liquid medium with appropriate antibiotics were harvested 
by centrifugation at 12,000 rpm for 1 minute using the 5415C centrifuge (Eppendorf, 
Germany). It is recommending to shortly spin the tube again and to use pipet to 
remove the residue medium. Then the bacterial pellet was resuspended in 200 µl of 
cell resuspension solution (100 mg/ml RNase A; 10mM EDTA; 25 mM Tris-HCl, pH 
7.5). 200 µl of cell lysis solution (0.2 M NaOH; 1% SDS) was added to the bacterial 
suspension and mixed by gently inverting the tube several times. This mixture was 
neutralized by adding 200 µl of neutralization buffer (1.32 M KOAc, pH 4.8). After 
being centrifuged in a microcentrifuge tube at 14,000 rpm for 10 minutes, the 
supernatant was transferred into a fresh 2-ml tube and 1 ml purification resin was 
added. The resin/DNA mix was transferred into a Minicolumn and washed with 2 ml 
of column wash solution (200 mM NaCl; 5 mM EDTA; 20 mM Tris-HCl, pH 7.5; 
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75% EtOH) using a vacuum manifold. The resin was drained by spinning the 
minicolumn at 14,000 rpm for 2 minutes. The minicolumn was then transferred to a 
new microcentrifuge tube and 30 µl of water was added. After 1 minutes incubation at 
room temperature, plasmid DNA was eluted from the column by centrifugation at 
14,000 rpm for 1 minutes. 
 
DNA gel electrophoresis 
Typical DNA electrophoresis was performed in 1% agarose gel unless special 
requirements were presented. The agarose powder was dissolved in 1XTAE (0.04 M 
Trisacetate; 0.001 M EDTA) by heating. After the solution was cooled to 60ºC, 
ethidium bromide was added to a final concentration of 0.5 µg/ml and mixed 
thoroughly. Alternatively, a few drops of Ethidium bromide were added to the run 
buffer to get an approximate concentration of 0.5µg/ml. A voltage of 1-5 V/cm was 
applied during the electrophoresis. 
 
For long fragment DNA ligation (insertion size above 2kb) and template DNA for in 
vitro transcription, instead of ethidium bromide, crystal violet is a better choice which 
can protect the DNA from UV exposure.  
 
Isolation of DNA from agarose gel 
QIAquick Gel Extraction Kit (Qiagen, USA) was used to recover DNA fragments of 
interest ranging from 100 bp to 10 kb from agarose gel according to manufacturer’s 
instructions. Briefly, the gel slide containing the DNA band of interest was cut from 
the gel and melted at 50ºC in Buffer QG for 10 minutes. The volume of the Buffer 
QG was approximately three times of the gel slice volume. It is recommending to 
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vortex or rotate the tube containing gel and QG buffer for several times during 50 ºC 
incubation. When the gel is completely melted, add 1 volume of isopropanel and 
vortex to mix. The column was then centrifuged at 14,000 rpm for 1 minute, washed 
by adding 0.75 ml of Buffer PE, and spin again. After removing residual Buffer PE by 
spinning at 14,000 rpm for 1 minute, 20-50 µl of sterile water was added to the top of 
the column. The column was incubated at room temperature for 1 minute and DNA 
fragment was eluted into a 1.5-ml centrifuge tube by centrifugation at 14,000 rpm for 
1 minute. 
 
Purification of PCR products 
Suitable PCR products can be directly purified from the PCR mix. This purified 
product can be used for various applications including cloning and ligation. QIAquick 
PCR purification kit was used to purify the PCR product. To begin with, five times 
volume of Buffer PB was added to one volume of PCR sample. QIAquick spin 
column was placed in a collection tube. The buffer and PCR sample mix was placed 
in the spin column and centrifuged for 1 minute. The flow through was discarded. 
0.75 ml of Buffer PE was added to the spin column and centrifuge for 1 minute. The 
flow through was discarded and centrifuged for additional 1 minute. The purified PCR 
product was then eluted with 20-50 µl of sterile water or TE buffer by incubating for 1 







Quantification of DNA  
DNA was quantified by optical density reading at 260nm and 280nm using UV-1601 
spectrophotometer (Shimadzu, Japan) or directed read by Nano-drop (NanoDrop 
Technologies, USA). One unit of OD260 is equivalent to 50µg/ml of DNA. 
 
2.1.2 Restriction endonuclease digestion of plasmid DNA 
Restriction enzyme digestion was employed to screen recombinant clones, isolate 
specific DNA fragments which is the first step for DNA cloning and mapping, and 
linearize the plasmid DNA for in vitro transcription. All the restriction enzymes used 
in the study were purchased from New England Biolabs or Promega (USA). For 
molecular cloning, digestions were performed at 37ºC for 1 to 2 hour; for in-situ 
probe plasmid linearization, digestions may take overnight to minimize the possibility 
of un-digested plasmid DNA which may reduce the yield of transcription. Normally 
2-4 units of enzyme were used to digest 1µg of plasmid DNA. Digested product can 
be purified by running agarose gel and gel extraction. If the digested product is only 
one fragment, QIAquick PCR purification kit can be used to purify the product. 
 
2.1.3 DNA ligation 
DNA ligation reaction was carried out typically in 20 µl of volume, containing 2 µl of 
10X ligation buffer (0.3 M Tris-HCl, pH 7.8; 0.1 M MgCl2; 0.1 M DTT and 5 mM 
ATP), insert DNA, vector DNA and 1 unit T4 DNA ligase. The molar ratio of insert 
to vector DNA was usually between 2:1 to 4:1. Ligation reaction was incubated at 
room temperature 1 hour for sticky end or 4ºC for blunt end ligation overnight. 
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Subsequently, the ligation reaction was terminated by inactivating the ligase by 
heating at 80ºC for 5 minutes and then transformation was carried out.  
 
2.1.4 Transformation 
Preparation of competent cells 
Successful cloning relies on high transformation efficiency. Normally >107 
transformed colonies per µg of supercoiled plasmid is good for most cloning 
applications. 
 
For the preparation of competent bacteria cells, 2 ml of LB broth was incubated with a 
single fresh colony of Escherichia coli (E.coli) strain DH5α at 37ºC with 250 rpm 
shaking overnight. In the following morning, 0.5 ml of the culture was re-inoculated 
into a 250 ml flask containing 50 ml of LB broth and shaken at 250 rpm at 37ºC until 
OD600 reached around 0.5. The culture was chilled on ice for 15 minutes after being 
transferred into 50 ml Falcon 2070 tubes. Cells were pelleted by centrifugation at 
1,000 g at 4ºC for 15 minutes. The cell pellets were drained thoroughly and 
resuspended in RF1 (100 mM RbCl2; 50 mM MnCl2; 30 mM CH3COOK); 10 mM 
CaCl2 and 15% glycerol) with 1/3 volume of the original bacteria culture. After 
incubation on ice for 15 minutes, the cells were spun down and resuspended in 1/12.5 
of the original volume of RF2 (10 mM MOPS; 10 mM RbCl2; 75 mM CaCl2; 15% 
glycerol). After another 15 minute-incubation on ice, the competent cells were 
transferred into 1.5 ml microcentrifuge tubes in aliquot and fast-frozen in liquid 
nitrogen. These aliquots can be stored at -80ºC for several months. 
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Competent XL-1 Blue cells were prepared by adding 500 µl of overnight culture to 
about 10-15 ml of fresh LB. The cells were grown by incubation at 37ºC with shaking 
until the optical cell density reaches an OD600 value of 0.3-0.6. The cells were 
centrifuged at 6000 rpm for 10 minutes at 4ºC. The pellet was resuspended with 1/10 
volume of TSB (LB with 10% Polyethylene glycol (PEG 3350), 5% Dimethyl 
sulphoxide (DMSO), 10mM MgCl2 and 10mM MgSO4) and incubated on ice for 10 
minutes. The cells can be used fresh or stored at –80ºC for about one month. 
 
Transformation 
Normally 5-10 µl of ligation reaction was added into 100 µl of E.coli DH5α 
competent cells. This transformation mixture was then incubated on ice for 30 
minutes. The mixture was heated at 42ºC for 60 seconds and cooled immediately on 
ice for 2 minutes. 900 µl of LB or SOC medium was added to the mixture and 
incubated with shaking (200 rpm) at 37ºC for 1 hr. After incubation, 1/10 and 9/10 of the 
transformation reaction mixture was spread onto two separate LB plates supplemented 
with appropriate antibiotics in order to produce proper density of transformant 
colonies. The plates were incubated at 37ºC overnight. 
2.1.5 Isolation of RNA 
Isolation of total RNA from tissue or embryos 
Total RNAs from zebrafish embryos and different tissues were extracted using 
RNAwiz (Ambion). Briefly, about 200 embryos or 100mg of tissues are homogenized 
in RNAwiz (use 1 ml of RNAWIZ for every 100 mg of tissue or 10 volumes of 
reagent per volume of tissue). Samples homogenized in RNAWIZ can be stored at -20 
or -80ºC for up to 1 month. Incubate the homogenate at room temperature (RT) for 5 
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min to dissociate the nucleoproteins from the nucleic acids. Then add 0.2X Starting 
Volume of chloroform to the homogenate. The chloroform should not contain isoamyl 
alcohol (IAA) or other additives. Cover the sample, shake vigorously for ~20 seconds, 
and incubate at RT for 10 minutes. After incubation, mixture is centrifuged at ≥
10,000 x g for 15 min at 4ºC. The mixture separates into 3 phases, the colorless upper 
aqueous phase (containing the RNA), the semi-solid interphase (containing most of 
the DNA), and the lower organic phase. Without disturbing the interphase, carefully 
transfer the aqueous phase, into a clean RNase-free tube. Add 0.5X Starting Volume 
of RNase-free water, 1 Starting Volume of isopropanol, mix well, and incubate at RT 
for 10 minutes. Centrifuge at ≥10,000 x g for 15 min at 4ºC to pellet the RNA. After 
centrifuge, decant the supernatant and wash the pellet with at least 1 Starting Volume 
of cold 75% ethanol by vortexing. Centrifuge at ≥10,000 x g for 5 min at 4ºC. 
Discard the supernatant and air dry the pellet for about 10 min; do not let the RNA dry 
completely, as this will make it difficult to resuspend. Finally, RNA is resuspended in 
an appropriate amount of RNase-free water, or in formamide. Briefly vortex or 
repeatedly pipet to aid in resuspension, and if necessary, heat to ~60ºC. If stored in 
formamide, the RNA should be precipitated with 4 volumes of ethanol prior to being 
used in experiments such as RT-PCR. 
 
Measurement of RNA concentration 
RNA was quantified by optical density reading at 260nm and 280nm using UV-1601 
spectrophotometer (Shimadzu, Japan) or directed read by Nano-drop (NanoDrop 
Technologies, USA). One unit of OD260 is equivalent to 40µg/ml of RNA, 
OD260:OD280 ratios >2.0 indicates good quality of RNA products. 
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RNA gel electrophoresis 
10µg of total RNA was fractionated on 1.2% denaturing agarose gel (1.2% agarose, 
1X MOPS, 6% formaldehyde). Each RNA sample contained 50% formamide, 1X 
MOPS, 7% formaldehyde, 0.1 mg/ml ethidium bromide, and was heated at 65ºC for 
10 minutes before loading with loading buffer (1X0.4% bromophenol blue, 6% 
sucrose in water). The gel was run at 80 volts in running buffer containing 1X MOPS 
and 3% formaldehyde until the dye runs out into the buffer. The gel was then rinsed in 
distilled water and a picture was taken with a ruler to show the distance among the 
bands. 
2.1.6 Polymerase chain reaction (PCR) 
PCR is a powerful tool to amplify DNA fragments by a thermostable DNA 
polymerase and a pair of primers. It has been extensively used for various purposes 
like rapid amplification of cDNA ends (RACE) and colony screening. 
 
Standard PCR 
Typical PCR was performed in a 50µl reaction using the Perkin Elmer DNA thermal 
cycler Model 480 and 9600 (Perkin Elmer, USA), Peltier Thermal Cycler PTC200 
(MJ Research, USA). Each reaction included 5µl of 10X PCR buffer (0.5M KCl, 
0.1M Tris-HCl, pH8.8, 15mM MgCl2, 1% Triton X-100), 1µl of 5mM dNTP, 1µl of 
10pmol sense primer, 1µl of 10pmol antisense primer, 0.2µl of 5U/µl Taq polymerase 
and 1µl template DNA. A typical PCR reaction cycle consists of the following steps: 
denaturation at 94ºC for 5 minutes, followed by 35 cycles of <94ºC for 30 seconds, 
annealing at the required temperature for 1 minute or its variable depending on the 
product size and 72ºC for 1-2 minutes and final extension at 72ºC for 10 minutes. 
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Reverse-transcriptase PCR (RT-PCR) 
RT-PCR was performed in either two-step reaction or one-step reaction. In two step 
reaction, first step involved synthesis of first strand cDNA and the second step 
involved amplification of fragments of interest from single strand cDNA as template 
with two gene specific primers. First strand cDNA was synthesized from total RNA. 
The first strand cDNA synthesis reaction was performed in 50 µl total volume 
containing 5 µl of 10X first-strand buffer (50 mM Tris-HCl, pH=8.3, 75 mM KCl, 3 
mM MgCl2 and 10 mM DTT), 1 µl of 50 mM dNTP, 1 µl of RNAse inhibitor (40 
U/µl), 5 µl of oligo dT primer (1 µg/µl), 5µg of total RNA and 1 µl of MMLV reverse 
transcriptase (50 U/µl). After incubating at 37ºC for 1.5 hours, the reaction can be 
stored at -80ºC or used as template for PCR immediately. PCR reaction was carried 
out using the standard condition described above. The one-step reaction was done 
using a Qiagen one-step RT-PCR kit (Qiagen, USA). The reaction mix contains all the 
components including a pair of genespecific primers as recommended by the kit 
specifications. 
 
Quantitative Reverse-transcriptase PCR (RT-PCR) 
qRT-PCR was performed in one-step reaction using QuantiTect SYBR Green RT-
PCR Kit (QIAGEN, USA) and Real-Time PCR Thermal Cycler (MJ Research, USA). 
The reaction was performed in 20µl total volume containing 10µl of 2X QuantiTect 
SYBR Green RT-PCR Master Mix, 0.2µl of QuantiTect RT Mix, 2 µl of primers 
(10µM). A typical qRT-PCR reaction cycle consists of the following steps: reverse 
transcription at 50°C for 30 minutes, denaturation at 95ºC for 15 minutes, followed 
by 35-45 cycles of 95ºC for 15 seconds, annealing at the required temperature for 15 
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seconds and 72ºC for 30 seconds. Threshold reading method is modified from 
Larionov’s study (Larionov et al., 2005). Results were analyzed by MJ Research 
Opticon 2 software (MJ Research, USA). 
 
Rapid amplification of cDNA ends (RACE) 
Combination of gene-specific primers and vector primer were applied for RACE. 
RACE PCR conditions were essentially the same as the standard one as described 
previously, except that different annealing temperatures were used depending on the 
melting temperature (Tm) of the gene-specific primers. 25 µl of PCR product was 
electrophoresized on a 1% agarose gel. The prominent and large bands were 
recovered by the QIAquick Gel Extraction Kit (Qiagen, USA). 
 
Colony screening PCR 
PCR is a simple, fast and sensitive way to detect trace amount of specific DNA 
molecules. Thus, PCR can be applied to screen for correct recombinant DNA directly 
using the bacteria colonies, as DNA would be effectively released from bacteria cells 
under the high temperature conditions during PCR. A pair of vector primers flanking 
cloned insert will define the size of insert by a PCR. Colony screening by PCR is 
more sensitive and less time-consuming than restriction enzyme digestion analysis of 
extracted and purified plasmids. 
 
For PCR screening, colonies to be examined were marked in numerical order. A 
toothpick was used to touch the colony and the attached bacteria was inoculated in 
PCR tube preloaded with 20µl pf PCR mixture, containing 0.6U of Taq DNA 
polymerase, 2µl of 10X PCR buffer, 1µl of 2mM dNTP mix and 0.2µg each of sense 
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and antisense primers. PCR program includes initial denaturation at 94ºC for 5 
minutes, followed by 30 cycles of denaturation at 94ºC for 30 seconds, annealing at 
appropriate temperature (for example 55ºC) for 45 seconds and elongation at 72ºC for 
1-2 minutes. PCR product was examined in 1~1.5% agarose gel. Colonies that yielded 
PCR products with expected size were inoculated for plasmid DNA preparation. 
 
Cloning of PCR products 
The recovered PCR products were cloned into the pGEMT easy vector (Promega, 
USA). The pGEMT easy vector is prepared by cutting vector with EcoRV and adding 
a 3’ terminal thymidine to both ends by the manufacturer. These single 3’-T 
overhangs at the insertion site greatly improve the efficiency of ligation of PCR 
products into the plasmid because the Taq DNA polymerase generates a 3’ adenine 
overhang in the PCR products. The ligation reaction was performed as described in 
section 2.1.3. 
 
2.1.7 Sequencing of double-stranded DNA 
Automated sequencing reactions were carried out using the ABI PRISM™ BigDye™ 
Terminator Cycle Sequencing Ready Reaction Kit (Perkin Elmer). The kit contains a 
sequencing enzyme AmpliTaq® DNA Polymerase called FS and a set of dye labeled 
terminators for fluorescent cycle sequencing lager fragments with more accuracy. 
Each sequencing reaction (20 µl) contains 8 µl of Terminator Ready Reaction Mix, 
200-500 ng of double strand DNA, and 1 µl of primer (0.2 µg/µl). PCR was 
performed on the GeneAmp PCR System 9600 (Perkin Elmer) with 25 cycles of 96ºC 
for 10 seconds, 50ºC for 5 seconds and 60ºC for 4 minutes, and finally hold at 4ºC. 
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Ethanol precipitation was carried out to purify the extension products. 2 µl of 3 M 
NaOAc (pH4.6) and 50 µl of 95% ethanol was mixed with the 20-µl reaction mix, and 
incubated at room temperature for 15 minutes. The tube was spun at 4ºC for 20 
minutes at 14,000 rpm. The pellet was rinsed with 250 µl of 70% ethanol and air-
dried. The DNA pellet was dissolved in 6 µl of loading dye [50 ml contains EDTA 
(25 mM, pH8.0) 1 ml; 10 ml deionised formamide; 50 mg Dextran blue and 39 ml 
H2O] and heated to 92ºC for 3 minutes. Samples then were chilled on ice for 2 
minutes before being loaded into the sequencing gel (18g urea; 5 ml 10X TBE; 5 ml 
long range gel solution and26 ml H2O; 250 µl 10%APS and 35 µl TEMED). The 
electrophoresis was carried out at 1,690 volts for 5-9 hours. The sequencing ladders 
were analyzed automatically by an ABI377 sequencer system and software. 
 
2.1.8 Vectors used 
pCS2+ 
pCS2+ is a multipurpose expression vector. Although originally designed for 
expressing proteins in Xenopus embryos from either injected RNA or DNA, pCS2+ is 
also useful for high-level transient expression in a wide variety of mammalian and 
avian cells. It is also functional in zebrafish embryos (as DNA or RNA), and it can be 
used for in vitro transcription/translation (using, for example, the Promega TnT 
system). A number of derivatives of CS2 have been constructed that allow fusions to 
epitope tags and other marker proteins, as well as nuclear localization signals or the 
gal4 DNA binding and activation domains. In almost all cases, the same reading 
frames are used for the fusion vectors, to facilitate moving genes between multiple 
CS2 derivatives.  
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pCS2+ contains a strong enhancer/promoter (simian CMV IE94) followed by a 
polylinker and the SV40 late polyadenlyation site. An SP6 promoter is present in the 
5' untranslated region of the mRNA from the sCMV promoter, allowing in vitro RNA 
synthesis of sequences cloned into the polylinker. A T7 promoter in reverse 
orientation between the polylinker and the SV40 polyA site for probe synthesis, as 
well as a second polylinker after the SV40 polyA site to provide several possible sites 
to linearize the vector for SP6 RNA transcription. The vector backbone is from 
pBluescript II KS+ and includes the amp resistance gene and an f1 origin for 
producing single stranded DNA. (Fig.2.1) 
 




The pGEM®-T and pGEM®-T Easy Vector Systems are convenient systems for the 
cloning of PCR products. The vectors are prepared by cutting Promega’s pGEM®-
5Zf(+)(b) and pGEM®-T Easy Vectors with EcoR V and adding a 3´ terminal 
thymidine to both ends. These single 3´-T overhangs at the insertion site greatly 
improve the efficiency of ligation of a PCR product into the plasmids by preventing 
recircularization of the vector and providing a compatible overhang for PCR products 
generated by certain thermostable polymerases (Fig.2.2). 
 
Fig.2.2 pGEM®-T easy vector map. (reproduced from www.promega.com) 
 
2.2 Expression analyses 
2.2.1 Zebrafish (Danio rerio) maintenance 
A local line of wild-type zebrafish was bought. A Tg(lfabp:RFP; elsA:GFP) fishes 
line, which has red fluorescent protein (RFP) and green fluorescent protein (GFP) 
expression in the liver and pancreas respectively (borrowed from Prof. Gong’s lab) 
and a Tg (fli-1:GFP) fish line, which has GFP expression in endothelial cells, was 
used.  The fishes were maintained according to The Zebrafish Book (Westerfield, 
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1995) and fed with blood worms and/or live brine shrimps thrice a day. Males and 
females were kept in separate tanks. 
 
Adult wild type zebrafish were bred according to methods described in The Zebrafish 
Book (Westerfield, 1995). For breeding, two to three pairs of fish were transferred to 
the breeding tank with RO water (supplemented with 60 mg/ml of sea salt) and left 
overnight. The males and females were separated using a divider, which was removed 
the following morning and the fish were allowed to spawn on natural light. Adult 
transgenic zebrafish were bred in a similar way, except that the breeding tank was set 
at photo period room (The room which has light automatically on at a pre-set time in 
the following morning) and no divider was used. As breeding and egg production can 
cause extensive energy loss to the fish, it is important to ensure that each fish is only 
used once a week for breeding. Also, the fish must be bred periodically to sustain the 
productivity of the breeding stocks and the quality and quantity of egg production. 
 
The embryos were collected by pouring all the water through a clean sieve. As the 
embryos could not pass through the small diameter of the individual hole of the sieve, 
they were retained on the sieve. The embryos were washed with water and all the 
debris were removed by siphoning. Embryos were transferred to egg water [1 L Milli 
Q water supplemented with 1.5 ml stock salts, The Zebrafish Book (Westerfield, 
1995)] and placed in an incubator at 28.5ºC. Embryos older than 24 hours post 
fertilization (hpf) were raised in 0.003% 1-phenyl-2-thiourea (PTU, Sigma) in egg 
water to inhibit the production of pigment. The embryos were constantly monitored 
under the microscope for staging. Time of development at 28.5oC and morphological 
features (Kimmel et al., 1995) were used to stage all the embryos in this project. 
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2.2.2 In situ hybridization 
Linearization of plasmid DNA 
10µg of plasmid DNA was linearized at the 5’ end of the cDNA insert by a proper 
restriction enzyme at 37ºC for 2 hours to overnight. Completion of linearization was 
confirmed by running the digestion product on 1% agarose gel. After confirming, if 
there is only one digestion site on the plasmid, digested product can be purified by 
PCR purification Kit. Otherwise mixed products should be loaded on the gel to 
separate and be purified by Gel extraction Kit (using crystal violet rather than EB).  
 
Probe incubation and precipitation 
1µg of linearized DNA was used to synthesize the DIG/Fluorescein labeled probe. 
The reaction was performed at 37ºC for 2 hours to overnight in a total volume of 20µl 
containing 2µl of 10X transcription buffer (Roche), 2µl of DIG/Fluorescein-NTP mix 
[10mM ATP, 10mM CTP, 10mM GTP, 6.5mM UTP and 3.5mM DIG/Fluorescein-
UTP (Roche)], 0.5µl of RNase inhibitor (40U/µl) (Roche) and 2µl of T7 or SP6 RNA 
polymerase (50U/µl) (Roche). Following the reaction, 1 µl of 0.5M EDTA (pH 8.0) 
was used to stop the restriction digestion. Subsequently, 2.5µl of 4M LiCl and 75µl of 
cold pure ethanol were added to precipitate the RNA. After washing with 75% ethanol, 
the RNA probe was resuspended in 50µl of DEPC treated water. 
 
Quantification of labeled probe 
The labeled probe was quantified visually by Gel Electrophoresis and quantitated 
using spectrophotometric analysis at OD260/280 nm or Nano-drop. 
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Preparation of zebrafish embryos 
All zebrafish embryos used in this study were staged according to the Zebrafish 
Book (Westerfield, 1989) and indicated as hours post fertilization (hpf) at 28.5ºC. 
Staged embryos were fixed in 4% paraformaldehyde (PFA)/PBS (0.8% NaCl, 0.02% 
KCl, 0.0144% Na2HPO4. 0.024% KH2PO4, pH 7.4) for 12 to 24 hours at room 
temperature or 4ºC. Embryos younger than 16 hpf were fixed before dechorionization 
and the chorion was removed afterwards. Embryos older than 16 hpf were 
dechorionated before fixation. Older embryos with tails were hibernated on ice before 
fixation to prevent the curling of tails. After fixation, the embryos were washed in 
PBST (0.1% Tween20 in PBS) twice for 1 minute each, followed by four times for 20 
minutes each on a nutator (ClAY ADAMS® Brand, Becton Dockinson, USA) at 
room temperature. After changing PBST to methanol by incubating with 50% and 
100% methanol (two times each), the embryos were kept at -20ºC for several months. 
Before they were used for in situ hybridization, the embryos were rehydrated in PBS 
in two or three times by changing half volume of solution each time. 
 
Proteinase K treatment 
This step is especially necessary for embryos older than 14 somites (>16hpf). 
Embryos were treated with 10 µg/ml of proteinase K in PBST at room temperature. 
The time of exposure depended upon embryos age and the specific activity of 
proteinase K, which varied from batch to batch. For most cases, the conditions used 
are as given. 
16-24 hpf 3-4 minutes 
24-32 hpf 5-6 minutes 
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32-50 hpf 10-20 minutes 
To stop the reaction, the proteinase K solution was removed completely, and the 
embryos were fixed again in 4% PFA/PBS for 20 minutes at room temperature. 





Prehybridization was performed by changing half the volume of washing solution 
with hybridization buffer [50% formamide, 5X SSC, 50 µg/ml Heparine, 500 µg/ml 
tRNA, 0.1% 0.1% Tween　20, pH6.0 (adjusted bycitric acid)] and incubated at room 
temperature for 1 hour. This solution was removed and replaced with hybridization 
buffer; embryos were incubated at 68ºC for 5-10 hours. 
 
Hybridization 
1-2µl of DIG-labeled probe was diluted in 200µl of hybridization buffer. The probe 
was denatured by heating at 80ºC for 5 minutes followed by 2 minutes of ice bath. 
Embryos of different stages or treatments were selected and placed in one tube or 
separate tubes depending on the experimental conditions. The original buffer was 
replaced with the denatured probe dissolved in hybridization buffer. Hybridization 
was performed at 68ºC in a circulating water bath overnight with shaking. 
 
Post-Hybridization washes 
The next day, the probe was removed and replaced with prewarmed 100% 
hybridization wash solution (hybridization buffer without tRNA and heparine) for 15 
76 
minutes. The embryos were then washed in the following order of wash solutions 
75% hybridization wash solution: 25% 2X SSCT (SSC with 0.1% Tween　20), 50% 
hybridization wash solution:50% 2X SSCT, 25% hybridization wash solution:75% 2X 
SSCT for 15-20 minutes each. This was followed by 2X SSCT wash twice for 30-45 
minutes each and 0.2X SSCT wash twice for 30-45 minutes each. Subsequently, the 
embryos were washed twice with PBST (PBS with 0.1% Tween 　 20) at room 
temperature for 5 minutes each. 
 
Preparation of preabsorbed DIG 
Commercial DIG-AP antibodies (Boehringer) should be preincubated with biological 
tissues, preferably of the same origin as the sample used for hybridization, in order to 
decrease the staining background and increase signal-to-noise ratio. Anti-DIG and 
Fluorescein-AP was diluted to 1:500 and 1:50 in Maleic Acid buffer (0.15M Maleic 
acid, 0.1M Nacl; pH 7.5)/10% FCS (Fetal calf serum, Gibco BRL) respectively and 
incubated with 50 zebrafish embryos of any stages on a nutator at 4ºC overnight. 
After that, the antibodies solution was transferred to a new tube and diluted to 1:5000 
and 1:500 with Maleic Acid buffer/10% FCS. 10µl of 0.5M EDTA (pH8.0) and 5µl of 
10% sodium azide were added to prevent bacterial growth. The preabsorbed antibody 
was stored at 4ºC and can be used for many times. 
 
Incubation with preabsorbed antibodies 
The embryos after hybridization and post hybridization washes were incubated in 
Maleic Acid buffer/10% FCS for 2 hours at room temperature to block non-specific 
binding sites for antibody. After removing the blocking solution, the embryos were 




Embryos were washed in PBST twice for 1 minute each, and 4 times for 15-20 
minutes each on a nutator at room temperature followed by washing in buffer 9.5 
(0.1M Tris-HCl, pH9.5, 50mM MgCl2, 10mM NaCl and 0.1% Tween　20) once for 
30 seconds and twice for 10 minutes each. 4.5µl of NBT (Nitroblue tetrazolium, 
Boehringer Mannheim, 50mg/ml in 70% dimethyl formamide) and 3.5µl of BCIP (5-
bromo, 4-chloro, 3-indodyl phosphate salt, Boehringer Mannheim, Germany; 
50mg/ml in H2O) was added into 1ml of buffer 9.5 with embryos and mixed 
thoroughly. Embryos were kept in dark at room temperature for few minutes to 
several hours, and the progress of staining was monitored from time to time under a 
Leica MZ12 microscope (Leica, Germany). To stop the reaction, staining solution was 
removed and the embryos were washed in 1X PBST twice for 10 minutes each. 
Embryos can be preserved in 4% PFA/PBS at 4ºC. 
 
Mounting and photography 
Selected embryos were washed with PBST twice for 10 minutes each and transferred 
to 50% glycerol/PBS, equilibrated at room temperature for several hours. For whole 
mounts, a single chamber was made by placing stacks of 3-5 small cover glasses on 
both side of a 25.4X76.2 mm microscope slide. Small cover glasses in the stacks will 
be perfectly solid 1 hour after placing a drop of Permount between them. Selected 
embryo was transferred to the chamber in a small drop of 50% glycerol/PBS and 
oriented by a needle. A 22X44 mm cover glass with a small drop of the same buffer 
was superimposed onto the embryo. The orientation of the embryo can be adjusted by 
gently moving the cover glass. For flat specimen, the yolk of selected embryo was 
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removed completely by needles. The embryo without yolk was then placed onto a 
slide with a small drop of 50% glycerol/PBS and adjusted to a proper orientation by 
removing excess of liquid and with the help of needles. A small fragment of cover 
glass (a bit larger than the specimen) was covered onto the embryo. Care was taken to 
avoid bubbles and a drop of 50% glycerol/PBS was added to fill the space under the 
cover glass. This specimen was sealed with nail polish along the edge of the cover 
glass to prevent it from drying. Photographs were taken using a camera mounted to an 
Olympus AX-70 microscope (Olympus, Japan). The films used were Kodak Gold 200 
and 400 ASA. 
 
2.2.3 Cryosectioning embryos 
Preparation of slides and blocks 
The fixed and stained embryos were first transferred into molten 1.5% bactoagar, 
equilibrated with 30% sucrose (at 48ºC) in a detached cap of eppendorf tube. The 
samples were adjusted to the required orientation with needles before the agar 
solidified. After the agar block solidified, a small block was cut with razor or blade in 
such a way that a flat base and a slanting top edge was created for proper positioning 
and sectioning of the sample. The block was then transferred to 30% sucrose solution 
and incubated at 4ºC overnight for equilibration. 
 
Sectioning, mounting and photography 
Subsequently, the block was placed on the frozen surface of a layer of tissue freezing 
medium cryostat (Reichert-Jung, Germany) on the prechilled tissue holder. The block 
was then coated with a drop of cryostat freezing medium and frozen in liquid nitrogen 
until the block had solidified completely. The frozen block was placed in the cryostat 
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chamber (Reichert-Jung, Germany) for 30 minutes to 1 hour to equilibrate with 
chamber temperature of –25ºC. Normally, 10µm thick sections were cut and placed 
on superfrost plus slides (Fisher, USA). The slides were dried on a 42ºC hot plate for 
about 30 minutes to 1 hour. The sections were then fixed briefly with 4% PFA-PBS 
for 10 minutes and washed gently with PBS for 3 times, 10 minutes each and 
cryosectioned (10-20 µm). These sections was either embedded in several drops of 
glycerol and covered with glass cover-slip for photography or used for section in situ 
hybridization or immunohistochemistry 
 
2.3 Functional analyses 
2.3.1 Microinjection into embryos 
The samples for injection were prepared to different concentrations in respective 
buffers. Morpholino antisense oligos were prepared in 1X Danieau solution (58 mM 
NaCl; 0.7 mM KCl; 0.4 mM MgSO4; 0.6 mM Ca(NO3)2; 5.0 mM pH 7.6 HEPES). 
The needles used for the microinjection were prepared using optimized conditions of 
heat and pull time for different purposes using the Sutter Micropipette puller P-97 
(Sutter Instruments Co, USA). The conditions for normal injections into 1-2 cell 
embryos used were Pressure-500, heat-500/550, pull-150/150, velocity-100/100 and 
time-150/150. Antisense oligos were injected into the cytoplasm of 1-2 cell stage 
zebrafish embryos using Picoinjector PLI-100 (Medical Systems Corp, Greenvale, 
NY, USA) by placing the embryos under a dissection microscope (Olympus SZX12). 
Each embryo received the specific volume of the samples depending on the 
concentration of the sample. The injected embryos were reared in egg water (1ml of 
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egg water contains 10% NaCl, 0.3% KCl, 0.4% CaCl2, 1.63% MgSO4.7H2O, 0.01% 
methylene blue, and 95 ml ddH2O). 
2.3.2 Design of morpholino anti-sense nucleotide oligo (MO)  
MO has become an attractive method to specifically block gene function (Nasevicius 
and Ekker, 2000; Summerton and Weller, 1997). Design of an efficient antisense 
Morpholino required the careful consideration of certain criterias. For translation 
blocking MO, the target sequence, approximately 25 bp for MO should be located in 
the post-spliced mRNA in the region from the 5'cap to about 30 bp 3' to the AUG 
translational start site. For splicing interfering MO, the target sequence, approximately 
25 bp for MO should be located in the pre-mRNA intron and exon junction. Different 
from translation blocking MO, splicing interfering MO modifies the mRNA splicing 
and alters the nucleotide sequence structure of mRNA. Hence, the knockdown effect 
by splicing interfering MO can be easily detected by RT-PCR. It is especially useful 
when antibody is not available. Using the criterias MOs were designed and ordered 
from http://www.gene-tools.com. 
 

























































Chapter 3. Results 
3.1 Cloning of Zebrafish hgfa, hgfb and c-met  
 
3.1.1 Isolation of hgfa, hgfb and c-met full-length cDNA 
 
3.1.1.1 Isolation of hgf full-length cDNA 
 
Degenerate PCR was first used to isolate the full-length cDNA and several attempts 
had proven this approach to be unsuccessful, which may be due to the low homology 
of HGF between zebrafish and other species. By blasting Xenopus hgf cDNA 
sequence against the Ensembl zebrafish genome database, a predicted cDNA 
sequence of 1650bp with the annotation of hgf was found. Based on that predicted 
zebrafish hgf fragment, a pair of primers (HGFpf and HGFpr) near 3’ prime end was 
designed to isolate the partial sequence from zebrafish. Because this cDNA sequence 
is assembled from the genome DNA sequence according to the predicted intron-exon 
junction, attention was paid to avoid primers crossing the predicted different exons 
and from the first or last exon. This precaution was later proven to be useful since 
there were some mismatch between the predicted cDNA sequence and the isolated 
cDNA sequence by RT-PCR, and the last exon in the predicted cDNA sequence can 
not be found in the isolated full-length cDNA sequence, which was due to the mis-
prediction of intron-exon junction by the genome database. 
 
Based on this isolated hgf fragment of 379bp, we designed primers for Rapid 
Amplification of cDNA Ends (RACE) to obtain the full-length cDNA by nested PCR. 
3’ RACE with nested PCR (HGF3ex and HGF3in) resulted in isolation of an 800bp 
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fragment that reaches to the 3’ end of the gene. 5’ RACE with nested PCR (HGF5ex 
and HGF5in) resulted in isolation of a 3000bp fragment that reaches to the 5’ end of 
the gene. These two fragments were cloned into pGEM®-T Easy vector (Promega, 
USA) and sequenced. Full-length cDNA was then amplified by RT-PCR from 24 hour 
post fertilization (hpf) zebrafish total RNA using a pair of primers (HGFf and HGFr) 
which flank the complete open reading frame (ORF) of 2339bp. Schematic 
representation of this cloning process is shown in Fig.3.1. The nucleotide sequence of 
the zebrafish hgf and its deduced amino acid sequence are shown in Fig.3.2. This hgf 
was later renamed hgfa after a second copy of hgf gene was found from the zebrafish 
genome.  
 
Fig.3.1 Schematic representation of the procedure of isolation and cloning of full-
length zebrafish hgfa cDNA clone by RACE-PCR.   
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1         TTGAGAAAGAGAGAGAGAGTGAGAGAGCAGTCGCTGCGGTTTGATCCTGTTCATCCTTCA 
61        CACCAGCAGCAGCAGCAGCATCAACTCGGACTTTATAGACTCTCCACCCCACAGCCTGGA 
121       ATATCAAACCGAGAAACATGAGATCGGACATTATGTGGATGTATCAAGCTCTTCTCTTTG 
1                           M  R  S  D  I  M  W  M  Y  Q  A  L  L  F    
181       TCGTACTGACCGTGAATGTGGATTGCAGAAAACAGACATTGCAGAGGTATCAGAAAAGTG 
15        V  V  L  T  V  N  V  D  C  R  K  Q  T  L  Q  R  Y  Q  K  S    
241       AAAACAGCCGACTGCTTTGTACAGACTGTCCAGAATCCCCTCGAATTAGGAACCTGTCGC 
35        E  N  S  R  L  L  C  T  D  C  P  E  S  P  R  I  R  N  L  S    
301       TGGAGGAATGCGCACGCAAATGTAGCAAGAGCAAGAAGTCCTGCAGGGCATTCTACTTTG 
55        L  E  E  C  A  R  K  C  S  K  S  K  K  S  C  R  A  F  Y  F    
361       ACCACATAAACAGGAAATGTCACTTTCTTCCTTTTGACCGTTTCTCCGAAGGCGCGAAGA 
75        D  H  I  N  R  K  C  H  F  L  P  F  D  R  F  S  E  G  A  K    
421       GAGAGCGAAAACCCAGTTGTGACCTTTACGAGAAGAAAGACTATGTGAGGGAGTGCATCA 
95        R  E  R  K  P  S  C  D  L  Y  E  K  K  D  Y  V  R  E  C  I    
481       TTGGGTCAGGTGTCAACTACAAGGGGAGAAGGTCATTCACAAAGACTGGAATTACGTGCC 
115       I  G  S  G  V  N  Y  K  G  R  R  S  F  T  K  T  G  I  T  C    
541       AATCCTGGAATATGTCCGTCCCACATGAGCACAATTTTAAGCCTACCAGACACAAAAAGT 
135       Q  S  W  N  M  S  V  P  H  E  H  N  F  K  P  T  R  H  K  K    
601       CTGACCTACGTCAGAACTTTTGCCGAAATCCAGACAATGATCCAAATGGGCCCTGGTGCT 
155       S  D  L  R  Q  N  F  C  R  N  P  D  N  D  P  N  G  P  W  C    
661       TCACTGAACTCACTGAGACCCGGCACCAGGATTGTGGACTGCCTCAGTGTTCAGATGTGG 
175       F  T  E  L  T  E  T  R  H  Q  D  C  G  L  P  Q  C  S  D  V    
721       AGTGTATGAAATGTAATGGGGAAACCTACAGAGGGCCCATGGATCATACAGAGAGTGGGA 
195       E  C  M  K  C  N  G  E  T  Y  R  G  P  M  D  H  T  E  S  G    
781       AAGAGTGCCAGAGATGGGACTCGCAGAAACCTCATAAACACACCTACCAGCCTCACAGGC 
215       K  E  C  Q  R  W  D  S  Q  K  P  H  K  H  T  Y  Q  P  H  R    
841       ATGTAGGTAAAGGTCTGGATGACAACTTCTGCCGCAATCCCAATAATGATGTTCGTCCGT 
235       H  V  G  K  G  L  D  D  N  F  C  R  N  P  N  N  D  V  R  P    
901       GGTGTTACACGATGGACAAAAACACCCCTTGGGAGTACTGTAACATCAGTGTGTGTGACT 
255       W  C  Y  T  M  D  K  N  T  P  W  E  Y  C  N  I  S  V  C  D    
961       CAGATAGCGATGTGGAAGTGGAGGTGACCAGCTCTTGTTTTCGGGGTCAAGGAGAGGGCT 
275       S  D  S  D  V  E  V  E  V  T  S  S  C  F  R  G  Q  G  E  G    
1021      ACAGGGGTACAGTCAACGTGACCCCTGCAGGTGTGACCTGTCAACGCTGGGACGCTCTCT 
295       Y  R  G  T  V  N  V  T  P  A  G  V  T  C  Q  R  W  D  A  L    
1081      CTCCTCACATCCATTCATACACTCCGCACAACTATAAATGCAAGGATCTGAGGGAGAACT 
315       S  P  H  I  H  S  Y  T  P  H  N  Y  K  C  K  D  L  R  E  N    
1141      ATTGCAGAAATCCTGATGGCTCTGAAATTCCCTGGTGTTTCACCACAGACGCAAAAGTGC 
335       Y  C  R  N  P  D  G  S  E  I  P  W  C  F  T  T  D  A  K  V   
1201      GCAAAGCTTTCTGTACCAACATTCCCAGATGCGAATCAGAGAGCTCTGACAGCACAGAAT 
355       R  K  A  F  C  T  N  I  P  R  C  E  S  E  S  S  D  S  T  E    
1261      GTTATGAAGACAACGGAGAGAGTTATCGTGGCAATTTGTCGAAAACGAGATCTGGTATTC 
375       C  Y  E  D  N  G  E  S  Y  R  G  N  L  S  K  T  R  S  G  I    
1321      CTTGCGGACTCTGGTCTGACCACACATTCAGGAGAGACACCCGGTCAGCGAAGGCCAGCG 
395       P  C  G  L  W  S  D  H  T  F  R  R  D  T  R  S  A  K  A  S    
1381      CGGGTTTAGAGTTGAACTTGTGCAGGAATCCAGACAGAGATAAGCACGGGCCGTGGTGCT 
415       A  G  L  E  L  N  L  C  R  N  P  D  R  D  K  H  G  P  W  C    
1441      ACACGTCCAACTCCTCCATTCCCTGGGACTACTGCGGACTGGAGCGCTGTAAATCAATGT 
435       Y  T  S  N  S  S  I  P  W  D  Y  C  G  L  E  R  C  K  S  M    
1501      CATCGGATGACCATCAAATGAGTGGAGGACCAAAACCATCTTGCTTTATACATAAAACCA 
455       S  S  D  D  H  Q  M  S  G  G  P  K  P  S  C  F  I  H  K  T    
1561      CACGGATTGTTGGGGGAATGCGAGTGCAGCGGGCAGAGGATGGAAGTTGGGTGGTCAGCA 
475       T  R  I  V  G  G  M  R  V  Q  R  A  E  D  G  S  W  V  V  S    
1621      TTCAGAAAGGGAACAGACACTGGTGCGGTGGCTCTCTCATCAGAGAAGAATGGGTTCTCA 
495       I  Q  K  G  N  R  H  W  C  G  G  S  L  I  R  E  E  W  V  L    
1681      CTGATCAACAGTGCTTCCCCACCTGCGTTCCTGACCTCTCCGAGTACACCGTGCAGGTGG 
515       T  D  Q  Q  C  F  P  T  C  V  P  D  L  S  E  Y  T  V  Q  V    
1741      GGCTTCTTCATCTCAATGCATCCGCCGGCACGCAGGCTCTCCGAATCGCACATGTGGTCT  
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535       G  L  L  H  L  N  A  S  A  G  T  Q  A  L  R  I  A  H  V  V    
1801      GCGGGCCCGAGGGATCCAACTTGGCCCTGCTCAAACTCACAACGCCTGCCCCTCTCTCTG 
555       C  G  P  E  G  S  N  L  A  L  L  K  L  T  T  P  A  P  L  S    
1861      AGCATGTGCGAACTGTTCAGCTTCCGGTCGCTGGCTGTGCTGTTGCAGAAGGCACTCTGT 
575       E  H  V  R  T  V  Q  L  P  V  A  G  C  A  V  A  E  G  T  L    
1921      GTCTCATGTATGGATGGGGAGACACTAAAGGCACAGGACACGAGGGCAGTCTGAAGATGG 
595       C  L  M  Y  G  W  G  D  T  K  G  T  G  H  E  G  S  L  K  M    
1981      TGGGACTTCCAATTGTCAGCAACAAGAGGTGTTCACAAAGCCACAATGGCATCCTGCCCA 
615       V  G  L  P  I  V  S  N  K  R  C  S  Q  S  H  N  G  I  L  P    
2041      TCACCGAGACCAAAATCTGTGCTGGAGGCAAGAGAGATCAGGGCGTTTGTGAGAAAGACT 
635       I  T  E  T  K  I  C  A  G  G  K  R  D  Q  G  V  C  E  K  D    
2101      ACGGTGGCCCTTTGGTGTGCCAGGAAGGAGAGAGCAAAGTGATAGTTGGCGTCAGCATCA 
655       Y  G  G  P  L  V  C  Q  E  G  E  S  K  V  I  V  G  V  S  I    
2161      ACGGCCGTGGTTGTGCAGTAGCGAGACGTCCTGCTGTCTTCGTCAACGTGGCCTTCTACT 
675       N  G  R  G  C  A  V  A  R  R  P  A  V  F  V  N  V  A  F  Y    
2221      CTGAATGGATCCGCAAGGTCTTCAAGTACTATTCAGACATGGAAATAAGTTACTAGATCT 
695       S  E  W  I  R  K  V  F  K  Y  Y  S  D  M  E  I  S  Y    
2281      CCATATGTGGTAAATAAGACTAAATGGTTTAGCATCTACATCGTGAAGGACGATTAGCAT 
2341      TCAAACATTTTGGAGGCTAAAGTTTGCTTTGGTGTATAGATGTTGCATAATAACCACTGG 
2401      TACAGAAAAGGTGCAAGATTATCGATGTGTTTGTGAACAAATGAAGGAAATGACAACATC 
2461      GGAACTTTTTTTAGGAGATTGTTGTGGCTGGTGAGAAATCAAGGACAGATGATGAATGAA 
2521      CTGTGGCGTTCATCCATGTGAAAGCAGATGTTGTTCTTAATGTCATTCCCTGGAATTACT 
2581      TGAAGACGACATTTTCGGTTTTTGTTTTTTGCAGCTTGCTGAATTTTACAGTGCTTTTAA 
2641      GGACTAGATTCAGTATTACTGTTTCCAAAACACCTTTTTTAACATTGGTTACTAAAGAAA 
2701      TCAGATTGCAAACCGCAATATGCGCTGCCGTTGGTTTATAAACGCCTATCTGGGGCATTA 
2761      TCAGACACTTCCAGAATGTTTCGGTGATGGTCTAACGTTTCGCACCTTGCCTTACTCCAG 
2821      TTTGGAGAGATTTTGTGGCTCCTTTGGGGCTGTTTTCTTTTTTTATGTACTGCACTCTAA 
2881      AGAGTGTGCTAAAATGTCACTCTGTAGGTCTTATAGATCTGAAATTACAAACATTTGGAG 
2941      GTCTTTTCTTTCACATGGTGTAATTTATATATATATCTGTCGAAATTTTATACGCGGTAT 
3001      TTATTTATACCTTTTATAGATGGACCCGAGCCGTGGCATTTCATCCTCCAGTAGTGTTTA 
3061      TTGTGTTTAATCTGGCGTGCAGATTTGAATCATAACATTTGTAAACAAAACAAACGGATG 
3121      ATATGTCTTTGAAGGAAAATATTGGGTCATAACAGAGCGCTTCGACTCAAAGACGACTCC 
3181      CTGAAGGTTTAAAAGCCACACATGCGGAGGGTCTTTTAAGAACAAGTTTAGCCATGAGTG 
3241      CAAAGATACTTCATCAAACTGCAGTACTGAATAGAGTAACGCACAGGCAGGGTTTTTACA 
3301      AGGTTTTTACAAGTACAAGAATGTATTTTGATTTAAATGTTGTGTTCGCTGTGTGTATAC 
3361      AGAAAAGTGCCTGTTTTTGTGGCGTTTTATTGATTTTCGCAGTTAATGTAATTCCTCTTT 
3421      GCGCTGCTGCCCTCATTGGTCGTTTTATTGAATATCTAGGCTGCTGTTATTTTTGACATT 
3481      ATTTTTAGGACTGTTTTGTATTTTCAACTTTTAAAAATGTATGTAAATACATCTGTGACA 
3541      TTTTGTTTTTTTTTTATTTGTAAATAATTAAATCGTTAAAAATAAAAAAAAAAAAAAAAA 
3601      AAAAAAAAAAAAAAAAAAA  
Fig.3.2 The nucleotide sequence of the zebrafish hgfa and deduced amino acid 
sequence. The position of nucleotides and amino acid residues are indicated on left 
side. Start codon in red. 
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When the isolated full-length cDNA sequence of zebrafish hgf was blasted against the 
zebrafish genome database, another hgf homologue was found. So we termed the first 
gene as hgfa and the latter one as hgfb. The predicted zebrafish hgfb cDNA ORF was 
1149bp in length. Based on this predicted sequence, a set of nested primers (HGFb3ex, 
HGFb5ex, HGFb3in and HGFb5in) was designed to isolate a 389bp partial sequence 
of zebrafish HGFb by RT-PCR. Similar to hgfa, some mismatches were found 
between the predicted hgfb cDNA sequence and the isolated hgfb cDNA sequence due 
to mis-prediction of intron-exon junction. 
 
The set of nested primers which were used for isolation of partial sequence of 
zebrafish hgfb, was used for RACE to obtain the full-length cDNA by nested PCR. 3’ 
RACE with nested PCR (HGFb3ex and HGFb3in) resulted in isolation of a 1200bp 
fragment that reached to the 3’ end of the gene. 5’ RACE with nested PCR (HGF5ex 
and HGFb5in) resulted in isolation of a 4000bp fragment that reach to the 5’ end of 
the gene. These two fragments were cloned into pGEM®-T Easy vector (Promega, 
USA) and sequenced. Full-length cDNA was then amplified by RT PCR from 24 hpf 
zebrafish total RNA using a set of nested primers (HGFbfex, HGFbrex, HGFbfin and 
HGFbrin) which flank the complete ORF of 2535bp. Schematic representation of this 
cloning process is shown in Fig.3.3. The nucleotide sequence of the zebrafish hgfb 
and deduced amino acid sequence are shown in Fig.3.4.  
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Fig.3.3 Schematic representation of the procedure of isolation and cloning of full-
length zebrafish hgfb cDNA clone by RACE-PCR. 
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1         AGGAAACGCCAAGATTCCTCACATATCTTTTGTATTTTTGTTTTTGGGTCACATTAAACT 
61        CTTTAAAGCGACATGTGGATTTACAAAATTTTGCTCTGTGTGGCCGTTTTGGTTTACTCA 
1                      M  W  I  Y  K  I  L  L  C  V  A  V  L  V  Y  S   
121       GAAACGAAGAGACATGCTCTGCAAGACTACCAGAAGACTGATGCCGTGCGCTTGGTCACT 
17         E  T  K  R  H  A  L  Q  D  Y  Q  K  T  D  A  V  R  L  V  T   
181       CCATCTGATGCATCCTACATGACCAAAGGCCGCAAGATGAGCATAGGAAAGTGTGCACGA 
37         P  S  D  A  S  Y  M  T  K  G  R  K  M  S  I  G  K  C  A  R   
241       CGCTGTAGCCGCAACAGGAAGCTCCAGTTCACCTGCAGAGCATTCAGCTTTGATCAGAAA 
57         R  C  S  R  N  R  K  L  Q  F  T  C  R  A  F  S  F  D  Q  K   
301       AGTACCAAATGTCATCTACTCTCCTATGACAGCCTCACCTTTGGTGTCCGCATGGAGAAT 
77         S  T  K  C  H  L  L  S  Y  D  S  L  T  F  G  V  R  M  E  N   
361       GACTTCAACTTCGATCTATATGAGAAGAAAGACTTCATGAGAGAATGCATCATTGGTAAT 
97         D  F  N  F  D  L  Y  E  K  K  D  F  M  R  E  C  I  I  G  N   
421       GGACTCAACTACAAAGGGAAAAGATCGGTGACTAAAAGTGGAGTCCAGTGCCAACTCTGG 
117        G  L  N  Y  K  G  K  R  S  V  T  K  S  G  V  Q  C  Q  L  W   
481       AATTCCAAAATGCCGCACGAGCACAATTTCTTACCCCAGAGGCACAAGCATCGAGATCTA 
137        N  S  K  M  P  H  E  H  N  F  L  P  Q  R  H  K  H  R  D  L   
541       CGGGATAATTTATGTCGTAATCCGGACAACACCACAACGGGTCCTTGGTGTTTTACCACA 
157        R  D  N  L  C  R  N  P  D  N  T  T  T  G  P  W  C  F  T  T   
601       GACCCCAAACTACGTCACCAGGACTGCAGCATCCCACAATGCTCGGAGGTGGAATGTATG 
177        D  P  K  L  R  H  Q  D  C  S  I  P  Q  C  S  E  V  E  C  M   
661       ACGTGTAACGGAGAAAGTTATCGTGGACCCTTGGACCACACGGAGAGTGGTCGGGAATGC 
197        T  C  N  G  E  S  Y  R  G  P  L  D  H  T  E  S  G  R  E  C   
721       CAGCGCTGGGACCTTGAGGAACCACATAAACACATTTTCCACCCTAAAAGGTACCCCGAT 
217        Q  R  W  D  L  E  E  P  H  K  H  I  F  H  P  K  R  Y  P  D   
781       AAAGGTCTAAAGGACAACTACTGCAGGAACCCAGACGGGCGCCAGAGACCCTGGTGTTTC 
237        K  G  L  K  D  N  Y  C  R  N  P  D  G  R  Q  R  P  W  C  F   
841       ACCACCGATCCCAGCACTCCATGGGAGTACTGTAACATCAAACAGTGCGATTCAGACAAC 
257        T  T  D  P  S  T  P  W  E  Y  C  N  I  K  Q  C  D  S  D  N   
901       AGTGGTGACGTTGAAAACACAACAACGTGTTTCCGTGGACGCGGAGAGGGGTATCGCGGG 
277        S  G  D  V  E  N  T  T  T  C  F  R  G  R  G  E  G  Y  R  G   
961       ACGGTTGGCATCACACCTGATGGAGTGACTTGTCAGCGATGGGATGCCCAGTTTCCCCAT 
297        T  V  G  I  T  P  D  G  V  T  C  Q  R  W  D  A  Q  F  P  H   
1021      CGACACTCGTATACGCCACAGAATTACCATTGCAAGGATCTGCGGGAGAACTACTGTAGA 
317        R  H  S  Y  T  P  Q  N  Y  H  C  K  D  L  R  E  N  Y  C  R   
1081      AATCCTGATGGTCGTCATCTTCCATGGTGCTTCACTACTGATCCCACTGTTCCTATAGCT 
337        N  P  D  G  R  H  L  P  W  C  F  T  T  D  P  T  V  P  I  A   
1141      TTCTGCACCAACATCCCTCGCTGTGGACTCAAACCTCCTGAACCTGAAGAGTGTTATAAG 
357        F  C  T  N  I  P  R  C  G  L  K  P  P  E  P  E  E  C  Y  K   
1201      GGCATTGGAGACATGTACAATGGCCACCGGTCAAAGACTCGCTCAGGCATTCCCTGTGCC 
377        G  I  G  D  M  Y  N  G  H  R  S  K  T  R  S  G  I  P  C  A   
1261      CCATGGAAAGACCACAGTGAAAGTAACGAAAGAGATGTGAACTTGCTGACGGCTGAACAG 
397        P  W  K  D  H  S  E  S  N  E  R  D  V  N  L  L  T  A  E  Q   
1321      GCAGGGAACTTCTGCAGAAATCCAGACAAGGACAAACACGGCCCGTGGTGTTACACCAAC 
417        A  G  N  F  C  R  N  P  D  K  D  K  H  G  P  W  C  Y  T  N   
1381      AGCTCATCCATCCCCTGGGATTACTGCTCTCTCAAACCCTGTGAGCCTTCACATAACAAT 
437        S  S  S  I  P  W  D  Y  C  S  L  K  P  C  E  P  S  H  N  N   
1441      CTGCCACAAAAAGATGAGGTTACAAAGAGCTCGTGTTTTGTTCATAAGCAGGTGAGAATC 
457        L  P  Q  K  D  E  V  T  K  S  S  C  F  V  H  K  Q  V  R  I   
1501      GTCGGTGGCGGGCCTGTCCCAATTAAAGAGGGCAGCTGGATGGTCAGCATACAGAAAGGG 
477        V  G  G  G  P  V  P  I  K  E  G  S  W  M  V  S  I  Q  K  G   
1561      AGCAGTCACTGGTGTGGAGGCGCTCTGGTCAGGGAGGAGTGGGTGCTGACAGACAAAGAC 
497        S  S  H  W  C  G  G  A  L  V  R  E  E  W  V  L  T  D  K  D   
1621      TGCTTCTCCTCATGTGTGCCTGACCTATCAGAGTACAGAGTTTGGCTCGGTATTACCCAT 
517        C  F  S  S  C  V  P  D  L  S  E  Y  R  V  W  L  G  I  T  H   
1681      CTGAACGAATCAGGTGAGAATGACTTCCACAGACAGGAGAGGAGAATCTCGCATGTCATC 
537        L  N  E  S  G  E  N  D  F  H  R  Q  E  R  R  I  S  H  V  I    
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1741      TGTGGCCCAGAAGACTCTAGTCTCGCCCTTCTCCGCCTTTCCCAACCTGCACTCCCGAGT 
557        C  G  P  E  D  S  S  L  A  L  L  R  L  S  Q  P  A  L  P  S   
1801      GAGCGTGTCCGAGTTATTCAGCTGCCCGTAGCAGACTGCAGCATTCAGGAGGACACCATC 
577        E  R  V  R  V  I  Q  L  P  V  A  D  C  S  I  Q  E  D  T  I   
1861      TGCTCTGTGTACGGCTGGGGGGAAACCAAAGGCACTGGACATGAGGGAACGCTGAAAAGA 
597        C  S  V  Y  G  W  G  E  T  K  G  T  G  H  E  G  T  L  K  R   
1921      GTTCATCTGCCCATAGTGAGCAATGAACGATGCCAGCAGCTTCACAGAGGGACTCTTCCC 
617        V  H  L  P  I  V  S  N  E  R  C  Q  Q  L  H  R  G  T  L  P   
1981      ATCACTAGTTCTAAACTGTGTGCCGGTGGCAGAAGAGATGAAGGAGTTTGTGAGAAAGAC 
637        I  T  S  S  K  L  C  A  G  G  R  R  D  E  G  V  C  E  K  D   
2041      TACGGGGGCCCTCTAGTATGTCAAGAGAGTAACAGTAAAGTCATTGTTGGTGTGAGCATA 
657        Y  G  G  P  L  V  C  Q  E  S  N  S  K  V  I  V  G  V  S  I   
2101      AATGGCAGAGGATGTGCCAGGCATAACCGACCAGCCATTTTTGTGAACGTGGCCTTCTAC 
677        N  G  R  G  C  A  R  H  N  R  P  A  I  F  V  N  V  A  F  Y   
2161      GCTGGATGGATTCATAAAGTTTACAGAAATTATCCAAACTCAGAACTGAACAATTGATCA 
697        A  G  W  I  H  K  V  Y  R  N  Y  P  N  S  E  L  N  N   
2221      CGAGAGCAGGATTGAAAATCCGATCTGTGATATAAGAACAAAATATCTCCACAAATCCAA 
2281      CAGCTCCTTTCTTGATTTATTTTGTTCATCAACAACAAAACAAGTATTATTGGAAGCTTT 
2341      CCCAGCGTGGCCATGAAGCATATATTCCAAAACTACTAAAAGTGCTTTAAACTGATGCTC 
2401      TAAATTCAAGCAGTTTGTACACCTAATAATGCCAGAACCGCAGAGCAAGGCACTGGGAGA 
2461      CAAGAGTCTCAACAGGCTATATTCGCAACTAGCCATACGGAAAGATAAAGACTACTGGAC 
2521      CGAAGTGCAGACGAG  
Fig.3.4 The nucleotide sequence of the zebrafish hgfb and deduced amino acid 
sequence. The position of nucleotides and amino acid residues are indicated on left 







3.1.1.2 Isolation of c-met full-length cDNA 
 
A 177bp partial cDNA clone of zebrafish c-met corresponding to the tyrosine kinase 
domain was obtained from previous study in Dr. Ge’s lab using degenerate PCR 
cloning. By blasting this sequence against NCBI database, a longer fragment of 
zebrafish c-met was obtained, which has 436bp nucleotides.  
 
Based on this 436 bp fragment, we design primers for RACE to obtain the full-length 
cDNA of c-met by nested PCR. 3’ RACE with nested PCR (c-met3ex and c-met3in) 
resulted in isolation of a 400bp fragment that reach to the 3’ end of the gene. First 
round 5’ RACE with nested PCR (c-met5ex1 and c-met5in1) resulted in isolation of a 
2000 bp fragment that did not reach the 5’ end of the gene. Therefore, a second round 
of 5’ RACE with nested PCR (c-met5ex2 and c-met5in2) against the 5’end of the 
2000 bp fragment was performed. This identified other two fragments of 900bp and 
2000 bp respectively, and the 2000 bp fragment contained the 5’ end of the gene. 
These four fragments were cloned into pGEM®-T Easy vector (Promega, USA) and 
sequenced. Full-length cDNA was amplified by RT PCR from 24hpf zebrafish total 
RNA using a pair of primers (c-metf and c-metr) which flank the complete ORF 
(4316bp). Schematic representation of this cloning process is shown in Fig.3.5. The 
nucleotide sequence of the zebrafish c-met and deduced amino acid sequence is 
shown in Fig.3.6. 
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Fig.3.5 Schematic representation of the procedure of isolation and cloning of full-
length zebrafish c-met cDNA clone by RACE-PCR. 
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 1         CGACCCGCAGCGTTTGCGGAGAGAACGACAACAAACCCTTTAAACTGCTGTGACCCATTC 
61        AGAGCCTGAGTCACCCTAGCACACATTCCCTGAGTGAATACGAGGTTCCGGAGAGAGAGG 
121       GAGGAAGAGCGGACAACTTTTGAGAGAAAGCGCGCAGAGATTCACCGTCGCATCCCATCC 
181       CGAGACTGTTGGCATCCGAGAGAAACTGCGCGCGCCTTGAGTAACAAGGACCGTTAAAAG 
241       ATGTGATTATTTCCTTTTTCTGTCTCCGACAGGTGTCTTTATTTTACAGAGGAACAAAGA                                                                      
301       TGACAATTCACTATTCTGAAGCTGCTTCCATCCTAATCATCCTTCAGTCGCTGTGGTGGG 
1         M  T  I  H  Y  S  E  A  A  S  I  L  I  I  L  Q  S  L  W  W    
361       GCTTGAATTGTCAATGTGAGGAACCAATAGAAAGCTCCAAACTCGACCTCTCAGTGACCT 
21        G  L  N  C  Q  C  E  E  P  I  E  S  S  K  L  D  L  S  V  T    
421       ATGACCTCCCTTACTTTGTGTCTGACACCCCCATTCAGAAGCTGTTGGAAATCAATGGAA 
41        Y  D  L  P  Y  F  V  S  D  T  P  I  Q  K  L  L  E  I  N  G    
481       CAGTGTATGTCGGTGCCGTCAATAGACTTTACGCTCTGTCGAAAGACCTGAAGAAGAAAC 
61        T  V  Y  V  G  A  V  N  R  L  Y  A  L  S  K  D  L  K  K  K    
541       ATGAGTATAAGACTGGACCGGTCCATGAGGGTCCAGACTGCAAGACCCCAACAGATCGAT 
81        H  E  Y  K  T  G  P  V  H  E  G  P  D  C  K  T  P  T  D  R    
601       GCAGTGGTTGTGAAAACAAGCCCCGCAACATAAACAACACCAATATGGCCCTGTTAATGG 
101       C  S  G  C  E  N  K  P  R  N  I  N  N  T  N  M  A  L  L  M    
661       AGACGTTCTATGACCTGGAACTTTTCAGCTGTGGCTCAGCCGGGAATGGCGTCTGCAGTC 
121       E  T  F  Y  D  L  E  L  F  S  C  G  S  A  G  N  G  V  C  S    
721       GTCATGTGTTAGAGGATGGGCCTCTGGGTGCGGAAGTAACTTGCATGTACACCAAAAAGA 
141       R  H  V  L  E  D  G  P  L  G  A  E  V  T  C  M  Y  T  K  K    
781       ATGAAGGCAGCAGCCATGGATGCCCAGACTGCCTGGCTGGACCTGCGGGCACTCAGATCC 
161       N  E  G  S  S  H  G  C  P  D  C  L  A  G  P  A  G  T  Q  I    
841       TCAACATAATGAGCGGTCGTGTTGTGAGGTTCTTCGTCGCGAACTCTGAACCTCTTGAGT 
181       L  N  I  M  S  G  R  V  V  R  F  F  V  A  N  S  E  P  L  E    
901       CAAACGGTCCACGTCTCCACCACACTATTTCCATTAGGAAGATGCGTGAAACTCAAGATG 
201       S  N  G  P  R  L  H  H  T  I  S  I  R  K  M  R  E  T  Q  D    
961       GCTTTGAGTTCTTTTCCGATCAGTCCTACATGGATTTGGCCCCTTCACTGCGGGGGAACT 
221       G  F  E  F  F  S  D  Q  S  Y  M  D  L  A  P  S  L  R  G  N    
1021      ATCCACTACATTATGTCTACTCTTTCCAGAGTGGTCCTTATGTATATTTTCTCACCGTCC 
241       Y  P  L  H  Y  V  Y  S  F  Q  S  G  P  Y  V  Y  F  L  T  V    
1081      AACGCGAAGGTGGCAACTCGAAAGCTTTCCACACGAGAATCGTACGCATGTGTTCTTCAG 
261       Q  R  E  G  G  N  S  K  A  F  H  T  R  I  V  R  M  C  S  S    
1141      ATTCTGAGATCCTGCGTTATGTAAAAATGCCCTTTGAGTGCATTTACTCTGAGCGAAGGA 
281       D  S  E  I  L  R  Y  V  K  M  P  F  E  C  I  Y  S  E  R  R    
1201      GAAAAAGGCGTTCGGCTCAAGTGGCTTTCAACGTTCTCCAGGCTGCTCATGTGGCCAAAG 
301       R  K  R  R  S  A  Q  V  A  F  N  V  L  Q  A  A  H  V  A  K    
1261      TTGGCTATGACTTTCAGCAGGAGATGGGCTTGAAAGAAGGAGAGGACGTGCTGTTTGCTG 
321       V  G  Y  D  F  Q  Q  E  M  G  L  K  E  G  E  D  V  L  F  A    
1321      CCTTTGCCCGGAGCAAACCGGACTCACCAGAGCCCACCGCCAGCTCCGCCGTTTGCCTTA 
341       A  F  A  R  S  K  P  D  S  P  E  P  T  A  S  S  A  V  C  L    
1381      TCTCCATCACGGACATCAATGAATTCTTCAAGGTTTTCATTCAGAAGGGTTACACAAGGA 
361       I  S  I  T  D  I  N  E  F  F  K  V  F  I  Q  K  G  Y  T  R    
1441      AACTCCATCACTTTCCAGGATCTGAAGAGAAAACCTTCAACCAGACGTTTGTAGGAGATT 
381       K  L  H  H  F  P  G  S  E  E  K  T  F  N  Q  T  F  V  G  D    
1501      CCTTCAGCTGTGAGAAACATGAAAGAGGCTATCGGCTAGAAGTTACAAGCACCAACCCGC 
401       S  F  S  C  E  K  H  E  R  G  Y  R  L  E  V  T  S  T  N  P    
1561      GCCGGGACTATTTTCATGGCCGCTTCCGGAATGTTCTTCTCACTTCCATAGCTGTGGTGC 
421       R  R  D  Y  F  H  G  R  F  R  N  V  L  L  T  S  I  A  V  V    
1621      CGATCCAAAACCACACTGTGGCCAGCCTTGGCACAGCTGAAGGCCGCGTCATCCAGGTGG 
441       P  I  Q  N  H  T  V  A  S  L  G  T  A  E  G  R  V  I  Q  V    
1681      TGGTTTCCCGCTTTGGCAAGACAGAGCCACATGTGGACTTCCGCTTGGACACGCTCCCTG 
461       V  V  S  R  F  G  K  T  E  P  H  V  D  F  R  L  D  T  L  P    
1741      TGTCTTCAGAAATGGCCCTGCTGTCTCCACAGCATCACAACGGCTCCTTATTGTTGATAA 
481       V  S  S  E  M  A  L  L  S  P  Q  H  H  N  G  S  L  L  L  I    
1801      CAGGAAACAAGGTCTCAAAGCTTCCTGTGATCGGGCCTGGATGTGAGCAGTTGTGGACTT 
501       T  G  N  K  V  S  K  L  P  V  I  G  P  G  C  E  Q  L  W  T     
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1861      GTAGCTCGTGTCTTCTTGCTCCGGGCTTCATGGGCTGTGGATGGTGCAGGACCAGCAACC 
521       C  S  S  C  L  L  A  P  G  F  M  G  C  G  W  C  R  T  S  N    
1921      TGTGCACCAGGGCCCCTCGATGCCCCCAGTCCCAATGGATCCAGGACTCCTGCCCCCTCC 
541       L  C  T  R  A  P  R  C  P  Q  S  Q  W  I  Q  D  S  C  P  L    
1981      TCATCACCTCGATCTCTCCTTCCTCCGCTCCACTCAGAGGTCAAACCAACATCACAATCT 
561       L  I  T  S  I  S  P  S  S  A  P  L  R  G  Q  T  N  I  T  I    
2041      GTGGCAAAAACTTTGGCTTTAACAAAAAAGACAGATTTGATACCAAACTGATAGACGTGG 
581       C  G  K  N  F  G  F  N  K  K  D  R  F  D  T  K  L  I  D  V    
2101      TGGTTGCTGGAACGAAGTGTAAATTGGAAAGGAAGGACAGTAACAATAATCGGTTGGTCT 
601       V  V  A  G  T  K  C  K  L  E  R  K  D  S  N  N  N  R  L  V    
2161      GTGGACTGGACCATGTGAACTGGTCCAGCGTGGACTCTGTGGTCACAGTGCGCAGTGGCA 
621       C  G  L  D  H  V  N  W  S  S  V  D  S  V  V  T  V  R  S  G    
2221      AGGAACAGGCCCAGAAAGATGGCTTCTCATTTGTGAATCCAGTTATCATAGAGATCTTCC 
641       K  E  Q  A  Q  K  D  G  F  S  F  V  N  P  V  I  I  E  I  F    
2281      CAGAGTTTGGACCTCAGTCTGGTGGGACAATGCTCACTATCAGCGGTTCATTCTTGGACA 
661       P  E  F  G  P  Q  S  G  G  T  M  L  T  I  S  G  S  F  L  D    
2341      GTGGAAATGTGCAAACAGTCACAGTGGGGAACGCTACCTGTGTGCTGCAGAGTGTTTCAG 
681       S  G  N  V  Q  T  V  T  V  G  N  A  T  C  V  L  Q  S  V  S    
2401      CCACAATGTTAACATGTCGTACACCACCTCAGCCCTCGCCATCCCAACACAAGGTACAGC 
701       A  T  M  L  T  C  R  T  P  P  Q  P  S  P  S  Q  H  K  V  Q    
2461      TGCACATTGATGGAGTAATATTTGAAGCGCCTGTCAGCTACACCTACAACAAGAACCCAC 
721       L  H  I  D  G  V  I  F  E  A  P  V  S  Y  T  Y  N  K  N  P    
2521      ACATCTCCAGCGTCCAGCCCAAACATTCTTTCATCAGTGGAGGAAGCACGGTGACAGTGA 
741       H  I  S  S  V  Q  P  K  H  S  F  I  S  G  G  S  T  V  T  V    
2581      ATGGCTTCTACCTGCACTCAGCTCTTCAGCCTCAGATGGTTCTCACTGCTGCCACTGAGG 
761       N  G  F  Y  L  H  S  A  L  Q  P  Q  M  V  L  T  A  A  T  E    
2641      GCAAACTCTTCCAAGTGACCTGCAGTCATGATGAGGATAAGAGAAATATCCTTTGCATCA 
781       G  K  L  F  Q  V  T  C  S  H  D  E  D  K  R  N  I  L  C  I    
2701      CGCCCTCCCTGAAAGGCCTCAGCGTTCAGCCTCCGGTCGCCACTAAAATGACCTTCGTCC 
801       T  P  S  L  K  G  L  S  V  Q  P  P  V  A  T  K  M  T  F  V    
2761      TGGATGGTTTTTCCACTGATCAGTACGACCTGCTGTACGTGGAAGATCCCAAATTTGAGG 
821       L  D  G  F  S  T  D  Q  Y  D  L  L  Y  V  E  D  P  K  F  E    
2821      AGTTTCAGAAGCCCACTGTCACACCAAGGGGCAAAAAGAACATTCTGGAGATTAAGGTCC 
841       E  F  Q  K  P  T  V  T  P  R  G  K  K  N  I  L  E  I  K  V    
2881      CCCCTGTGAATCAAGAGGCGGTGAAAAACGGTGAGGTGCTGAGAGTTTCAAATCGGACCT 
861       P  P  V  N  Q  E  A  V  K  N  G  E  V  L  R  V  S  N  R  T    
2941      GCGAGAGCGTCACTTTGGTGGGCAACACGCTCGAATGCACCGTACCCATGGAGCTCCAGA 
881       C  E  S  V  T  L  V  G  N  T  L  E  C  T  V  P  M  E  L  Q    
3001      CCGCCGCCAAAGAGCTGGAGGTGGAGTGGAAGCAGGCCACATCATCTGTGATCTTGGGCC 
901       T  A  A  K  E  L  E  V  E  W  K  Q  A  T  S  S  V  I  L  G    
3061      GTGTGATTTTGGCTCAAGACCAGGATTACAGGATACTGATCACTGGAGGAGTGTGTGTGT 
921       R  V  I  L  A  Q  D  Q  D  Y  R  I  L  I  T  G  G  V  C  V    
3121      CCATCCTCCTCCTGCTCCTGATCGCTGTGTTTGTTTGGATCAAGAGAAAGAAGCACATTA 
941       S  I  L  L  L  L  L  I  A  V  F  V  W  I  K  R  K  K  H  I    
3181      ATGATTTAGCTAAGACTATGGTTTGGTATGACGGCCGGGCTCACATTCCGCACTTGGACA 
961       N  D  L  A  K  T  M  V  W  Y  D  G  R  A  H  I  P  H  L  D    
3241      TGTTGGCAAACGCGAGGAGTGTCAGTCCCACTAATGAAATGGTCTCTCACGAGTCGGTGG 
981       M  L  A  N  A  R  S  V  S  P  T  N  E  M  V  S  H  E  S  V    
3301      ACTATAGAACCACTTTGCTTGAGGACCAAAACTTGCCTCTGTCTCAGACAGAGTCCTGCC 
1001      D  Y  R  T  T  L  L  E  D  Q  N  L  P  L  S  Q  T  E  S  C    
3361      GGCCTCATCTCTACGCTCATTCCCATGTGGATCTGTCCCCAATGCTCGGGCCAATGGAAG 
1021      R  P  H  L  Y  A  H  S  H  V  D  L  S  P  M  L  G  P  M  E    
3421      GGGACCTGGCGTCTCCGCTGCTGCCCTCTACAGCGCCTATAGATCTAGGCAGCCTCCATC 
1041      G  D  L  A  S  P  L  L  P  S  T  A  P  I  D  L  G  S  L  H    
3481      CTGAGCTGCTGAAGGAGGTCCAGCATGTGGTCATCGCAAGAGAAGATCTGCTCTTACATG 
1061      P  E  L  L  K  E  V  Q  H  V  V  I  A  R  E  D  L  L  L  H    
3541      TCAATGAGATCATCGGGAGAGGGCACTTCGGCTGCGTGTTTCATGGAACCCTCCTCGAGC 
94 
1081      V  N  E  I  I  G  R  G  H  F  G  C  V  F  H  G  T  L  L  E    
3601      CAGATGGCCAGAAGCAGCACTACGCCATCAAGTCCTTAAACCGAATCACAGATATCGAGG 
1101      P  D  G  Q  K  Q  H  Y  A  I  K  S  L  N  R  I  T  D  I  E    
3661      AGGTGTCTCAGTTTCTGAAGGAGGGCATCATCATGAAGGATTTCAGCCATCCCAATGTGC 
1121      E  V  S  Q  F  L  K  E  G  I  I  M  K  D  F  S  H  P  N  V    
3721      TTTCTCTGCTGGGAATCTGCCTGCCCAGCGAGGGTTCGCCTCTCGTCGTGTTGCCTTACA 
1141      L  S  L  L  G  I  C  L  P  S  E  G  S  P  L  V  V  L  P  Y    
3781      TGAAGCACGGAGATCTGCGCAACTTTATCAGAGATGAAAGTCATAACCCCACAGTGAAGG 
1161      M  K  H  G  D  L  R  N  F  I  R  D  E  S  H  N  P  T  V  K    
3841      ACCTGATGGGTTTCGGGCTGCAGGTGGCTAAAGGAATGGAGTATCTCGCCAGCAAGAAAT 
1181      D  L  M  G  F  G  L  Q  V  A  K  G  M  E  Y  L  A  S  K  K    
3901      TTGTTCACCGAGACCTCGCGGCCAGAAACTGCATGCTGGATGAGAGCTACACAGTGAAGG 
1201      F  V  H  R  D  L  A  A  R  N  C  M  L  D  E  S  Y  T  V  K    
3961      TGGCAGATTTTGGCCTGGCCAGAGACGTGTATGATAAAGAATACTACAGCGTACACAACA 
1221      V  A  D  F  G  L  A  R  D  V  Y  D  K  E  Y  Y  S  V  H  N    
4021      AGCACGGAGTGAAGCTGCCTGTCAAATGGATGGCGTTAGAAAGCCTGCAGACACACAAGT 
1241      K  H  G  V  K  L  P  V  K  W  M  A  L  E  S  L  Q  T  H  K    
4081      TCACAACCAAATCGGATGTGTGGTCGTTTGGTGTTTTGCTGTGGGAACTGATGACCCGAG 
1261      F  T  T  K  S  D  V  W  S  F  G  V  L  L  W  E  L  M  T  R    
4141      GCGCTCCGCCATACTCTGATGTGAACTCCTTCGACATTACAGTGTTTCTTCTGCAAGGCC 
1281      G  A  P  P  Y  S  D  V  N  S  F  D  I  T  V  F  L  L  Q  G    
4201      GGAGACTGTTACAACCAGAGTTCTGCCCTGATGCACTCTATAATGTCATGATTGAGTGCT 
1301      R  R  L  L  Q  P  E  F  C  P  D  A  L  Y  N  V  M  I  E  C    
4261      GGCACCCCAAACCCGAGCGTCGACCAACTTTCTCAGAACTAGTGTCTCGCATCTCCGCCA 
1321      W  H  P  K  P  E  R  R  P  T  F  S  E  L  V  S  R  I  S  A    
4321      TCTTCTCAAGCTTCAGCGGAGAGCACTACATCCTCCTGAACACCACCTACGTCAACATCG 
1341      I  F  S  S  F  S  G  E  H  Y  I  L  L  N  T  T  Y  V  N  I    
4381      ACAAAATGACACCCTACCCCTCTCTCATATCATCTCAGAGCAACCTCGACCGCGACTGCT 
1361      D  K  M  T  P  Y  P  S  L  I  S  S  Q  S  N  L  D  R  D  C    
4441      GCACCTGAGACACCTAAAAAAAAAAAAAAAAAAAAAAAAA 
1381      C  T      
 
Fig.3.6 The nucleotide sequence of the zebrafish c-met and deduced amino acid 
sequence. The position of nucleotides and amino acid residues are indicated on left 
side. Start codon in red. 
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3.1.2 Sequence analyses of zebrafish Hgfa, Hgfb and c-Met 
 
HGF amino acid sequences of different species are aligned (Fig.3.8) and the protein 
domains of zebrafish Hgfa and Hgfb are predicted by SMART (http://smart.embl-
heidelberg.de/) and signal peptide is predicted by SignalP 3.0 Server 
(http://www.cbs.dtu.dk/services/SignalP/), and compared with human HGF (Fig.3.9).  
 
Amino acid identity between zebrafish Hgfa and Hgfb is 60% while the nucleotide 
identity between zebrafish hgfa and hgfb is only 50%. Amino acid identities between 
zebrafish Hgfa with other vertebrate species including Human, Mice, Rat, Cat, Dog, 
Chicken and Xenopus HGF are 44% to 46% while identities between zebrafish Hgfb 
with other vertebrate species HGF are 46% to 49%. Amino acid identities of PAN_AP 
domain (divergent subfamily of APPLE domains) between zebrafish Hgfa with other 
verterbrate species’ HGF are 24% to 34% while amino acid identities of PAN_AP 
domain between zebrafish Hgfb with other verterbrate species’ HGF are 31% to 43%. 
Amino acid identities of kringle domain between zebrafish Hgfa with other 
verterbrate species’ HGF are 53% to 57% while amino acid identities of kringle 
domain between zebrafish Hgfb with other verterbrate species’ HGF are 56% to 59%. 
Amino acid identities of trypsin-like serine protease domain between zebrafish Hgfa 
with other verterbrate species’ HGF are 40% to 42% while amino acid identities of 
trypsin-like serine protease domain between zebrafish Hgfb with other verterbrate 
species’ HGF are 43% to 47%. Compared to other domains in HGF, kringle domain is 
the most conserved domain in HGF. 
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Results show that zebrafish Hgfa, Hgfb and human HGF share the same domains and 
structural organization (Fig.3.7). From the N terminal to C terminal, the domains are: 
a signal peptide which lead HGF to secretion; a PAN_AP domain which is a divergent 
subfamily of APPLE domains and possess protein- and/or carbohydrate-binding 
functions; four kringle domains which possess affinity for free lysine and lysine-
containing peptides; a trypsin-like serine protease domain which is most likely not 
catalytically active due to some of the required catalytic sites were not detected in this 
domain and catalytic residue H is replaced with Q(518) in Hgfa and S(520) in Hgfb, 
D is replace with N(561) in Hgfa and S(563) in Hgfb, S is replace with Y(595) in 
Hgfa Y(597) in Hgfb (Fig.3.8) (Kitadokoro et al., 1994). 
 
 
Fig.3.7 Comparison of the predicted domain and signal peptide of zebrafish Hgfa 
and Hgfb with human HGF. Domains are predicted by SMART 
(http://smart.embl-heidelberg.de/) and signal peptide is predicted by 
SignalP 3.0 Server (http://www.cbs.dtu.dk/services/SignalP/). SP, singnal peptide; 
PAN_AP, divergent subfamily of APPLE domains; KR, Kringle domain; Tryp_SPc, 




Cat                 -----MWVTKLLPVLLLQHVLLHLLLLP--IPYAEGQKKRRNTLHEFKKSAKTTLIKEDP 53 
Dog                 -----MWVTKLLPLLVLQQLLLHLLLLPVAVPRAEGQKKRRNTLHEFKKSAKTTLIKEDP 55 
Human               -----MWVTKLLPALLLQHVLLHLLLLPIAIPYAEGQRKRRNTIHEFKKSAKTTLIKIDP 55 
Mice                ----MMWGTKLLPVLLLQHVLLHLLLLHVAIPYAEGQKKRRNTLHEFKKSAKTTLTKEDP 56 
Rat                 ----MMWGTKLLPVLLLQHVLLHLLLLPVTIPYAEGQKKRRNTLHEFKKSAKTTLTKEDP 56 
Chicken             -----MWATQLLPALLLH----QLLLPPITIPAAEGKGKRRNPLHDYKKTGELMLIKVNK 51 
Xenopus             -----MWTTKCMVIFLLIT-------------LAEGRGKKRNAFDDYKKTAETTLTRLNK 42 
Zebrafish_Hgfa      MRSDIMWMYQALLFVVLTVN----------------VDCRKQTLQRYQKSENSRLLC-TD 43 
Zebrafish_Hgfb      -----MWIYKILLCVAVLVY----------------SETKRHALQDYQKTDAVRLVTPSD 39 
                         **  : :  . :                      :::.:. ::*:    *      
 
Cat                 LLKIKTKKMNTADQCANRCIRNKGLPFTCKAFVFDKARKRCLWFPFNSMTSGVKKEFGHE 113 
Dog                 LLKIKTKKMNTADQCANRCIRNKGLPFTCKAFVFDKARKRCLWFPFNSMTSGVKKEFGHE 115 
Human               ALKIKTKKVNTADQCANRCTRNKGLPFTCKAFVFDKARKQCLWFPFNSMSSGVKKEFGHE 115 
Mice                LLKIKTKKVNSADECANRCIRNRGFTFTCKAFVFDKSRKRCYWYPFNSMSSGVKKGFGHE 116 
Rat                 LVKIKTKKVNSADECANRCIRNKGFPFTCKAFVFDKSRKRCYWYPFNSMSSGVKKGFGHE 116 
Chicken             TLEVKTKLLNTTEQCAKRCSRNKGLSFTCKAFAYDRVTKRCHWLSFNSLTNGVRKKQDHA 111 
Xenopus             ALEVKTKMFNTTENCAKRCSRNKGLPFTCKAFAFDKNIKRCHWFSFNTMSAGIKDKYDIS 102 
Zebrafish_Hgfa      CPESPRIRNLSLEECARKCSKSKK---SCRAFYFDHINRKCHFLPFDRFSEGAKRERKPS 100 
Zebrafish_Hgfb      ASYMTKGRKMSIGKCARRCSRNRKLQFTCRAFSFDQKSTKCHLLSYDSLTFGVRMENDFN 99 
                              :  :**.:* :.:    :*:** :*:   :*   .:: :: * :       
 
Cat                 FDLYENKDYIRNCIIGKGGSYKGTVSITKSGIKCQPWNSMIPHEHSFLPSSYRGKDLQEN 173 
Dog                 FDLYENKDYIRNCIIGKGGSYKGTVSITKSGIKCQPWNSMIPHEHSFLPSSYRGKDLQEN 175 
Human               FDLYENKDYIRNCIIGKGRSYKGTVSITKSGIKCQPWSSMIPHEH-----SYRGKDLQEN 170 
Mice                FDLYENKDYIRNCIIGKGGSYKGTVSITKSGIKCQPWNSMIPHEHSFLPSSYRGKDLQEN 176 
Rat                 FDLYENKDYIRNCIIGKGGSYKGTVSITKSGIKCQPWNSMIPHEHSFLPSSYRGKDLQEN 176 
Chicken             FDLFEKKDYVRNCIIGKGAEYKGTISITKSGIQCQAWNSMIPHEHSFLPSSYRGKDLREN 171 
Xenopus             FDLYEKKDYIRDCIHGKGSNYRGTRNVTKRGLACQPWNSMIPHEHSFLPSTYRGKDLKEN 162 
Zebrafish_Hgfa      CDLYEKKDYVRECIIGSGVNYKGRRSFTKTGITCQSWNMSVPHEHNFKPTRHKKSDLRQN 160 
Zebrafish_Hgfb      FDLYEKKDFMRECIIGNGLNYKGKRSVTKSGVQCQLWNSKMPHEHNFLPQRHKHRDLRDN 159 
                     **:*:**::*:** *.* .*:*  ..** *: ** *.  :****      ::  **::* 
 
Cat                 YCRNPRGEEGGPWCFTSNPEVRYEVCDIPQCSEVECMTCNGESYRGPMDHTESGKICQRW 233 
Dog                 YCRNPRGEEGGPWCFTSNPEVRYEVCDIPQCSEVECMTCNGESYRGPMDHTESGKICQRW 235 
Human               YCRNPRGEEGGPWCFTSNPEVRYEVCDIPQCSEVECMTCNGESYRGLMDHTESGKICQRW 230 
Mice                YCRNPRGEEGGPWCFTSNPEVRYEVCDIPQCSEVECMTCNGESYRGPMDHTESGKTCQRW 236 
Rat                 YCRNPRGEEGGPWCFTSNPEVRYEVCDIPQCSEVECMTCNGESYRGPMDHTESGKTCQRW 236 
Chicken             YCRNPRGEEGGPWCFTTSPQMRHEVCDIPLCSEVECMTCNGESYRGPMDHTESGKECQRW 231 
Xenopus             YCRNPKGEEGGPWCFTKSPEVRHDVCDIPFCSEVDCVTCNGEHYRGPMDYTESGKECQRW 222 
Zebrafish_Hgfa      FCRNPDNDPNGPWCFTELTETRHQDCGLPQCSDVECMKCNGETYRGPMDHTESGKECQRW 220 
Zebrafish_Hgfb      LCRNPDNTTTGPWCFTTDPKLRHQDCSIPQCSEVECMTCNGESYRGPLDHTESGRECQRW 219 
                     **** .   ******  .: *:: *.:* **:*:*:.**** *** :*:****: **** 
 
Cat                 DRQTPHRHKFLPERYPDKGFDDNYCRNPDGKPRPWCYTLDPDTPWEYCAIKMCAHSTMND 293 
Dog                 DHQTPHRHKFLPERYPDKGFDDNYCRNPDGKPRPWCYTLDPDTPWEYCAIKMCAHSTMND 295 
Human               DHQTPHRHKFLPERYPDKGFDDNYCRNPDGQPRPWCYTLDPHTRWEYCAIKTCADNTMND 290 
Mice                DQQTPHRHKFLPERYPDKGFDDNYCRNPDGKPRPWCYTLDPDTPWEYCAIKTCAHSAVNE 296 
Rat                 DQQTPHRHKFLPERYPDKGFDDNYCRNPDGKPRPWCYTLDPDTPWEYCAIKMCAHSAVNE 296 
Chicken             DLQRPHKHKFRPERYPDKGFDDNYCRNPDGKLRPWCYTLDPNTPWEFCAIKTCDVGILNS 291 
Xenopus             DLQRPHKHKFRPERYPNKGLNDNYCRNPDGKSRPWCYTLDPDTSWEFCAIKPCVHSIVNN 282 
Zebrafish_Hgfa      DSQKPHKHTYQPHRHVGKGLDDNFCRNPNNDVRPWCYTMDKNTPWEYCNISVCDSDSDVE 280 
Zebrafish_Hgfb      DLEEPHKHIFHPKRYPDKGLKDNYCRNPDGRQRPWCFTTDPSTPWEYCNIKQCDSDNSGD 279 
                    * : **:* : *.*: .**:.**:****:.  ****:* *  * **:* *. *  .   . 
 
Cat                 TDVPMETTECIQGQGEGYRGTINSIWNGVPCQRWDSQYPHQHDITPENFKCKDLRENFCR 353 
Dog                 TDVPMETTECIQGQGEGYRGTINTIWNGVPCQRWDSQYPHQHDITPENFKCKDLRENYCR 355 
Human               TDVPLETTECIQGQGEGYRGTVNTIWNGIPCQRWDSQYPHEHDMTPENFKCKDLRENYCR 350 
Mice                TDVPMETTECIQGQGEGYRGTSNTIWNGIPCQRWDSQYPHKHDITPEKFKCKDLRENYCR 356 
Rat                 TDVPMETTECIKGQGEGYRGTTNTIWNGIPCQRWDSQYPHKHDITPENFKCKDLRENYCR 356 
Chicken             TEAVAETTTCIQGQGEGYRGTVNTIWSGIQCQRWDSQFPHQHNITPENFKCKDLRENYCR 351 
Xenopus             TDI---TKDCMKGQGEGYRGSVSTTYNGIQCQRWDSQFPHLHNFTPENYKCKDLSENYCR 339 
Zebrafish_Hgfa      VEV---TSSCFRGQGEGYRGTVNVTPAGVTCQRWDALSPHIHSYTPHNYKCKDLRENYCR 337 
Zebrafish_Hgfb      VEN---TTTCFRGRGEGYRGTVGITPDGVTCQRWDAQFPHRHSYTPQNYHCKDLRENYCR 336 
                    .:    *. *::*:******: .    *: *****:  ** *. **.:::**** **:** 
 
98 
Cat                 NPDGAESPWCFTTDPNIRVGYCSQIPKCDVSSGQ--DCYRGNGKNYMGNLSKTRSGLTCS 411 
Dog                 NPDGAESPWCFTTDPNIRVGYCSQIPKCDVSSGQ--DCYRGNGKNYMGNLSKTRSGLTCS 413 
Human               NPDGSESPWCFTTDPNIRVGYCSQIPNCDMSHGQ--DCYRGNGKNYMGNLSQTRSGLTCS 408 
Mice                NPDGAESPWCFTTDPNIRVGYCSQIPKCDVSSGQ--DCYRGNGKNYMGNLSKTRSGLTCS 414 
Rat                 NPDGAESPWCFTTDPNIRVGYCSQIPKCDVSSGQ--DCYRGNGKNYMGNLSKTRSGLTCS 414 
Chicken             NPDGSESPWCFTTDPNIRIGYCSQIPKCDVSNEQ--DCYRGNGKSYMGNLSNTRIGLTCS 409 
Xenopus             NPDGSESPWCFTTDPNIRIGHCSQIKKCQASNQQ--ECYYGNGSTYKGTLSRTRFRLPCS 397 
Zebrafish_Hgfa      NPDGSEIPWCFTTDAKVRKAFCTNIPRCESESSDSTECYEDNGESYRGNLSKTRSGIPCG 397 
Zebrafish_Hgfb      NPDGRHLPWCFTTDPTVPIAFCTNIPRCGLKPPEPEECYKGIGDMYNGHRSKTRSGIPCA 396 
                    **** . *******..:  ..*::* .*  .  :  :** . *. * *  *.**  :.*. 
 
Cat                 MWEKNMEDLHRH--IFWEPDASKLNKNYCRNPDDDAHGPWCYTGNPLIPWDYCPISRCEG 469 
Dog                 MWEKNMEDLHRH--IFWEPDASKLNKNYCRNPDDDAHGPWCYTGNPLIPWDYCPIFRCEG 471 
Human               MWDKNMEDLHRH--IFWEPDASKLNENYCRNPDDDAHGPWCYTGNPLIPWDYCPISRCEG 466 
Mice                MWDKNMEDLHRH--IFWEPDASKLNKNYCRNPDDDAHGPWCYTGNPLIPWDYCPISRCEG 472 
Rat                 MWDKNMEDLHRH--IFWEPDASKLTKNYCRNPDDDAHGPWCYTGNPLVPWDYCPISRCEG 472 
Chicken             TWDKNIEDLRRHIQIFREPDVSKLKKNYCRNPDDDFHGPWCYTDDPLIPWDYCPISRCTG 469 
Xenopus             MWEKNLQDLKRH--TFNEPDVSILQKNYCRNPDNDAHGPWCYTDDPFVPWDYCPISRCEG 455 
Zebrafish_Hgfa      LWSDHTFRRDTR----SAKASAGLELNLCRNPDRDKHGPWCYTSNSSIPWDYCGLERCKS 453 
Zebrafish_Hgfb      PWKDHSESNERD----VNLLTAEQAGNFCRNPDKDKHGPWCYTNSSSIPWDYCSLKPCEP 452 
                     *..:                :    * ***** * *******... :***** :  *   
 
Cat                 DTTPTIVNLDHPVISCAKTKQLRVVNG--IPTRTNVGWMVSLKYRNKHICGGSLIKESWI 527 
Dog                 DTTPTIVNLDHPVISCAKTKQLRVVNG--IPTRTNVGWMVSLKYRNKHICGGSLIKESWI 529 
Human               DTTPTIVNLDHPVISCAKTKQLRVVNG--IPTRTNIGWMVSLRYRNKHICGGSLIKESWV 524 
Mice                DTTPTILNLDHPVISCAKTKQLRVVNG--IPTQTTVGWMVSLKYRNKHICGGSLIKESWV 530 
Rat                 DTTPTIVNLDHPVISCAKTKQLRVVNG--IPTQTTVGWMVSLKYRNKHICGGSLIKESWV 530 
Chicken             DTTPTTTSLDDTVIPCASTKHLRVVNG--IPTQTNEGWVVSLTYRNKHICGGTLVKEEWV 527 
Xenopus             DTAKIMANIDSP-ITCSSSKQLRVVNG--IPAQTRKVWMVSVRYRNAHKCGGTLIKENWV 512 
Zebrafish_Hgfa      MSSDDHQMSGGPKPSCFIHKTTRIVGGMRVQRAEDGSWVVSIQKGNRHWCGGSLIREEWV 513 
Zebrafish_Hgfb      SHNNLPQKDEVTKSSCFVHKQVRIVGGGPVPIKE-GSWMVSIQKGSSHWCGGALVREEWV 511 
                               .  .*   *  *:*.*  :       *:**:   . * ***:*::*.*: 
 
Cat                 LTARQCFPSRNKDLKDYEAWLGIHDVHGRGDEKR-KQVLNVSQLVYGPEGSDLVLLKLAR 586 
Dog                 LTARQCFPSRNRDLKDYEAWLGIHDVHGKGDEKR-KQVLNVSQLVYGPEGSDLVLLKLAR 588 
Human               LTARQCFPSR--DLKDYEAWLGIHDVHGRGDEKC-KQVLNVSQLVYGPEGSDLVLMKLAR 581 
Mice                LTARQCFPARNKDLKDYEAWLGIHDVHERGEEKR-KQILNISQLVYGPEGSDLVLLKLAR 589 
Rat                 LTARQCFPARNKDLKDYEAWLGIHDVHERGEEKR-KQILNISQLVYGPEGSDLVLLKLAR 589 
Chicken             LTARQCFPSRYKDLKDYKAWLGVHNIKGKGEEKH-RQVRNISQLIYGPAGSDLVLLKLSR 586 
Xenopus             LTARQCFLSGDIDLKYYEAWLGVHNIYST-TEKH-KQILNISQLVHGPKGSNLVLLKLSR 570 
Zebrafish_Hgfa      LTDQQCFPTCVPDLSEYTVQVGLLHLNASAG----TQALRIAHVVCGPEGSNLALLKLTT 569 
Zebrafish_Hgfb      LTDKDCFSSCVPDLSEYRVWLGITHLNESGENDFHRQERRISHVICGPEDSSLALLRLSQ 571 
                    ** ::** :   **. * . :*: .:          *  .::::: ** .*.*.*::*:  
 
Cat                 PAVLDDFVSTIDLPNYGCTIPEKTTCSVYGWGYTGSINSDGLLRVAHLYIMGNEKCSQYH 646 
Dog                 PAILDDFVSTIDLPNYGCTIPEKTTCSVYGWGYTGSINFDGLLRVAHLYIMGNEKCSQYH 648 
Human               PAVLDDFVSTIDLPNYGCTIPEKTSCSVYGWGYTGLINYDGLLRVAHLYIMGNEKCSQHH 641 
Mice                PAILDNFVSTIDLPSYGCTIPEKTTCSIYGWGYTGLINADGLLRVAHLYIMGNEKCSQHH 649 
Rat                 PAILDNFVSTIDLPSYGCTIPEKTTCSIYGWGYTGLINADGLLRVAHLYIMGNEKCSQHH 649 
Chicken             PAILTNFVEIIRLPISGCTIPEKTSCSVFGWGYTGLPNYDGLLRVANLFILGNEKCNQYL 646 
Xenopus             PATLNAYVDRIKLPNYGCTIPEKTTCSVYGWGHTGTNDYDGQLQEGTLHIVGNEKCNENH 630 
Zebrafish_Hgfa      PAPLSEHVRTVQLPVAGCAVAEGTLCLMYGWGDTKGTGHEGSLKMVGLPIVSNKRCSQSH 629 
Zebrafish_Hgfb      PALPSERVRVIQLPVADCSIQEDTICSVYGWGETKGTGHEGTLKRVHLPIVSNERCQQLH 631 
                    **     *  : **  .*:: * * * ::*** *   . :* *:   * *:.*::*.:   
 
Cat                 QGKVTLNESEICAGAENIVSGPCEGDYGGPLVCEQHKMRMVLGVIVPGRGCAIPNRPGIF 706 
Dog                 QGKVTLNESEICAGAENIVSGPCEGDYGGPLVCEQHKMRMVLGVIVPGRGCAIPNRPGIF 708 
Human               RGKVTLNESEICAGAEKIGSGPCEGDYGGPLVCEQHKMRMVLGVIVPGRGCAIPNRPGIF 701 
Mice                QGKVTLNESELCAGAEKIGSGPCEGDYGGPLICEQHKMRMVLGVIVPGRGCAIPNRPGIF 709 
Rat                 QGKVTLNESELCAGAEKIGSGPCEGDYGGPLICEQHKMRMVLGVIVPGRGCAIPNRPGIF 709 
Chicken             KGKITVNESEICAVAETIGAGPCERDYGGPLVCEQNRLKIVVGVIVPGRGCAIRNRPGIF 706 
Xenopus             KGKITVNESEICAIGETANIGPCERDYGGPLICEENRTHLVQGVIIPGRGCAIQKRPVIF 690 
Zebrafish_Hgfa      NGILPITETKICAGGKRD-QGVCEKDYGGPLVCQEGESKVIVGVSINGRGCAVARRPAVF 688 
Zebrafish_Hgfb      RGTLPITSSKLCAGGRRD-EGVCEKDYGGPLVCQESNSKVIVGVSINGRGCARHNRPAIF 690 
                    .* :.:..:::** ..    * ** ******:*:: . ::: ** : *****  .** :* 
 
99 
Cat                 VRVAYYAKWIHKIILTYKIPQS-- 728 
Dog                 VRVAYYAKWIHKIILTYKIQQS-- 730 
Human               VRVAYYAKWIHKIILTYKVPQS-- 723 
Mice                VRVAYYAKWIHKVILTYKL----- 728 
Rat                 VRVAYYAKWIHKVILTYKL----- 728 
Chicken             VRVSYYSRWIHKIMMTYRKP---- 726 
Xenopus             VRVAYYAKWIHKIMLTYKAP---- 710 
Zebrafish_Hgfa      VNVAFYSEWIRKVFKYYSDMEISY 712 
Zebrafish_Hgfb      VNVAFYAGWIHKVYRNYPNSELNN 714 
                    *.*::*: **:*:   *        
 
Fig.3.8 Amino acid sequence alignment of HGFs from Cat, Chicken, Dog, 
Human, Mice, Rat, Xenopus and Zebrafish. The identical residues are indicated by 
asterisk. Required catalytic sites for trypsin-like serine protease domain are not 
detected and catalytic residues are replaced with amino acids are highlighted in 
yellow. Human HGF’s domains are highlighted in different colors: singnal peptide in 
pink; PAN_AP domain (divergent subfamily of APPLE domains) in green; Kringle 
domain in red; Trypsin-like serine protease domain in turquoise.  
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 c-Met amino acid sequences of different species are also aligned (Fig.3.10) and the 
protein domains of zebrafish c-Met is predicted by SMART (http://smart.embl-
heidelberg.de/) and signal peptide is predicted by SignalP 3.0 Server 
(http://www.cbs.dtu.dk/services/SignalP/), and compared to human c-MET (Fig. 3.9).  
Amino acid identities between zebrafish c-Met with other vertebrate species including 
Human, Mice, Rat, Cat, Dog, Chicken and Xenopus c-MET are 51% to 53% while 
identity between zebrafish c-Met with fugu Met is 59%. Amino acid identities of 
semaphorin domain between zebrafish c-Met with other verterbrate species’ c-MET 
are 43% to 47%. Amino acid identities of PSI domain (domain found in Plexins, 
Semaphorins and Integrins) between zebrafish c-Met with other verterbrate species’ c-
MET are 41% to 50%. Amino acid identities of IPT domain (Ig-like, plexins, 
transcription factors) between zebrafish c-Met with other verterbrate species’ c-MET 
are 38% to 52%. Amino acid identities of tyrosine kinase catalytic domain between 
zebrafish c-Met with other verterbrate species’ c-MET are 81% to 90%. Compared to 
other domains in c-MET, tyrosine kinase catalytic domain is the most conserved 
domain in c-MET. 
 
Results show that zebrafish c-Met and human c-MET share the same domains and 
structural organization (Fig.3.9). From the N terminal to C terminal, the domains are: 
a signal peptide which lead c-Met to form transmembrane protein; a semaphorin 
domain; a PSI domain which is found in Plexins, Semaphorins and Integrins; four IPT 
domains which has an immunoglobulin like fold; a tyrosine kinase domain which is 
highly conseverd and have 80% to 90% identities with other vertebrate species’ c-




Fig.3.9 Comparison of the predicted domain and signal peptide of zebrafish c-
Met with human c-MET. Domains are predicted by SMART (http://smart.embl-
heidelberg.de/) and signal peptide is predicted by SignalP 3.0 Server 
(http://www.cbs.dtu.dk/services/SignalP/). SP, singnal peptide; Sema, semaphorin 
domain; PSI, domain found in Plexins, Semaphorins and Integrins; IPT, Ig-like, 





Cat             MKAPAVLAPGILVLLFTLVQKSYGECREALVKSEMNVNMKYQLPNFTAETPIQNVVLHKH 60 
Dog             MKAPAVLAPGILVLLFTLVQKSYGECKEALVKSEMNVNMKYQLPNFTAETPIQNVVLHKH 60 
Human           MKAPAVLAPGILVLLFTLVQRSNGECKEALAKSEMNVNMKYQLPNFTAETPIQNVILHEH 60 
Mice            MKAPTVLAPGILVLLLSLVQRSHGECKEALVKSEMNVNMKYQLPNFTAETPIQNVVLHGH 60 
Rat             MKAPTALAPGILLLLLTLAQRSHGECKEALVKSEMNVNMKYQLPNFTAETPIQNVVLHGH 60 
Chicken         MKPVTAYPSGIILFLFALLQRSHGQCKEAAKKSEMNLNVKYDLPNFITETPIQNVVLYKH 60 
Xenopus         ----MLVAVPVALLFLSLLPQCMGQCEEAAKMAEMDLNLKLNLQNFTTDTPIQSIIMFKG 56 
Fugu            --MNLCSFPAAVLLLWALSASAEGHCQKSPEPNKLNLSVSYELPTFTAEFPIQNVVTLDG 58 
Zebrafish       MTIHYSEAASILIILQSLWWGLNCQCEEPIESSKLDLSVTYDLPYFVSDTPIQKLLEING 60 
                            ::: :*      .*.:.    ::::.:. :*  * :: ***.::     
 
Cat             HIYLGAVNYIYVLNDKDLQKVAEYKTGPVLEHPDCFPCQDCSHKANLSGGVWKDNIN--- 117 
Dog             HIYLGAVNYIYVLNDKDLQKVAEYKTGPVLEHPDCSPCQDCSHKANLSGGVWEDNIN--- 117 
Human           HIFLGATNYIYVLNEEDLQKVAEYKTGPVLEHPDCFPCQDCSSKANLSGGVWKDNIN--- 117 
Mice            HIYLGATNYIYVLNDKDLQKVSEFKTGPVLEHPDCLPCRDCSSKANSSGGVWKDNIN--- 117 
Rat             HIYLGATNYIYVLNDKDLQKVSEFKTGPVVEHPDCFPCQDCSSKANVSGGVWKDNVN--- 117 
Chicken         HVYIGAVNKIYVLN-ETLQNISVYKTGPILESPGCAPCEDCKDKANLSNSVWKDNVN--- 116 
Xenopus         YVYVGAVNKIYVLN-ENLTKISEYKTGPLLKHSDCLPCKNCTDNLLSPNGTWKDSVN--- 112 
Fugu            IIYVGATNRIYALA-PSLTKLSEYRTGPLLANQTCGQKVANAS----SGGGRKDNLN--- 110 
Zebrafish       TVYVGAVNRLYALS-KDLKKKHEYKTGPVHEGPDCKTPTDRCS----GCENKPRNINNTN 115 
                 :::**.* :*.*    * :   ::***:     *                   .:*    
 
Cat             MALLIDTYYDDQLISCGSVHRGTCQRHVLPPSNTAD-------ILSKVHCMYSPQADEES 170 
Dog             MALLVDTYYDDQLISCGSVHRGTCQRHILPPSNIAD-------IQSEVHCMYSSQADEEP 170 
Human           MALVVDTYYDDQLISCGSVNRGTCQRHVFPHNHTAD-------IQSEVHCIFSPQIEE-P 169 
Mice            MALLVDTYYDDQLISCGSVNRGTCQRHVLPPDNSAD-------IQSEVHCMFSP--EEES 168 
Rat             MALLVDTYYDDQLISCGSVNRGTCQRHVLPPDNAAD-------IQSEVHCMFSPLAEEES 170 
Chicken         MALLLETYYDDQLISCGSVSGGVCHRHIIPPDNPAD-------IESEVHCMYSPQVDGEA 169 
Xenopus         MALFVQDFYDDQLISCGNIRKGECQRHTLHSDKPWD-------IASDVHCLYSSQMVEDK 165 
Fugu            VALVVENIYDKGLFSCGSADNGVCRRHVLEDDVSLDEEGRQKSVDELVYCFTDLKQDKGQ 170 
Zebrafish       MALLMETFYDLELFSCGSAGNGVCSRHVLEDGP----------LGAEVTCMYTKKNEGSS 165 
                :**.::  **  *:***.   * * ** :  .           :   * *:          
 
Cat             SHCPDCVVSALGTKVLISEKGRFINFFVGNTINSSY----LTDHSLHSISVRRLKETQDG 226 
Dog             SQCPDCVVSALGTKVLISEKDRFINFFVGNTINSSD----HPDHSLHSISVRRLKETQDG 226 
Human           SQCPDCVVSALGAKVLSSVKDRFINFFVGNTINSSY----FPDHPLHSISVRRLKETKDG 225 
Mice            GQCPDCVVSALGAKVLLSEKDRFINFFVGNTINSSY----PPGYSLHSISVRRLKETQDG 224 
Rat             GQCPDCVVSALGAKVLLSEKDRFINFFVGNTINSSY----PPDYSLHSISVRRLKETQDG 226 
Chicken         DNCPDCVVSTLGTKVLVTEKDRFVNFFVGNTMTSAF----QPPHVLHSISVRRLKETQDG 225 
Xenopus         DSCPDCIVSTAGSKILVTVGDRFVKFFVGSTLTGQ-------PSTIHSVSVRRLKETQDG 218 
Fugu            PRDSDVVVSPSGSQVLNVESN-MIMFFVGNSEIPGSGNVTGPTARPHTMSLRKMKTSQNG 229 
Zebrafish       HGCPDCLAGPAGTQILNIMSGRVVRFFVANSEPLES---NGPRLH-HTISIRKMRETQDG 221 
                   .* :... *:::*    . .: ***..:               *::*:*::: :::* 
 
Cat             FKFLTDQSYIDVLPEFRDSYPIKYIHAFESNRFIYFLTVQRETLDAQTFHTRIIRFCSVD 286 
Dog             FKFLTDQSYIDVLPEFRDSYPIKYVHAFESNHFIYFLTVQRETLDAQTFHTRIIRFCSVD 286 
Human           FMFLTDQSYIDVLPEFRDSYPIKYVHAFESNNFIYFLTVQRETLDAQTFHTRIIRFCSIN 285 
Mice            FKFLTDQSYIDVLPEFQDSYPIKYIHAFESNHFIYFLTVQKETLDAQTFHTRIIRFCSVD 284 
Rat             FKFLTDQSYIDVLGEFRDSYPIKYIHAFESNHFIYFLTVQKETLDAQTFHTRIIRFCSVD 286 
Chicken         FEFLTDQSYIDILPQFRDSYPIKYVHAFEHDHFVYFLTVQRESLDSQTFHTRIIRFCTLD 285 
Xenopus         FEYLTDQSYIDVLPHLRDIYPIRYIYTFESNNFVYFLTVQRESLDSQAYHTRIVRICSSD 278 
Fugu            FTFFSNRSYMDLIPPLRGSYYLRYVYSFHSGPFTYFLTVQQVSKDSQTYHTRIVRMCSSD 289 
Zebrafish       FEFFSDQSYMDLAPSLRGNYPLHYVYSFQSGPYVYFLTVQREGGNSKAFHTRIVRMCSSD 281 
                * :::::**:*:   ::. * ::*:::*. . : ******:   :::::****:*:*: : 
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Cat             SGLHSYMEMPLECILTEKRRKRS-TREEVFNILQAAYVSKPG--AHLAKQIGANLNDDIL 343 
Dog             SGLHSYMEMPLECILTEKRRKRS-TREEVFNILQAAYVSKPG--AHLAKQIGANLNDDIL 343 
Human           SGLHSYMEMPLECILTEKRKKRS-TKKEVFNILQAAYVSKPG--AQLARQIGASLNDDIL 342 
Mice            SGLHSYMEMPLECILTEKRRKRS-TREEVFNILQAAYVSKPG--ANLAKQIGASPSDDIL 341 
Rat             SGLHSYMEMPLECILTEKRRKRS-TREEVFNILQAAYVSKPG--ANLAKQIGASPYDDIL 343 
Chicken         SEMRSYMEMPLECIFTEKRRKRS-IRKEVFNILQAAYVSKPG--AALAHEMGLGLIDDIL 342 
Xenopus         SELRSYIEMPLECIFTEKRRKRS-TASAVFNIVQAAYLGRAG--EDLAEEMGVKPDDDIL 335 
Fugu            HDIRRYVEMPLECISTDKRRRRSMEDVKVFNILQAATVTKVGSDVELQRQLRLEEGDDVL 349 
Zebrafish       SEILRYVKMPFECIYSERRRKRRSAQV-AFNVLQAAHVAKVG--YDFQQEMGLKEGEDVL 338 
                  :  *::**:*** :::*::*      .**::*** : : *    : .::     :*:* 
 
Cat             YGVFAQSKPDSAEPMNRSAVCAFPIKYVNEFFNKIVNKNNVRCLQHFYGPNHEHCFN--- 400 
Dog             YGVFAQSKPDSAEPMNRSAVCAFPIKYVNEFFNKIVNKNNVRCLQHFYGPNHEHCFN--- 400 
Human           FGVFAQSKPDSAEPMDRSAMCAFPIKYVNDFFNKIVNKNNVRCLQHFYGPNHEHCFN--- 399 
Mice            FGVFAQSKPDSAEPVNRSAVCAFPIKYVNDFFNKIVNKNNVRCLQHFYGPNHEHCFN--- 398 
Rat             YGVFAQSKPDSAEPMNRSAVCAFPIKYVNDFFNKIVNKNNVRCLQHFYGPNHEHCFN--- 400 
Chicken         YGVFAQTNQIPQEPTNRSAVCAVSVRTINEFFNKIVDKQNMKCLQHFYGKDSKYCLN--- 399 
Xenopus         YGVFAQSKPDSPEPNNRSAVCAVSVKTINEFFNSAADKQNTKCLEHFYGKDNRLCINN-- 393 
Fugu            FAAFARGKPNSTEATPNSAICVMSLKLINSMFKMYMQKCNTVDLYHFTGSDKKSCYNVSS 409 
Zebrafish       FAAFARSKPDSPEPTASSAVCLISITDINEFFKVFIQKGYTRKLHHFPGSEEKTFNQTFV 398 
                :..**: :  . *.   **:* ..:  :*.:*:   :*     * ** * : .   :    
 
Cat             -RTLLRNSSGCEVRSDEYRTEFTTALQRVDLFMGQFNQVLLTSISTFIKGDLTIANLGTS 459 
Dog             -RTLLRNSSGCEARNDEYRTEFTTALQRVDLFMGQFNQVLLTSISTFIKGDLTIANLGTS 459 
Human           -RTLLRNSSGCEARRDEYRTEFTTALQRVDLFMGQFSEVLLTSISTFIKGDLTIANLGTS 458 
Mice            -RTLLRNSSGCEARSDEYRTEFTTALQRVDLFMGRLNQVLLTSISTFIKGDLTIANLGTS 457 
Rat             -RTLLRNSSGCEVRSDEYRTEFTTALQAVDLFMGRLNHVLLTSISTFIKGDLTIANLGTS 459 
Chicken         -RAFSRNASYCRAQDDEYRLEVTTPLQRVDLFMGQFNNILLTSISVFTKGNLTIANLGTS 458 
Xenopus         -KRFLRNASHCSTPIDEYRVEVTTVLRRLDLFMDQFRNVLLTSISVFTQGRLTIANLGTS 452 
Fugu            SDDCDPHEGIHEGKEGKYRLQVTQFVQRLEYWQKVLTNTLVTSITVVTVHGRAVGYLGTA 469 
Zebrafish       GDSFS-----CEKHERGYRLEVTSTNPRRDYFHGRFRNVLLTSIAVVPIQNHTVASLGTA 453 
                                 ** :.*      : :   : . *:***:..     ::. ***: 
 
Cat             EGRFMQVVVSRSGSSTPHVNFRLDSHPVSSEAIVEHPLNQNGYTLVVTGKKITKIPLNGL 519 
Dog             EGRFMQVVVSRSGLSTPHVNFRLDSHPVSPEAIVEHPLNQNGYTLVVTGKKITRIPLNGL 519 
Human           EGRFMQVVVSRSGPSTPHVNFLLDSHPVSPEVIVEHTLNQNGYTLVITGKKITKIPLNGL 518 
Mice            EGRFMQVVLSRTAHLTPHVNFLLDSHPVSPEVIVEHPSNQNGYTLVVTGKKITKIPLNGL 517 
Rat             EGRFMQVVLSRTAHFTPHVNFLLDSHPVSPEVIVEHPSNQNGYTLVVTGKKITKIPLNGL 519 
Chicken         EGRFMQIVVSRSEPTAPHVSFQLDSHAVSPQVVVEQSAAADGYTLVVTGKKITKVPLNGP 518 
Xenopus         EGRFMQVIISRTGQPKPHVNFLLEARPISPEIVINTASEESGYTLVNTGMQIIKVPLVVL 512 
Fugu            DGRHIQVVFSRFAS--PHVNIRLDSRPVSGSVVLPGQDPSEGALLLTTGNKITKVPLIGP 527 
Zebrafish       EGRVIQVVVSRFGKTEPHVDFRLDTLPVSSEMALLSPQHHNGSLLLITGNKVSKLPVIGP 513 
                :** :*::.**     ***.: *:: .:* .  :      .*  *: ** :: ::*:    
 
Cat             GCEHFQSCSQCLSAPPFVQCGWCHDK--CVQLEECPSGTWTQEICLPTIYEVFPTSAPLE 577 
Dog             GCEHFQSCSQCLSAPPFVQCGWCHDR--CVHLEECPTGAWTQEVCLPAIYEVFPTSAPLE 577 
Human           GCRHFQSCSQCLSAPPFVQCGWCHDK--CVRSEECLSGTWTQQICLPAIYKVFPNSAPLE 576 
Mice            GCGHFQSCSQCLSAPYFIQCGWCHNQ--CVRFDECPSGTWTQEICLPAVYKVFPTSAPLE 575 
Rat             GCGHFQSCSQCLSAPYFIQCGWCHNR--CVHSNECPSGTWTQEICLPAVYKVFPTSAPLE 577 
Chicken         GCHHFQSCSQCLLAPAFMRCGWCGQQ--CLRAPECNGGTWTQETCLPRVYEILPSSAPLE 576 
Xenopus         TCGHLKSCSHCLSSPS-VNCGWSKNH--CSTKQECLNEEWIQETCPPAVYEVFPSSAPLE 569 
Fugu            GCDHLTTCTSCLVSSRVTECGWCEGR--CTRANQCPPSVWTQEYCTPVVTKVFPTSGPIR 585 
Zebrafish       GCEQLWTCSSCLLAPGFMGCGWCRTSNLCTRAPRCPQSQWIQDSCPLLITSISPSSAPLR 573 
                 * :: :*: ** :.    ***.     *    .*    * *: *   : .: *.*.*:. 
 
Cat             GGTMLTVCGWDFGFRRNNKFDLKKTRVFLGNESCTLTLSESTT--NMLKCT-VGPAVNEH 634 
Dog             GGTVLTVCGWDFGFRRNNKFDLKKTKVFLGNESCTLTLSESTT--NMLKCT-VGPAVNEH 634 
Human           GGTRLTICGWDFGFRRNNKFDLKKTRVLLGNESCTLTLSESTM--NTLKCT-VGPAMNKH 633 
Mice            GGTVLTICGWDFGFRKNNKFDLRKTKVLLGNESCTLTLSESTT--NTLKCT-VGPAMSEH 632 
Rat             GGTMLTICGWDFGFKKNNKFDLRKTKVLLGNESCTLTLSESTT--NTLKCT-VGPAMSEH 634 
Chicken         GGTKLTLCGWDFGFSKNNRFELRNTVVHIGGQICALEAKSSNK--NKLECT-APAAKNAS 633 
Xenopus         GGTQLTICGSDFVLSKNNNFDLKNTVVIIGKKRCKIEGKFSNQ--NKLVCR-TDSSVSSV 626 
Fugu            GSTTVTMCGRNFGFDKTESFKASLVTVEVAGVPCKLSRQDYASRWTEIQCSPMFSGNFTP 645 
Zebrafish       GQTNITICGKNFGFNKKDRFDTKLIDVVVAGTKCKLERKDSNN--NRLVCG-LDHVNWSS 630 
                * * :*:** :* : :.: *.     * :.   * :  .      . : *           
 
Cat             FNISIIISNGRGTAQYSTFSYVDPVITSIFPSYGPKTGGTLLTLTGKYLNSGNSRHISIG 694 
Dog             FNISIIISNGRGTAQYSTFSYVDPIITSISPSYGPKNGGTLLTLTGKYLNSGNSRHISMG 694 
Human           FNMSIIISNGHGTTQYSTFSYVDPVITSISPKYGPMAGGTLLTLTGNYLNSGNSRHISIG 693 
Mice            FNVSVIISNSRETTQYSAFSYVDPVITSISPRYGPQAGGTLLTLTGKYLNSGNSRHISIG 692 
Rat             FNVSVIVSNSRETTQYSAFSYVDPVITSISPRYGPHAGGTLLTLTGKYLNSGNSRHISIG 694 
Chicken         FNISSSVSVGHGKTLFNTFSYVNPIITSISPTYGPKSGGTLLTIAGKYLNSGKSRRIFVG 693 
Xenopus         FNMSSSVSNGKQVVNFTTFSYVNPIITSIRPSYGPRAGRTLLTIKGHYLDSGKDRKVYIG 686 
Fugu            SGHTVKVTSGHKIATIEGFTFVDPVVSEIFPTFGPKSGNTMLTIRGAFLDTGNKREVTVG 705 
Zebrafish       VDSVVTVRSGKEQAQKDGFSFVNPVIIEIFPEFGPQSGGTMLTISGSFLDSGNVQTVTVG 690 
                 .    :  .:  .    *::*:*:: .* * :**  * *:**: * :*::*: : : :* 
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Cat             GKTCTLKSVSDSILECYTPAQTIPTEFPIKLKIDLANREMN-SFSYQEDPIVYAIHPTKS 753 
Dog             GKTCTLKSVSDSILECYTPAQATATEFPIKLKIDLANREMN-SFSYQEDPIVYAIHPTKS 753 
Human           GKTCTLKSVSNSILECYTPAQTISTEFAVKLKIDLANRETS-IFSYREDPIVYEIHPTKS 752 
Mice            GKTCTLKSVSDSILECYTPAQTTSDEFPVKLKIDLANRETS-SFSYREDPVVYEIHPTKS 751 
Rat             GKTCTLKSVSDSILECYTPGHTVSAEFPVKLKIDLADRVTS-SFSYGEDPFVSEIHPTKS 753 
Chicken         EKPCSLKSTSESSVECYTPAQRIPQEYRVRVGIDGAIRDAKGYFTYREDPVVLKIHPAKS 753 
Xenopus         KEMCNIKSVSSAAIVCLTPGQGTTGTYLVALKIDNANRESSTRFTYMEDPSVSSIKPVKS 746 
Fugu            KAACKIQSLSATMLTCKTPPHAVPSKQPVRLTVDSVARDAPVLYTYHQDPIISSIQPSRS 765 
Zebrafish       NATCVLQSVSATMLTCRTPPQPSPSQHKVQLHIDGVIFEAPVSYTYNKNPHISSVQPKHS 750 
                   * ::* * : : * ** :  .    : : :* .       ::* ::* :  ::* :* 
 
Cat             FISGGSTITAVGKNLNSVSVLRMVISVHETRRNFTVACHHRSNSEIICCTTPSLQQLNLQ 813 
Dog             FISGGSTITAVGKNLNSVSVLRMVIDVHETRRNFTVACQHRSNSEIICCTTPSLQQLNLQ 813 
Human           FISGGSTITGVGKNLNSVSVPRMVINVHEAGRNFTVACQHRSNSEIICCTTPSLQQLNLQ 812 
Mice            FISGGSTITGIGKTLNSVSLPKLVIDVHEVGVNYTVACQHRSNSEIICCTTPSLKQLGLQ 811 
Rat             FISGGSTITGIGKNLNSVSTPKLVIEVHDVGVNYTVACQHRSSSEIICCTTPSLQQLDLQ 813 
Chicken         FLSGGSTITAQGINLNSVCFPRMVITVPKLGMNFSVACSHRSSSEIICCTTPSLKAFNLQ 813 
Xenopus         FLSGGSSITAYGKNLNAVASPLMVIHLSKLEVSYNMSCIHRSTSELIWCSTPSLKELNLE 806 
Fugu            FVSGGCTVAAHGLFLQSGLQPQMVLTTGQDAEVFHVSCVYGENRTSIQCTTPSLAKLALQ 825 
Zebrafish       FISGGSTVTVNGFYLHSALQPQMVLTAATEGKLFQVTCSHDEDKRNILCITPSLKGLSVQ 810 
                *:***.:::  *  *::     :*:        : ::* : .    * * ****  : :: 
 
Cat             LPLKTKAFFMLDGIHSKYFDLIYVHNPVFKPFEKPVMISIGNENVLEIKGNDIDPEAVK- 872 
Dog             LPLKTKAFFMLDGIHSKYFDLIYVHNPVFKPFEKPVMISIGNENVLEIKGNDIDPEAVK- 872 
Human           LPLKTKAFFMLDGILSKYFDLIYVHNPVFKPFEKPVMISMGNENVLEIKGNDIDPEAVK- 871 
Mice            LPLKTKAFFLLDGILSKHFDLTYVHNPVFEPFEKPVMISIGNENVVEIKGNNIDPEAVK- 870 
Rat             LPLKTKAFFLLDGILSKHFDLTYVHDPMFKPFEKPVMISMGNENVVEIKGDDIDPEAVK- 872 
Chicken         PPFVTKVFFIFDGVSSLYFDFDYVNNPVFKHFEKPVLISRSNPNVLEIKGNHIDSEAVK- 872 
Xenopus         PPITTRVFFILDGVISNNFELSYVNNPIFETFGKPVVFPIGNKNILEIKGDHIDSEAVR- 865 
Fugu            PPVVTKVAFVLDGYMTEQWDLIYVEDP---LFQDPKLTSKDNKSIVELKGDRMDREAMK- 881 
Zebrafish       PPVATKMTFVLDGFSTDQYDLLYVEDPKFEEFQKPTVTPRGKKNILEIKVPPVNQEAVKN 870 
                 *. *:  *::**  :  ::: **.:*    * .* : . .: .::*:*   :: **::  
 
Cat             GEVLKVGNKSCETIYSDSEAVLCKVPNDLLKLN-NELNIEWKQAVSSTILGKVIVQPDQN 931 
Dog             GEVLKVGNKSCETIYSDSKAVLCKVPNDLLKLN-NELNIEWKQAVSSTVLGKVIVQPDQN 931 
Human           GEVLKVGNKSCENIHLHSEAVLCTVPNDLLKLN-SELNIEWKQAISSTVLGKVIVQPDQN 930 
Mice            GEVLKVGNQSCESLHWHSGAVLCTVPSDLLKLN-SELNIEWKQAVSSTVLGKVIVQPDQN 929 
Rat             GEVLKVGNKSCENLHWHSEALLCTVPSDLLKLNGGELNIEWKQAVSSTVLGKVIVQPDQN 932 
Chicken         GEVLKVGNKSCENLLLQSETILCTVPSDLLKSN-SELNIEWKQEVLSTVIGKVLIRQDQN 931 
Xenopus         GEVLKVGNKSCEIVQSKSDSVSCSVPTDLFKSN-SELKIEFVQEVPSIIIGKVMVTQDQN 924 
Fugu            CQVLTVSNHSCESLTLVGNTLECTVPTELQTTTSKELQVEWRQADSIRHLGKVTLAQEQD 941 
Zebrafish       GEVLRVSNRTCESVTLVGNTLECTVPMELQT-AAKELEVEWKQATSSVILGRVILAQDQD 929 
                 :** *.*::** :   . :: *.** :* .    **::*: *      :*:* :  :*: 
 
Cat             FTGLIVGVISISIILLLLLGVFLWLKKRKQIKDLGSELVRYDARVHTPHLDRLVSARSVS 991 
Dog             FTGLIAGVISISTIVLLLLGLFLWLKRKKQIKDLGSELVRYDARVHTPHLDRLVSARSVS 991 
Human           FTGLIAGVVSISTALLLLLGFFLWLKKRKQIKDLGSELVRYDARVHTPHLDRLVSARSVS 990 
Mice            FAGLIIGAVSISVVVLLLSGLFLWMRKRK-HKDLGSELVRYDARVHTPHLDRLVSARSVS 988 
Rat             FAGLIIGAVSISVVVLLVSGLFLWLRKRK-HKDLGSELVRYDARVHTPHLDRLVSARSVS 991 
Chicken         FTGLIAGVVSTSVLIYIFLVFFLWRRKKKQIKDLGSDLVRYDGRVHTPHLDRLVSARSVS 991 
Xenopus         FTGIITGVVSCVVLLLLMFGILIWMKKRKQLKDLGGDMVLYDGRVHTPHLDRLVSARSIS 984 
Fugu            YTGLIVGCMCVSLLLLLLGTLLLWKK-NKHIDDLS--EVWYDGRGHIQHLDRLANARSVS 998 
Zebrafish       YRILITGGVCVSILLLLLIAVFVWIKRKKHINDLAKTMVWYDGRAHIPHLDMLANARSVS 989 
                :  :* * :.    : :.  .::* : .*  .**.   * **.* *  *** *..***:* 
 
Cat             PTTEMVSNESVDYRATFPEDQFPNSSQNGSCRQVQYPLT--DLSP---MLNSG-----DS 1041 
Dog             PTTEMVSNESVDYRATFPEDQFPNSSQNGSCRQVQYPLT--DLSP---MLTSG-----DS 1041 
Human           PTTEMVSNESVDYRATFPEDQFPNSSQNGSCRQVQYPLT--DMSP---ILTSG-----DS 1040 
Mice            PTTEMVSNESVDYRATFPEDQFPNSSQNGACRQVQYPLT--DLSP---ILTSG-----DS 1038 
Rat             PTTEMVSNESVDYRATFPEDQFPNSSQNGACRQVQYPLT--DLSP---ILTSG-----DS 1041 
Chicken         PTTEMVSSESVDYRSTFLEDQFPSMSQNGSCRPAQYPHS--DLSP---ILSSG-----DS 1041 
Xenopus         PTTEMVSSESVDYRSTVQEDPFPNSSQNGSCRPAQYAHR--DLSP---ILSSG-----DS 1034 
Fugu            PTNEMVSHESVDYRTNLLEDQGSDRPETCRAGPPIYGGNGELLSPRLVALGSGLGLGMEG 1058 
Zebrafish       PTNEMVSHESVDYRTTLLEDQNLPLSQTESCRPHLYAHSHVDLSP---MLGP-----MEG 1041 
                **.**** ******:.. **     .:.  .    *      :**    * .      :. 
 
Cat             DISSPLLQNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDS 1101 
Dog             DISSPLLQNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDN 1101 
Human           DISSPLLQNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDN 1100 
Mice            DISSPLLQNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDN 1098 
Rat             DISSPLLQNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDS 1101 
Chicken         DLASPLLQTNVHIDISALNPDLVKEVQHVVIGADSLMVHFSEVIGRGHFGCVSHGTLLDN 1101 
Xenopus         DIASPLLHSYVHIDISALSTDLMKEIEHMVIRVDRLIVHFNRVIGRGLSGCVSHGTLHDT 1094 
Fugu            ELVSPLLMAPVHIDPSCLHPDLLTEVQHVVIAREQLLLHLNQVIGRGHFGCVFHGTLLEP 1118 
Zebrafish       DLASPLLPSTAPIDLGSLHPELLKEVQHVVIAREDLLLHVNEIIGRGHFGCVFHGTLLEP 1101 
                :: ****   . ** ..* .:*:  ::*:**  . *::*...:****  *** **** :  
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Cat             DDKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 1161 
Dog             DDKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 1161 
Human           DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 1160 
Mice            DGKKIHCAVKSLNRITDIEEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 1158 
Rat             DGKKIHCAVKSLNRITDIEEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 1161 
Chicken         DGRKIHCAVKSLNRITDLEEVAQFLKEGIIMKDFTHPNVLSLLGICLPNEGSPLVVLPYM 1161 
Xenopus         DGKNIHCAVKSLNRITDIEEVSQFLKEGIIMKDFSHPNVLSLLGICLPTEGSPLVVLPFM 1154 
Fugu            DGQKQHCAVKSLNRITDLEEVSQFLKEGIIMKDFSHPNVLSLLGICLPPEGSPLMVLPYM 1178 
Zebrafish       DGQKQHYAIKSLNRITDIEEVSQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 1161 
                *.:: * *:********: **:***.********:************  *****:***:* 
 
Cat             KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKV 1221 
Dog             KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKV 1221 
Human           KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKV 1220 
Mice            KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKV 1218 
Rat             KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKV 1221 
Chicken         KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKV 1221 
Xenopus         KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCILDENFTVKV 1214 
Fugu            KHGDLRNFIRDESHNPTVKDLMGFGLQVARGMEYLASKKFVHRDLAARNCMLDESYTVKV 1238 
Zebrafish       KHGDLRNFIRDESHNPTVKDLMGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESYTVKV 1221 
                **********:*:********:*******:**:*****************:***.:**** 
 
Cat             ADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 1281 
Dog             ADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 1281 
Human           ADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 1280 
Mice            ADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 1278 
Rat             ADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 1281 
Chicken         ADFGLARDVYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 1281 
Xenopus         ADFGLARDVYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGILLWELMTRG 1274 
Fugu            ADFGLARDVYDKEYYSVHNKSGVKLPVKWMALESLQTHKFTSKSDVWSFGVLLWELMTRG 1298 
Zebrafish       ADFGLARDVYDKEYYSVHNKHGVKLPVKWMALESLQTHKFTTKSDVWSFGVLLWELMTRG 1281 
                ********:*********** *.**************:***:********:********* 
 
Cat             APPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAELRPSFSELVSRISAI 1341 
Dog             APPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPRAELRPSFSELVSRISAI 1341 
Human           APPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 1340 
Mice            APPYPDVNTFDITIYLLQGRRLLQPEYCPDALYEVMLKCWHPKAEMRPSFSELVSRISSI 1338 
Rat             APPYPDVNTFDITIYLLQGRRLLQPEYCPDALYEVMLKCWHPKAEMRPSFSELVSRISSI 1341 
Chicken         APPYPDVNSFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKPEMRPAFSELVSKISTI 1341 
Xenopus         APPYPDVNSFDITIYLLQGRRLLQPEYCPDPLFEVMLKCWHPRPELRPTFSELVSRISSI 1334 
Fugu            APPYSDVNSFDITVFLLQGRRLLQPEFCPDALYTVMIECWHPNPERRPSFSELVEPISSI 1358 
Zebrafish       APPYSDVNSFDITVFLLQGRRLLQPEFCPDALYNVMIECWHPKPERRPTFSELVSRISAI 1341 
                ****.***:****::***********:***.*: **::****..* **:*****. **:* 
 
Cat             FSTFIGEHYVHVNATYVNVKCVAPYPSLLSSQD--------------------------N 1375 
Dog             FSTFIGEHYVHVNATYVNVKCVAPYPSLLSSQD--------------------------N 1375 
Human           FSTFIGEHYVHVNATYVNVKCVAPYPSLLSSED--------------------------N 1374 
Mice            FSTFIGEHYVHVNATYVNVKCVAPYPSLLPSQD--------------------------N 1372 
Rat             FSTFIGEHYVHVNATYVNVKCVAPYPSLLPSQD--------------------------N 1375 
Chicken         FSTFIGEHYVHVNATYVNVKCVAPYPSLLSSQD--------------------------N 1375 
Xenopus         FSTFLGEHYVLFNATYVNIKCAAPYPSLLSPEG--------------------------N 1368 
Fugu            FSSFSGEHYILLNTTYVNIEKLNPYPSLFASTHLTPSSSSLSSDPTTSTSLPAQSPLFCR 1418 
Zebrafish       FSSFSGEHYILLNTTYVNIDKMTPYPSLISS----------------------QS----N 1375 
                **:* ****: .*:****:.   *****:..                            . 
 
Cat             IDGEGDT--------- 1382 
Dog             IDGEGDT--------- 1382 
Human           ADDEVDTRPASFWETS 1390 
Mice            IDGEGNT--------- 1379 
Rat             IDGEANT--------- 1382 
Chicken         TDMDVDT--------- 1382 
Xenopus         IEFSIDT--------- 1375 
Fugu            VERACCT--------- 1425 
Zebrafish       LDRDCCT--------- 1382 
                 :    *          
 
Fig.3.10 Amino acid sequence alignment of Cat, Dog, Human, Mice, Rat, 
Chicken, Xenopus, Fugu and Zebrafish c-Met. The identical residues are indicated 
by asterisk. Conserved tyrosine residues in zebrafish c-Met tyrosine kinase catalytic 
domain are highlighted in red. Human c-MET’s domains are highlighted in different 
colors: singnal peptide in pink; semaphorin domain in turquoise; PSI domain (domain 
found in Plexins, Semaphorins and Integrins) in yellow; IPT domains (Ig-like, plexins, 
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transcription factors) in grey; transmembrane domain in blue; Tyrosine kinase 




3.1.3 Phylogenetic analyses of zebrafish Hgfa, Hgfb and c-Met 
 
Phylogenetic analyses were performed to explore the relationship between HGF or c-
MET from different vertebrate species by ClustalW in http://www.trex.uqam.ca. 
Parameters for data anlysis and results output are used as default setting, expect for 
data analysis using slow mode and results output in radial style. As shown in Fig.3.11, 
zebrafish Hgfa and Hgfb were most closely related to the Xenopus hgf. And in 
Fig.3.12, although zebrafish c-Met was most closely related to predicted Fugu c-met, 
the closest c-met homologue are Xenopus c-met. 
 
 
Fig.3.11 Phylogenetic tree of Cat, Chicken, Dog, Human, Mice, Rat, Xenopus, 










Fig.3.12 Phylogenetic tree of Cat, Chicken, Dog, Fugu, Human, Mice, Rat, 




3.1.4 Genomic localization and synteny analyses of zebrafish hgfa, hgfb 
and c-met 
 
3.1.4.1 Genomic localization and synteny analyses of zebrafish hgfa 
 
Genomic localization of zebrafish hgfa was analyzed through Ensembl zebrafish 
genome database (version: Ensembl release 45 - Jun 2007). Zebrafish hgfa was found 
to locate at Chromosome 4 from 21682362 to 21713937. Similar to human HGF, 
zebrafish hgfa also contains 18 exons.  
 
To determine the syntenic relationship, genes adjacent to zebrafish hgfa were 
examined. In zebrafish, four genes and hgfa are found to be arranged in the following 
sequence from 5’ to 3’: snd1 (Staphylococcal nuclease domain-containing protein 1), 
hgfa, si:ch211-251k4.1 (encoding a protein similar to CACNA2D1 (calcium channel, 
voltage-dependent, alpha 2/delta subunit 1)), atp6v1f (ATPase, H+ transporting, 
lysosomal 14kDa, V1 subunit F) and si:dkey-159a18.7 (a putative orthologue of 
NP_001008396.1). In human, these four genes are also found to be adjacent to HGF, 
however, in a different arrangement as in the following sequence from 5’ to 3’: 
ATP6V1F, HGF, CACNA2D1, NP_001008396.1and SND1 (Fig.3.13). Although these 
five genes are adjacent to each other in zebrafish and human, their arrangements are 




Zebrafish Chr4 snd1 hgfa si:ch211-251k4.1 atp6v1f si:dkey-159a18.7 




Fig.3.13 Genomic localization of zebrafish hgfa. (A). Orthologues of zebrafish and 
human genes in hgfa chromosome region. (B). Syntenic relationship between 
zebrafish chromosome 4 and human chromosome 7 showing chromosomal shuffling. 




3.1.4.2 Genomic localization of zebrafish hgfb 
 
Genomic localization of zebrafish hgfb was also analyzed similarly through Ensembl 
zebrafish genome database (version: Ensembl release 45 - Jun 2007). Zebrafish hgfb’s 
first 9 exons are located in scaffold Zv6_NA2108 from 84183 to 124854 and last 8 
exons of hgfb are in scaffold Zv6_NA946 from 243369 to 257447. There is a gap of 
96bp between the 9th exon and the 11th exon which can not be located in the 
zebrafish genome database. Both of the scaffolds haven’t been mapped yet. Seventeen 
exons of zebrafish hgfb have been found, which is one exon (exon 10 missing) less 
than the human HGF. It is possible that there are still gaps in the zebrafish genome 
sequence and the hgfb gene region.  
 
To determine the syntenic relationship, genes adjacent to zebrafish hgfb were 
examined. In scaffold Zv6_NA946, no adjacent gene can be found. In scaffold 
Zv6_NA2108, the only gene adjacent to hgfb, LOC558257, encoding a protein similar 
to CACNA2D1, is found at 5’ of hgfb, while CACNA2D1 is located adjacent to HGF 
and 3’. Thus, the region containing hgfb on zebrafish scaffold Zv6_NA2108 might be 





Zebrafish scaffold Zv6_NA2108 LOC558257 hgfb 




Fig.3.14 Genome localization of hgfb. (A) Ortholoues of zebrafish and human genes 
in hgfb chromosome region. The orthologs are aligned in the same column. (B). The 




3.1.4.3 Genomic localization and synteny analyses of zebrafish c-met 
 
Zebrafish c-met was found to locate at Chromosome 25 from 10668539 to 12040365 
(version: Ensembel release 45 – Jun 2007). In previous version of zebrafish genome 
data v19.3a.2 (3 Mar 2004), zebrafish c-met can be found at three scaffolds: NA13458, 
ctg 15876 and ctg 11348. Combining the blast results from these two versions of 
zebrafish genome database, 21 exons can be located which is identical to the human c-
met exon number. 
 
Based on genomic localzation of zebrafish c-met and synteny analysis, the region 
containing c-met on zebrafish Chromosome 25 might be syntenic to the chromosomal 
region containing c-MET in human chromosome 7. Presence of cav1 (caveolin 1) and 
cav2 (caveolin 2)  close to the map position of c-met on zebrafish Chromosome 25 
corresponds to their conserved presence on human chromosome 7 in close vicinity of 
map positions of c-met in human. Some chromosomal rearrangement might have 
occurred during evolution on the site near c-met in zebrafish chromosomal 25 since 
several genes locate on zebrafish chromosomal 25 close to c-met, namely, eif3s1 and 
557889, while their orthologues in human are found on chromosome 15 and 2, 




Zebrafish Chr25 met cav1 cav2 




Fig.3.15 Genome localization of c-met. (A). Ortholoues of zebrafish and human 
genes in c-met chromosome region. The orthologs are aligned in the same column. (B). 
Syntenic relationship between zebrafish chromosome 25 and human chromosome 7 
showing chromosomal rearrangement. The genes adjacent to c-met on one side of 




3.2 Expression analysis of hgfa, hgfb and c-met during zebrafish 
embryonic development 
 
3.2.1 Expression analysis by real-time RT-PCR 
 
In order to understand the functions of hgfa, hgfb and its receptor c-met during 
development, it is important to determine its temporal expression profile. Embryos at 
different developmental stages were collected and RNA was extracted. Expression 
level of hgfa, hgfb and c-met were then determined by SYBR green real-time RT-PCR 
using β actin as the internal reference. 
 
All three genes can be detected at 0 hpf stage, but the expression level is very low 
(Fig.3.16), indicating possible low level maternal mRNA. hgfa zygotic expression 
profile has one peak around 24hpf (Fig.3.16.A), a stage of active somitogenesis and 
neurogenesis occurs. hgfb zygotic expression profile has two peaks, one is around 24 
hpf and another is around 3 day post fertilization (dpf) to 4dpf, (Fig.3.16.B). c-met 
zygotic expression profile has one peak at 12hpf and decrease sharply at 24hpf, then 
increase gradually and the second peak around 3-4dpf (Fig.3.16.C). The peak 
expression of hgfb and c-met around 3-4dpf correspond to the stage of liver growth.  
Although all three genes can be detected at 1 cell stage (0 hpf) by qRT-PCR, which 
indicated their maternal expression, their expression pattern at 1cell stage can not be 
detected by whole mount in-situ hybridization. Importantly, all three genes are 
expressed at all stages analyzed, suggesting important and multiple roles of this 







































































Fig.3.16 Relative mRNA levels of zebrafish hgfa, hgfb and c-met in WT embryos. 
(A) hgfa. (B) hgfb. (C) c-met. Relative mRNA levels are compared to 0hpf stage. 
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3.2.2 Expression analysis by whole mount in situ hybridization (WISH) 
 
In order to understand the functions of hgfa, hgfb and its receptor c-met during 
development, it is important to determine their spatial and temporal expression profile. 
Embryos at different developmental stages were collected and the spatial distribution 
of transcripts of hgfa, hgfb and c-met were analyzed by WISH. 
 
3.2.2.1 Expression analysis of hgfa 
 
To study the spatial and temporal expression of hgfa during zebraifhs embryonic 
development, WISH was carried out using digoxigenin labeled RNA probe. Embryos 
from 0hpf stage to 6dpf were examined. The signal of hgfa was discernable starting 
from 7 somites stage in the somites, and this expression persisted up to 30hpf 
(Fig.3.17 A-E). hgfa’s expression in pectoral fin and ear is evident 30hpf to 48hpf 
(Fig.3.17 E-H). Although HGF mRNA was found in liver in other vertebrates, 




Fig.3.17 Expression pattern of zebrafish hgfa detected by WISH. Embryos are 
anterior to the left and dorsal to the top, except in B, D, G, and H, which are dorsal 
views with anterior to the top. (A) The 7-somites stage. (B) The 7-somites stage (flat 
mount dorsal view). (C) The 16-somites stage. (D) The 16-somites stage (dorsal view). 
(E) The 30-hpf stage. (F) The 30-hpf stage (dorsal view). (G) 48-hpf stage. (H) 48-hpf 
stage (dorsal view). The black arrowhead points to the somites. The white arrowhead 
points to the otic vesicle (G) or ear (H). The black arrow points to the fin bud. 
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3.2.2.2 Expression analysis of hgfb 
 
To study the spatial and temporal expression of hgfb during zebraifhs embryonic 
development, WISH was carried out using digoxigenin labeled RNA probe. Embryos 
from 0hpf stage to 6dpf were examined. At 6dpf stage, digoxigenin labeled RNA 
probe of hgfb and fluorescein labeled RNA probe of ceruloplasmin (Cp) were used in 
the expression analysis of hgfb in liver by two-color WISH. The signals of hgfb were 
discernable starting from 1-somite stage in dorsolateral placode on both sides of the 
midline which later become restricted into several patches in the neural system, and 
this expression persists up to 36hpf (Fig.3.18 A-N). hgfb expression in nephric duct 
opening was detectable as early as 12-somite stage and last till 4dpf (Fig.3.18 F-S). 
hgfb expression in swimbladder was also seen from 36hpf to 4dpf  (Fig.3.18 N-R) and 
at 24hpf hgfb could be detected in the primordium of swimbladder  (Fig.3.18 K-L). 
Expression of hgfb in liver was first detected at 4dpf in a scattered manner and this 
expression pattern persisted at least till 6dpf (Fig.3.18 R). Two-color WISH of hgfb 
and Cp as well as tissue section revealed hgfb expression in liver mesenchymal cells 
at 6dpf but not in hepatocytes (Fig. T-V). This expression pattern of hgfb is 
completely different from the Hanies’ hgfs’ where they did not detect any differences 





Fig.3.18 Expression pattern of zebrafish hgfb detected by WISH. Embryos are 
anterior to the left and dorsal to the top, except in B, E, J, L, N and P, which are dorsal 
views with anterior to the top, in H and T, which are ventral views with anterior to the 
top. (A) The 1-somites stage. (B) The 1-somites stage (dorsal view). (C) The 7-
somites stage. (D) The 7-somites stage (dorsal lateral view). (E) The 7-somites stage 
(flat mount dorsal view). (F) The 12-somites stage. (G) The 12-somites stage (dorsal 
lateral view). (I) The 18-somites stage. (J) The 18-soimtes stage (dorsal view, 
direction indicated in I as red arrow). (K) The 24hpf stage. (L) The 24 hpf stage 
(dorsal view). (N) The 36hpf stage (dorsal view). (O) The 48hpf stage. (P) The 48hpf 
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stage (dorsal view). (Q) The 3dpf stage. (R) The 4dpf stage. (S) The 4dpf stage. (T) 
The 6dpf stage (Two probes staining: Ceruloplasmin stained with red color; HGFb 
stained with blue color). (U) The 6dpf stage (ventral view). (V) The 6dpf stage. 
Shown is a transverse section through the plate in S. The black arrowhead points to 
the dorsolateral placode. The white arrow points to the anterior primordium of nephric 
duct. The blue arrowhead points to the pronephric duct opening (I, K and S) or the 
primordium of pronephric duct opening (F and H). The blue arrow points to the 
trigeminal placode. The white arrowhead points to the swimbladder (M to R) and the 
primordium of swimbladder (K and L). The black arrow points to the liver.  
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3.2.2.3 Expression analysis of c-met 
 
The signals of c-met were first discernable starting at 1somite stage in the presumptive 
forebrain and midbrain, and this expression persists up to 12somitestage (Fig.3.19 A-
F). c-met’s expression in the pronephric mesoderm or the pronephric duct is 
detectable from 1somite stage to 24hpf (Fig.3.19 B-N). c-met’s expression in 
migrating lateral line primordial is detectable from 18hpf to 24hpf (Fig.3.19 J-M), 
which was also revealed in Haines’ study (Haines et al., 2004). Tussue section 
revealed c-met expression in motor neurons from 18hpf to 24hpf (Fig.3.19 J-N). c-met 
expression is also detected in the pectoral fin and gut from 48hpf to 3dpf (Fig.3.19 O-
Q). The expression of c-met in pancreas is only detectable at 4pdf (Fig.3.19 T and V). 
c-met is expressed in liver from 48hpf to 6dpf  (Fig.3.19 P-U). At 3dpf, it is expressed 




Fig.3.19 Expression pattern of zebrafish c-met detected by WISH. Embryos are 
anterior to the left and dorsal to the top, except in B, C, E, H, I, K, M, P, Q, T, U, V 
and X, which are dorsal views with anterior to the top. (A) The 1-somites stage. (B) 
The 1-somites stage (dorsal view, direction indicted in A as red arrow). (C) The 1-
somites stage (dorsal view, direction indicted in A as green arrow). (D) The 7-somites 
stage. (E) The 7-somites stage (dorsal lateral view). (F) The 12-somites stage. (G) The 
12-somites stage (dorsal lateral view). (H) The 12-somites stage (dorsal view, 
direction indicted in G as green arrow). (I) The 12-somites stage (dorsal view, 
direction indicted in G as red arrow). (J) The 18-soimtes stage. (K) The 18-somites 
stage (dorsal view). (L) The 24hpf stage. (M) The 24hpf stage (dorsal view). (N) The 
24hpf stage. Shown is a transverse section through the plate in L. (O) The 48hpf stage. 
(P) The 48hpf stage (dorsal view). (Q) The 3dpf stage (dorsal view). (R) The 3dpf 
stage (Two probes staining: Ceruloplasmin stained with red color; c-met stained with 
blue color). Shown is a transverse section through the plate in Q. (S) The 4dpf stage. 
(T) The 4dpf stage (dorsal view). (U) The 4dpf stage (dorsal lateral view from left 
side). (V) The 4dpf stage (dorsal lateral view from right side). (W) The 6dpf stage. (X) 
The 6dpf stage (dorsal view). The black arrowhead points to the presumptive 
forebrain. The white arrowhead points to the presumptive midbrain. The black arrow 
points to the pronephric mesoderm (B and E) or the pronephric duct (G to M). The 
white arrow points to the migrating lateral line primordia. The blue arrowhead points 
to the motor neuron. The green arrowhead points to the pectoral fin. The yellow arrow 
points to the gut. The red arrowhead points to the liver. The blue arrow points to the 
caudal hindbrain. The yellow arrowhead points to the pancreas. 
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3.3 Functional study of hgfa, hgfb and c-met in zebrafish embryonic 
development 
 
To study the function of hgfa, hgfb and its receptor c-met, gene knockdown by 
microinjecting morpholino modified antisense oligonucleotides targeting at each gene 
into 1-2 cell stage fertilized embryos were carried out.  Morpholino modified 
antisense oligonucleotides have been shown to effectively and specifically suppress 
gene expression in zebrafish embryos (Corey and Abrams, 2001; Draper et al., 2001; 
Nasevicius and Ekker, 2000). 
 
3.3.1 Role of hgfa in zebrafish embryonic development 
 
3.3.1.1 Knockdown of hgfa induces curved trunk 
 
Two types of antisense morpholino oligonucleotides (MO) were used in this analysis. 
One targets at the start codon region to inhibit translation, named as HGFa-ATG MO.  
A 5bp mismatch control MO was designed and named as HGFa-ATG5mis MO. 
Another MO HGFa-ex1 is designed against the splice-donor sites of exon 1 to 
interfere with mRNA splicing. Both MOs induced a curved trunk phenotype (Fig.3.20 
and Fig.3.21) and the percentage of the embryos showing this phenotype did not vary 
much during different developmental stage from 2dpf to 5dpf (Fig.3.21 and Fig.3.22). 
To verify the knockdown effect, different approaches were applied for these two types 
of MO. For HGFa-ATG MO, different doses of MO were injected and a dosage-
dependent induction of the curved-tail phenotype was observed.  At the 1ng per 
embryo injection dose, no curved trunk phenotype was observed in the pool of 
embryos injected with HGFa-ATG5mis MO, but persisted in the HGFa-ATG pool at 
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40% (Fig.3.22). In contrast, hgfb morphants showed relative low percentage of 
embryos with curved trunk (7% at 10ng per embryo injection, 15% at 1ng per embryo 
injection) compared to the hgfa morphants (53% at 10ng per embryo injection, 40% at 
1ng per embryo injection) (Fig.3.22). For MO blocking mRNA splicing, embryos 
were separated into different pools based on the phenotype. hgfa mRNA level of each 
pool was examined by qRT-PCR and the result showed that hgfa mRNA level is 






Fig.3.20 Zebrafish hgfa knockdown induces curved trunk. Embryos are dorsal 
view with anterior to the top. (A) control-injected embryo at 48hpf stage. The black 
arrowhead points to the normal trunk. (B) hgfa knockdown morphant at 48hpf stage. 





































































Fig.3.22 Curved trunk observed in hgfa and hgfb morphants.  

















































Confirmation of knockdown effect of HGFa MO 
 
HGFa-ex1 MO is against the first exon and first intron junction, which will lead to the 
first intron inclusion into the splicing interfered product, and the first intron inclusion 
will introduce a premature stop codon. hgfa splicing interfered product is verified by 
RT-PCR using the forward primer from first intron and the reverse primer from the 
third or fourth exon which can avoid amplify the genome DNA and sequencing results 
showed that the splicing products is just as predicted (data not show). And the 
endogenous hgfa mRNA level is verified by qRT-PCR using the forward primer from 
first exon and the reverse primer from the second exon, which can avoid amplify the 
hgfa splicing interfered product due to the large 5000bp first intron size. Results 
showed that endogenous hgfa mRNA level was lower in morphants with curved trunk, 
ISV growth delay compared to morphants without phenotype. However this lower 
level of hgfa mRNA can not been determined for the morphants with liver shifting 
phenotype (Fig.3.23). And the knockdown product can be detected (Fig.3.24). 
However, in WT (24hpf and 36hpf) this knockdown product can still be detected 
(Fig.3.24). 
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Phenotype 1: curved trunk 
Phenotype 2: ISV growth delay 
Phenotype 3: curved trunk with liver on left side 
Phenotype 4: curved trunk with liver on right side 
 
Fig.3.23 Relative mRNA levels of zebrafish hgfa in hgfa morphants compared to 
WT embryo. A, B and C are knockdown level in hgfa morphants at 24hpf, 36hpf and 
3dpf respectively. 
 


























































Fig.3.24 Detection of knockdown product of HGFa-ex1 MO in hgfa morphants 
and WT embryos. RNA template for each lane are: 1. 24hpf wt; 2. 24hpf hgfa 
morphants without phenotype; 3. 24hpf hgfa morphants with curved trunk; 4. 36hpf 
wt; 5. 36hpf hgfa morphants without phenotype; 6. 36hpf hgfa morphants showing 
ISV growth delay; 7. 3dpf wt; 8. 3dpf hgfa morphants showing curved trunk at 24hpf; 
9. 3dpf hgfa morphants without phenotype; 10. 3dpf hgfa morphants showing curved 
trunk with liver on left side; 11. 3dpf hgfa morphants showing curved trunk with liver 
on right side; M: Marker. (A): Primers are A Splice Sense and A Splice Antisense. (B): 
Primers are A RT Sense and A RT Antisense. 
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3.3.1.2 hgfa is required for zebrafish somitogenesis 
 
hgfa expression in somites and the curved trunk phenotype in hgfa morphants indicate 
that hgfa might play a role in somitogenesis. Expression of myoD, a marker for 
myocytes which represents the terminal differentiation of somites, was analyzed in the 
hgfa morphants at the 9-somite stage. 
 
Wild-type (WT) embryos expressed myoD in the adaxial cells and in the posterior 
halves of the somites (Fig. 3.20.A). Analysis of hgfa morphants revealed four 
phenotypes that were not observed in the control WT embryos. The four phenotypes 
were 
1) Reduced myoD expression in the somites (Fig.3.25.B); 
2) myoD expression in the somites on the left side only (Fig.3.25.C); 
3) myoD expression in the somites on the right side only (Fig.3.25.D); and 
4) No expression of myoD in the somites (Fig.3.25.E). 
The most significant observation was the reduction in myoD expression in the somites, 
as it accounted for 38% of the hgfa morphants (Fig.3.26). 
 
By testing HGFa-ATG MO at two injection concentrations (10ng and 1ng per 
embryo), HGFa-ATG Morphant’s phenotype is dosage dependent (Fig.3.26). 
However, HGFa-ATG5mis Morphant (10ng per embryo) as control can still generate 
the similar phenotype as HGFa-ATG Morphant, at a lower percentage compared to 
HGFa-ATG Morphants (10ng or 1ng per embryo). The possibility is that the HGFa-
ATG5mis MO can still bind to hgfa mRNA start codon region with a lower affinity 
compared to HGFa-ATG MO, and can generate moderate knockdown effect. Further 
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Fig.3.25 Zebrafish hgfa knockdown disrupts myoD expression pattern. Embryos 
are dorsal view with anterior to the top. (A) control-injected embryo at 9 somites stage. 
The black arrowhead points to the normal myoD staining in somites. (B) hgfa 
knockdown morphant at 9 somites stage. The black arrowhead points to the reduced 
MyoD expression in somites. (C) hgfa knockdown morphant at 9 somites stage. The 
black arrowhead points to the ablation of MyoD expression in the right side somites. 
(D) hgfa knockdown morphant at 9 somites stage. The black arrowhead points to the 
ablation of MyoD expression in the left side somites. (E) hgfa knockdown morphant 
at 9 somites stage. The black arrowhead points to the ablation of MyoD expression in 
somites on both sides. 
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Since myoD expression is disrupted in hgfa morphants and fgf8 signalling is required 
for myoD expression in the somites (Groves et al., 2005), fgf8 expression was 
analyzed in hgfa morphants to investigate the possibility that knocking down hgfa 
might affect the myoD expression through fgf8. Therefore, fgf8 expression was 
analyzed in hgfa morphants (HGFa-ATG MO). At the 8-somite stage, WT embryos 
expressed fgf8 in each of the newly formed somite and presomitic mesoderm (PSM) 
(Fig.3.27.A). Two abnormal phenotypes were detected in the hgfa morphants:  
1) Asymmetrical fgf8 expression in the somites (Fig.3.27.B and C); and 
2) Reduced fgf8 expression in somites and reduced numbers of somites (Fig.3.27.D). 
Thus, the knockdown of hgfa significantly reduced the expression of fgf8, with 45% 




Fig.3.27 Zebrafish hgfa knockdown disrupts fgf8 expression pattern. Embryos are 
dorsal view with anterior to the top. (A) control-injected embryo at 8 somites stage. 
The black arrowhead points to the normal fgf8 staining in somites. (B) hgfa morphant 
at 8 somites stage. The black arrowhead points to the asymmetry fgf8 expression in 
somites, the expression region of fgf8 is wider on the left side of embryo.  (C) hgfa 
morphant at 8 somites stage. The black arrowhead points to the asymmetry fgf8 
expression in somites, the expression region of fgf8 is different at the axial level 
between left and right side of embryo. (D) hgfa morphant at 8 somites stage. The 









Fig.3.28 Phenotypes observed in HGFa-ATG and HGFa-ATG5mis morphants at 
8-somite stage, with fgf8 as marker. 
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Since fgf8 and myoD expression pattern is disrupted in hgfa morphants, and the 
expression of fgf8 and myoD in the somites and/or presomitic mesoderm (PSM) are 
regulated by RA (retinoic acid) (Hamade et al., 2006), the expression of a key enzyme 
in RA synthesis- aldehyde dehydrogenase 1 A2 (aldh1a2, previous name: raldh2) was 
analyzed in hgfa morphants.   
 
At the 12-somite stage, WT embryos expressed aldh1a2 in each somite and the 
presomitic mesoderm (PSM) (Fig.3.29.A). Two phenotypes that were not observed in 
the WT embryos were detected in the hgfa morphants and the appearance of these 
phenotypes is dose-dependent (Fig.3.30). The two phenotypes were: 
1) Reduced expression of aldh1a2 in somites (Fig.3.29.C); and 
2) Asymmetry expression of aldh1a2 in somites (Fig.3.29.D and E). 
Thus, the knockdown of hgfa disrupted the expression of aldh1a2, with 18% of the 
hgfa morphants showing a reduction in aldh1a2 expression and/or number of somites 
and 20% of the hgfa morphants showing asymmetry expression of aldh1a2 (Fig.3.30). 
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Fig.3.29 Zebrafish hgfa knockdown disrupts aldh1a2 expression pattern. 
Embryos are dorsal view with anterior to the top, except in A, which is lateral view 
with anterior to the left. (A) control-injected embryo at 12 somites stage (lateral view). 
The black arrowhead points to the normal aldh staining in somites. (B) control-
injected embryo at 12 somites stage. The black arrowhead points to the normal 
aldh1a2 staining in somites. (c) hgfa morphant at 12 somites stage. The black 
arrowhead points to the widened aldh1a2 expression in somites with reduced 
expression level. (D) hgfa morphant at 12 somites stage. The black arrowhead points 
to the asymmetry aldh1a2 expression in somites, the expression region of aldh1a2 is 
wider on the right side of embryo. (E) hgfa morphant at 12 somites stage. The black 
arrowhead points to the asymmetry aldh1a2 expression in somites, the expression 
region of aldh1a2 is different at the axial level between left and right side of embryo. 
 
 
Fig.3.30 Phenotypes observed in HGFa-ATG and HGFa-ATG5mis morphants at 
12-somite stage, with aldh1a2 as marker.  
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3.3.1.3 hgfa is involved in blood vessel development 
 
Angiogenic property of HGF has been evidenced by many studies in vivo (Grant et al., 
1993;Kuba et al., 2000;Lamszus et al., 1997;Nagashima et al., 2001). However, 
HGF’s impact on embryonic angiogenesis is not clear yet.  Here, we take the 
advantage of Tg(fli1:GFP), which illuminate the blood vessel with green fluorescence, 
to study if hgfa or hgfb has any roles in blood vessel development. In this transgenic 
line, GFP expression was under the control of the endothelial cell specific fli-1 gene 
promoter (Lawson and Weinstein, 2002). Two types of MO were used in this analysis. 
One targets at the start codon region to inhibit translation, named as HGFa-ATG MO. 
Another MO is designed against the splice-donor sites of exon 1 to interfere with 
mRNA splicing which is named as HGFa-ex1 MO. Both HGFa-ATG and HGFa-ex1 
MO can cause delay in intersegmental vessel (ISV) and dorsal longitudinal 
anastomotic vessel (DLAV) growth (Fig.3.31). In HGFa-ex1 morphants, 58% (n=81) 
shows ISV and DLAV growth delay and embryos were separated into different pools 
based on the blood vessel phenotype. hgfa mRNA level of each pool was examined by 
qRT-PCR and the result showed that hgfa mRNA knockdown is more effective in the 





Fig.3.31 Zebrafish hgfa knockdown causes growth delay of ISV and DLAV. 
Embryos are lateral view with anterior to the left. (A) control-injected embryo at 
48dpf. The white arrowhead points to the normal ISV. The green arrowhead points to 
the normal DLAV. (B) HGFb knockdown morphant at 48hpf. The green arrowhead 
points to the normal DLAV. (C) hgfa knockdown morphant at 48hpf. The white 
arrowhead points to the ISV which stops sprouting at midway for more than 10 hours. 
The green arrowhead points to the missing DLAV. 
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3.3.1.4 hgfa is involved in the asymmetric positioning of liver during 
zebrafish development 
 
Since HGF is a known mitogen for hepatocytes in mammals, we investigated if hgfa 
play a role in zebrafish liver formation. Two types of MO were used in this analysis. 
One targets at the start codon region to inhibit translation, named as HGFa-ATG MO. 
Another MO is designed against the splice-donor sites of exon 1 to interfere with 
mRNA splicing which is named as HGFa-ex1 MO. Both HGFa-ATG and HGFa-ex1 
MO lead to the shift of liver from left side to right side of the embryo (Fig.3.32). For 
HGFa-ATG MO, this phenotype is dosage dependent (Fig.3.33).  For HGFa-ex1 MO, 
embryos were separated into different pools based on the phenotype. hgfa mRNA 
level of each pool was examined by qRT-PCR. There is no relationship between the 
knockdown level and this phenotype (Fig.3.39). However, there is a correlation of the 
curved trunk phenotype with the liver position switching phenotype which proves the 
specificity of the MO knockdown effect. Otherwise, the specificity of the MO 
knockdown would be doubted with the question that why one MO can generate two 
phenotypes are not correlated. More embryos in the curved-trunk pool (45%) which 
have this phenotype compared to the non-curved trunk pool (10%) (Fig.3.34). hgfb is 
much less effective in this function. At 1ng per embryo MO dose, only hgfa MO 
generated a shift in liver position. These results indicate a role of hgfa, but not hgfb in 




Fig.3.32 Zebrafish hgfa knockdown causes liver shifting from left side to right 
side. A and B are embryos stained with ceruloplasmin, a liver maker. In A and B, 
pictures are taken by stereo microscope and embryos are dorsal view with anterior to 
the top. C and D are lfabp:RFP embryos, which show liver with red florescence. In C 
and D, pictures are taken by inverted microscope and embryos are ventral view with 
anterior to the top. (A) control-injected embryo at 36hpf. The black arrowhead points 
to the normal liver position which is on the left side of the embryo. (B) hgfa 
knockdown morphant at 36hpf. The black arrowhead points to the shifted liver 
position which is on the right side of the embryo. (C) control-injected embryo at 3dpf. 
The black arrowhead points to the normal liver position which is on the left side of the 
embryo. (D) hgfa knockdown morphant at 3dpf. The black arrowhead points to the 





















Fig.3.33 Liver asymmetrical position observed in hgfa and hgfb morphants. With 
HGFb-ATG and HGFa-ATG5mis MO as control and the different dose of injection, 






















Fig.3.34 Relation between two phenotypes in hgfa or hgfb morphants: curved 
trunk and liver on the right side.  





































































Relation between two phenotypes:

















































































3.3.1.5 Pancreas position is shifted from right side to left side in hgfa 
morphants 
 
Pancreas and liver share a same pool of progenitor cells (Ward et al., 2007), and 
pancreas is located on the right side which is opposite to liver’s position. Since liver 
position was shown to be shifted from left side to right side in hgfa morphants, 
pancreas was examined in hgfa morphants. HGFa-ATG MO was used in this analysis 
and the result showed pancreas position is shifted from right side to left side in hgfa 
morphants in a dose-dependent manner (Fig.3.35 and Fig.3.36). The position of both 
endocrine pancreas and exocrine pancreas are shifted to the left in hgfa morphants as 




Fig.3.35 Zebrafish hgfa knockdown causes pancreas shifting from right side to 
left side. Embryos are dorsal view with anterior to the top. A-D are embryos stained 
with insulin, an endocrine pancreas maker. E and F are embryos stained with elastase 
B, an exocrine pancreas marker.  (A) control-injected embryo at 3dpf. The black 
arrowhead points to the normal endocrine pancreas position which is on the right side 
of the embryo. (B) hgfa morphant at 3dpf. The black arrowhead points to the shifted 
endocrine pancreas position which is on the left side of the embryo. (C) control-
injected embryo at 6dpf. The black arrowhead points to the normal endocrine 
pancreas position which is on the right side of the embryo. (D) hgfa morphant at 6dpf. 
The black arrowhead points to the shifted endocrine pancreas position which is on the 
left side of the embryo. (E) control-injected embryo at 6dpf. The black arrowhead 
points to the normal exocrine pancreas position which is on the right side of the 
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embryo. (F) hgfa morphant at 6dpf. The black arrowhead points to the shifted 


































































Fig.3.36 Pancreas shifting observed in hgfa morphants, with insulin or elastaseB 
as marker.  
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3.3.1.6 Simultaneous position shift of liver and pancreas in hgfa 
morphants 
 
To determine if liver and pancreas were shifted simultaneous in hgfa morphants, 
double in-situ hybridization of liver marker Cp and exocrine pancreas marker elaB 
were carried out. Result showed that in the hgfa morphants, liver and pancreas were 
shifted simultaneously to the opposite side of the embryo (Fig.3.37). All together, the 
above results indicate that hgfa is involved in the asymmetrical positioning of liver 





Fig.3.37 Zebrafish hgfa knockdown causes liver and pancreas shifting 
simultaneously within single embryo. Embryos are dorsal view with anterior to the 
top and stained with elastase B in black, ceruloplasmin in red.  (A) control-injected 
embryo at 6dpf. The black arrowhead points to the normal exocrine pancreas position 
which is on the right side of the embryo. The red arrowhead points to the normal liver 
position which is dominantly on the left side of the embryo. (B) hgfa morphant at 
6dpf. The black arrowhead points to the shifted exocrine pancreas position which is 
on the left side of the embryo. The red arrowhead points to the shifted liver position 




3.3.2 Liver development is disrupted in hgfb morphants 
 
 
Based on the expression of hgfb in liver, its role in liver development was predicted. 
Loss of function study by MO knockdown was carried out, and Tg(lfabp:RFP) was 
used as an indicator for liver development. At 3dpf, liver formed normally in control 
and the hgfb morphants (Fig.3.38.A and B). However, obvious differences between 
control embryos and the hgfb morphants were discernable subsequently with liver in a 
much smaller size from 4dpf to 6dpf (Fig.3.38 D, G and J). Some of the morphants 
with the smaller liver phenotype was accompanied with a heart edema (Fig.3.38.E, H 
and K). In HGFb-ex2, HGFb-ex3 or HGFb-ex2+HGFb-ex3 morphants, the smaller 
liver phenotype is dose-dependent (Fig.39). It seems that hgfb is required for the 
growth phase of liver development, possibly by promoting hepatocyte proliferation. 
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Fig.3.38 Zebrafish hgfb knockdown causes liver growth defect. Embryos are 
lateral view with anterior to the left. White arrowhead in all the figures points to liver. 
(A) control-injected embryo at 3dpf. (B) hgfb morphant at 3hpf. (C) control-injected 
embryo at 4dpf. (D) hgfb morphant at 4hpf. (E) hgfb morphant at 4hpf with heart 
edema. (F) control-injected embryo at 5dpf. (G) hgfb morphant at 5hpf. (H) hgfb at 
5hpf with heart edema. (I) control-injected embryo at 6dpf. (J) hgfb morphant at 6hpf. 









































Fig.3.39 Smaller liver size in hgfb morphants was revealed by Tg(lfabp: RFP) 
transgenic zebrafish. 
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Confirmation of knockdown effect of HGFb MO 
 
HGFb-ex1 MO is against the first exon and first intron junction, which will lead to the 
first intron inclusion into the splicing interfered product, and the first intron inclusion 
will introduce a premature stop codon. hgfb splicing interfered product is verified by 
RT-PCR using the forward primer from first intron and the reverse primer from the 
third exon, which can avoid amplify the hgfb splicing interfered product due to that 
the first intron size is above 5000bp. And the endogenous hgfb mRNA level is 
verified by qRT-PCR using the forward primer from first exon and the reverse primer 
from the second exon. 
  
For the endogenous hgfb mRNA, an unexpected increase was detected in the HGFb-
ex1 morphants (Fig.3.40) though the splicing interfered product is detectable 
(Fig.3.41). Hence, another set of MOs blocking pre-mRNA splicing, HGFb-ex2 and 
HGF-ex3, was designed. HGFb-ex2, which is against the second exon and second 
intron junction, will lead to the second exon deletion; HGFb-ex3, which is against the 
third exon and third intron junction, will lead to third exon deletion. And co-injection 
of these two MOs would lead to the exon2 and exon3 deletion. Splicing interfered 
products of HGFb-ex2 and/or HGFb-ex3 are verified by RT-PCR using the primers 
flanking the exon2 and exon3. And the endogenous hgfb mRNA level in HGFb-ex2 
morphant is verified by qRT-PCR using the forward primer from the second exon and 
the reverse primer from the fourth exon; the endogenous hgfb mRNA level in HGFb-
ex3 morphant is verified by qRT-PCR using the forward primer from the third exon 
and the reverse primer from the fourth exon; the endogenous hgfb mRNA level in 
HGF-ex2 and HGF-ex3 co-injected morphant is verified by qRT-PCR using forward 
primer from second exon and third exon junction and the reverse primer from the 
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fourth exon. Results showed that endogenous hgfb mRNA level is lower in the pools 
with phenotype and this difference is more distinguishable in the HGFb-ex2 and 
HGFb-ex3 co-injected morphants (Fig.3.42).  
 
In the detection of knockdown product of HGFb-ex2 and/or HGFb-ex3, totally six 
different bands are detected according to size (Fig.3.43). After sequencing, band 1 is 
matching the WT hgfb sequence; band 3 and band 4 are matching the hgfb exon2 or 
exon3 deletion sequence respectively; band 6 is matching the hgfb exon2 and exon3 
deletion sequence; band 2 is matching the hgfb exon2 partial deletion sequence which 
is due to a cryptic splicing site (AGGA) within exon2; band 5 is matching the hgfb 
exon2 partial deletion and exon3 deletion sequence. 
 
Splicing interfered products of band 2, band 3 and band 4 will cause the reading frame 
shifting and introduce a premature stop codon. Splicing interfered products of band 5 
and band 6 will cause the deletion of hairpin loop domain which is an essential site for 
heparin binding and biological activity of HGF (Mizuno et al., 1994). 
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Fig.3.40 Relative mRNA levels of zebrafish hgfb in HGFb-ex1 morphants 
















Fig.3.41 Detection of knockdown product of HGFb-ex1 in hgfb morphants and 
WT embryos. RNA template for each lane are: 1. 4dpf wt; 2. 4dpf HGFb-ex1 
morphants without phenotype; 3. 4dpf HGFb-ex1 morphants with smaller liver. 



























































































































































Fig.3.42 Relative mRNA levels of zebrafish hgfb in HGFb-ex2 and/or HGFb-ex3 
morphants compared to WT embryo. A is the HGFb-ex2 morphants, B is the 
HGFb-ex3 morphant and C is the HGFb-ex2 and HGFb-ex3 co-injected morphant.  








Fig.3.43 Detection of knockdown product of HGFb-ex2 and/or HGFb-ex3 MO in 
hgfb morphants and WT embryos. ex2, HGFb-ex2; ex3, HGFb-ex3; ex2+3, HGFb-
ex2 and HGFb-ex3; NL, normal liver; SL, smaller liver; M, marker. 1, WT hgfb; 2, 
hgfb exon2 partial deletion; 3, hgfb exon2 deletion; 4, hgfb exon3 deletion; 5, hgfb 
exon2 partial deletion and exon3 deletion; 6, hgfb exon2 and exon3 deletion. 
 









































3.3.3. Liver development is disrupted in c-met morphants 
 
 
Based on the expression of c-met in liver, its role in liver development was predicted. 
Loss of function study by MO knockdown was carried out in Tg(lfabp:RFP) line. At 
3dpf, liver in control and c-met morphants formed normally (Fig.3.44.A and B). 
However, obvious differences between control and c-met morphants were discernable 
subsequently with liver in a much smaller size from 4dpf to 6dpf (Fig.3.44 D, G and 
J). Some of the morphants with the smaller liver phenotype was accompanied with a 
heart edema (Fig.3.44.E, H and K). At the dose of 10ng per embryo MO injection, 
61% (n=194) of embryos showed smaller liver phenotype at 4dpf, and at a lower dose 
of 1ng per embryo MO injection, 0% (n=123) of embryos showed smaller liver 
phenotype at 4dpf.  These results indicate a requirement of c-met in liver growth. 
Very likely, hgfb functions through c-met to promote liver growth. 
 
 
Fig.3.44 Zebrafish c-met knockdown causes liver growth defect. Embryos are 
lateral view with anterior to the left. White arrowhead in all the figures points to liver. 
(A) control-injected embryo at 3dpf. (B) c-met morphant at 3hpf. (C) control-injected 
embryo at 4dpf. (D) c-met morphant at 4hpf. (E) c-met morphant at 4hpf with heart 
edema. (F) control-injected embryo at 5dpf. (G) c-met morphant at 5hpf. (H) c-met 
morphant at 5hpf with heart edema. (I) control-injected embryo at 6dpf. (J) c-met 
morphant at 6hpf. (K) c-met morphant at 6hpf with heart edema. 
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Confirmation of knockdown effect of c-Met MO 
 
c-met-ex1 MO is against the first exon and first intron junction, which will lead to the 
first intron inclusion into the splicing interfered product, and the first intron inclusion 
will introduce a start codon and a premature stop codon. c-met splicing interfered 
product is verified by RT PCR using the forward primer from first intron and the 
reverse primer from the third exon and sequencing results showed that the splicing 
products is just as predicted (data not show). And the endogenous c-met mRNA level 
is verified by qRT-PCR using the forward primer from first exon and the reverse 
primer from the second exon, which can avoid amplify the c-met splicing interfered 
product due to that the first intron size is above 5000bp. Results showed that 
endogenous c-met mRNA level is lower in the pools with phenotype (Fig.3.45). And 
























Fig.3.45 Relative mRNA levels of zebrafish c-met in c-met-ex1 morphants 













Fig.3.46 Detection of knockdown product of c-met-ex1 MO in c-met morphants 
and WT embryos. RNA template for each lane are: 1. 4dpf wt; 2. 4dpf c-met-ex1 
morphants without phenotype; 3. 4dpf c-met-ex1 morphants with smaller liver. 
Primers are C Splice Sense and C Splice Antisense. 









































Chapter 4. Disscussion 
4.1 Zebrafish is a complementary model to study the function of HGF 
and its receptor in vertebrate development 
During the past decades, numerous efforts have been put into the study of HGF and its 
receptor c-met. The early embryonic lethality of HGF or c-met knock-out mice made 
the functional study of this ligand/receptor pair in later embryonic and fetal 
development as well as adult difficult. Use of zebrafish model with the morpholino 
antisense oligonucleotide knock-down approach makes the study of HGF and c-met at 
late development stages possible. Additionally, in contrast to other vertebrates, liver is 
not a site of hematopoiesis in fish embryos, allowing the investigation of hepatic 
development independently of defects due to anemia. With the small body size, 
zebrafish embryos receive sufficient amounts of oxygen by simple diffusion allowing 
the embryo developing relatively normally (Stainier, 2001). To study hgf and c-met in 
zebrafish model, full length cDNA of two hgfs (hgfa and hgfb) and one c-met were 
isolated and cloned. Their expression and function during zebrafish embryonic 
development were analyzed by various experimental tools. Since hgfa is expressed in 
the somites of zebrafish embryo, hgfa is hypothesized to have a role in the 
development of the somites. Hence, the distinctive role of hgfa during zebrafish 
development, in particular, hgfa’s function in somitogenesis, was investigated by 
using MO knockdown method and subsequently visualization of the somites by whole 
mount in situ hybridization for myoD, fgf8 and aldh1a2. Although hgfa can not be 
detected in liver, knocking down of hgfa can affect the positioning of liver as well as 
pancreas. Expression patterns of hgfb and c-met in liver implied their roles in 
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zebrafish liver development. Functional analysis using MO knockdown method 




4.2 Zebrafish hgfa and hgfb and c-met genes  
Most of the zebrafish genome contains duplicated segments that probably result from 
an genome-wide duplication about 400 million years ago. This duplication occurred in 
the ray fin fish lineage after it diverged from the lobe fin lineage (that includes avian 
or mammalian species). For this reason, zebrafish often have two copies of a gene that 
is present as a single copy in mammals (Postlethwait et al., 2000). In this work, we 
isolated two zebrafish hgf genes, named as hgfa and hgfb. However, only one c-met 
was found. It is possibly that there is another c-met which has not been discovered. 
Alternatively, the two hgfs could share one common receptor and carry out distinct 
functions in different organs or developmental stages. 
 
Our results support both the hypothesis. From the expression pattern, hgfa and c-met 
are co-expressed in fin, hgfb and c-met are co-expressed in liver. These co-expression 
of hgfs and c-met support the hypothesis that the two hgfs could share one receptor. 
HGF and c-met mRNA transcripts was found to co-localize in somite in mice and 
chicken (Andermarcher et al., 1996; Daston et al., 1996; Thery et al., 1995; Yang et 
al., 1996). However, only hgfa was detected in somite and no c-met somitic 
expression is detected. Haines et al. (Haines et al., 2004) showed earlier that c-met 
expression in somitic is specifically restricted to the ventral lateral margin of anterior 
somites. However, c-met’s expression in nephric duct (Fig.3.19) is not detect in 
Haines’s study. Initially I speculated that Haines’s c-met expression in somite and this 
study’s c-met expression in nephric duct, which are both located at the ventral lateral 
region of the trunk, may be spatially in vicinity and difficult to differentiate. However, 
after comparing the sections (Fig.3.19 N) (Haines et al., 2004), Haines’s c-met ventral 
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lateral expression is within the somite and my c-met ventral lateral expression is not 
within the somite but within the nephric duct. The possible reason is that the two 
sections are not at the same axial level. Hence, it is possible that in the anterior part 
(maybe first two or three somites according to Hanies’s results), c-met is expressed in 
the ventral lateral part of somites. However, in the posterior part, c-met is expressed in 
the nephric duct. This means c-met is not expressed in most of the somites, which is in 
contrast with c-met’s expression in other vertebrates (Andermarcher et al., 1996; 
Daston et al., 1996; Thery et al., 1995; Yang et al., 1996). And this disaccord supports 
the hypothesis that there might be one additional zebrafish c-met to co-express with 
hgfa in somites. Functionally, knockdown hgfb or c-met both induce smaller liver, and 
knockdown hgfa alone induce curved trunk. This result also suggested that this c-met 
is probably the recptor of hgfb, but not hgfa and maybe one more zebrafish c-met 
exists to support hgfa function in somites. 
 
To investigate the possibilities raised above, the following experiment can be 
designed. Human cell line’s c-MET excelluar domain can be replaced by zebrafish c-
met extracelluar domain. And the signaling pathway activated by zebrafish hgfa or 
hgfb in this cell line can be measured. If both hgfs can activate the c-MET signaling 
pathway, then it will support the hypothesis that the two hgfs could share one receptor. 
Otherwise, there is possibly one additional c-met in zebrafish. If both hgfs can bind to 
this hybrid c-MET and activate the signaling pathway, in vitro study can be done to 
investigate if the two hgfs have any difference at the biological level (eg. Scatter 
activity, morphogenetic activity, anti-apoptosis activity, etc.) to further support the 
idea that the two hgfs might bind to the same receptor to carry out distinct functions in 
different organs or developmental stages 
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4.3 Distinct expression pattern of hgfa and hgfb 
Two partial cDNA sequences of zebrafish hgf have been reported earlier (Haines et al., 
2004). The two different hgfs, named as hgf1 (NCBI accession NO.: NM_001013274) 
and hgf2 (NCBI accession NO.: AY690481) exhibited identical expression profiles 
during development (Haines et al., 2004). However, in this study, the expression 
pattern of hgfa (corresponding to hgf1 by sequence comparison) and hgfb 
(corresponding to hgf2 by sequence comparison) are distinct both temporally as well 
as spatially. The possible reason of this discrepancy could be the probes they used 
which are based on partial sequences and short cDNA fragmants. In contrast, the 
probes used in this study are generated from the full length cDNA sequences 
including UTR. Although the updated hgf1 sequence in NCBI (updated by zebrafish 
genome database at 03-JAN-2007) covers the whole ORF, Haines et al. only isolated 
the fragment of hgfs for probe synthesis. And the updated hgf1 sequence is missing 
39bp of  hgfa in ORF region, which may be due to the mis-prediction of the intron-
exon junction. hgf2 isolated by Haines et al. is only 205bp in length and located at the 
3 prime end (Fig.4.1). By alignment of hgf1 and hgf2’s nucleotide sequences at the 
corresponding region, they share 65% of identity, indicating this region of hgfs share 
higher homology than the full ORF sequence of two hgfs, which is 50% based on our 
sequence comparison. And using this higher homology region for probe synthesis 
may be difficult to differentiate the hgf1 and hgf2’s expression pattern.   
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Fig.4.1 Comparison of hgf1, hgf2, hgfa and hgfb. Numbers indicate nucleotides 
position from start codon (hgf1, hgfa and hgfb) or from the first nucleotide revealed 
(hgf2).  
 
Comparing hgfa and hgfb’s expression pattern in this study with hgfs expression 
pattern in Haines’ study, common expression pattern can be found between hgfa in 
this study and hgfs in Haines’ study (Haines et al., 2004). In Hanies’ study, hgfs 
transcripts can be detected throughout the fin bud mesenchyme with increased 
expression in the fin at 36 and 48hpf (Haines et al., 2004). In my study, hgfa’s 
expression in fin can be detected at 30 and 48hpf (Fig.3.17), however, not throughout 
the whole fin bud mesenchyme, but in the dorsaventral dorsal and ventral muscle 
mass within the fin (Fig.3.17 G). This result parallels the result obtained on Hgf 
expression in the mouse (Ebens et al., 1996), in which Hgf is expressed in the dorsal 
and ventral muscle mass within forelimb. The possibility for this difference between 
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Haine’s hgfs and hgfa’s expression in fin might be due to the different length of 
cDNA sequence used for probe synthesis. 
 
Haines found hgfs initiates expression broadly and at low level within somites at all 
axial levels at 22hpf, with stronger expression evident at somite boundaries (Haines et 
al., 2004). However, I found hgfa initiates expression broadly within somite at all 
axial levels from 7somites stage, not at the somite boundaries, and at 48hpf, hgfa 
transcripts can no longer be detected within the somite (Fig 3.17). For hgfs expression 
in notochord and neueral tube (Haines et al., 2004), I failed to detect the same 
expression pattern in my study for either hgfa or hgfb. Some additional expression 
pattern of hgfa was found in the developing ear (Fig 3.17), which has no parallel in 
other species. 
 
hgfb’s expression pattern is quite different from the hgfa’s expression pattern and the 
published hgfs expression pattern (Haines et al., 2004). There are many tissues or 
organs expressing hgfb. hgfb’s expression in liver was detectable from 4dpf in a salt 
and pepper pattern, and the section of two probes WISH of hgfb and Cp at 6dpf 
revealed that hgfb is expressed in stromal cells in liver, not hepatocyte (Fig.3.18). 
hgfb’s expression at the pronephric duct opening was evident from 12somites stage to 
4dpf (Fig.3.18), which has no parallel in other species. Interestingly, in the swim 
bladder, an organ unique to fish, hgfb is expressed from 36hpf to 4dpf (Fig.3.18).  
 
qRT-PCR of hgfa and hgfb during different developmental stages revealed their 
different expression profile at the temporal level (Fig 3.16). For hgfa, there is a peak 
at 24hpf to 36hpf stage, corresponding to the stage of somitogensis and fin budding. 
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For hgfb, there are two peaks, one at 24hpf and another at 3dpf to 4dpf. The 3dpf to 
4dpf expression peak of hgfb is corresponding to the stage of liver growth, together 
with the expression pattern of hgfb in liver, indicating hgfb may be required for liver 
growth. 
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4.4 c-met express in various tissues and organs 
In Haines’ study (Haines et al., 2004), c-met expression is detected in fin and PHM 
(posterior hypaxial muscle) muscle precursors, as well as the PLLP (posterior lateral 
line primordial). In this study, c-met expression in fin and PLLP is very 
distinguishable and the expression of c-met in PLLP is not necessary at the same axial 
level when migrating caudally (Fig.3.19). c-met’s expression in fin is only restricted 
to dorsoventral muscle masses of the fin (Fig.3.19 Q), which was also found in 
Hanies’s study (Haines et al., 2004). With hgfa’s expression in dorsaventral muscle 
masses (Fig.3.17 G), it is highly likely that hgfa/c-met signaling pathway might play 
role in fin development. Two probes WISH of hgfa and c-met and section cross the fin 
would help to investigate if it is a paracrine or autocrine signaling in fin development. 
Several new expression profiles of c-met were revealed in this study. c-met expression 
in head is evident from 1-somite stage to 12-somites stage (Fig.3.19), corresponding 
to the peak expression level of c-met at 12somite stages in qRT-PCR analysis 
(Fig.3.16). c-met was found to be expressed in the developing pronephric duct 
(Fig.3.19). This expression pattern can also be found in Xenopus (Koibuchi et al., 
2004). The expression of hgfb in the posterior opening of the pronephric duct suggests 
the involvement of hgfb and c-met paracrine signaling in pronephric duct development.  
 
c-met expression in motor neuron is evident at 18somites stages to 24hpf (Fig 3.19). 
In mouse or rat, c-Met was also found in motor neuron and Hgf act as an axonal 
chemoattractant, a neurotrophic factor and a survival factor for motor neuron (Ebens 
et al., 1996; Yamamoto et al., 1997). However, zebrafish c-met expression in motor 
neuron is not revealed in Haines’ study (Haines et al., 2004). 
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Expression of c-met in liver was distinguishable from 48hpf, section of two probes 
WISH of c-met and ceruloplasmin at 3dpf revealed that c-met might be expressed in 
hepatocyte (Fig 3.19). With the expression of hgfb in the liver mesenchyme cells, this 
expression of c-met in hepatocyte may indicate paracrine signaling of hgfb and c-met 
in liver growth. And this co-expression of HGF and c-met in liver was also revealed 
in rat or mice (Hu et al., 1993; Yang and Park, 1995), in which HGF was localized in 
the nonparanchymal cells and c-met in the hepatocyte.  
 
c-met expression in exocrine pancreas is only detectable at 4dpf in this study (Fig 
3.19). Although c-met was reported to be expressed or play roles in the adult pancreas, 
regenerating pancreas or pancreatic cancer cells (Otonkoski et al., 1996; Otte et al., 




4.5 hgfa plays a role in somitogenesis and myogenesis 
From the above results, different phenotypes of hgfa morphants were observed at 
different somite stages. Curved trunk is morphological evident in hgfa morphants 
(Fig.3.20) and together with the expression of hgfa’s expression in somite, indicating 
hgfa’s role in somitogenesis. To initially test the possibility that hgfa plays a role 
during somitogenesis, the expression of myoD, a marker for terminal differentiation of 
somites, was analyzed for the hgfa morphants at the 9-somite stage. At the 9-somite 
stage, although myoD expression in either the left or right somites only were revealed, 
the main phenotypes observed were the reduction in myoD expression and myoD 
expression in the adaxial cells was not affected (Fig.3.25). Hence, hgfa is required for 
normal myoD expression in the somites, indicating hgfa’s role in somitogenesis. 
 
Meanwhile, although some of the phenotypes of the hgfa morphants were also seen in 
the HGFa-ATG5mis MO injected embryos, this could be due to the close similarity 
between the MO sequences. Both of these MOs are 25 bases in length, with only 5 
random bases being different between them. Moreover, the HGFa-ATG MO functions 
as a steric hindrance that prevents the translation of the specific mRNA which it binds 
to. Hence, it is possible that the HGFa-ATG5mis MO could also bind the same 
mRNA, but with lowered affinity (due to the 5 mismatched bases). As seen in Fig.4.2, 
MO less than 20-mer still have inhibition effects. Also, compared to the HGFa-ATG 
morphants (which were microinjected with 10ng of HGFa-ATG MO per embryo), the 
number of HGFa-ATG5mis MO injected embryos (which were microinjected with 
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10ng of HGFa-ATG5mis morpholino) showing the phenotypes were smaller (Fig.3.26, 
Fig.3.28 and Fig.3.30). 
 
Fig.4.2 In a cell-free translation system the great gains in efficacy with increasing 
length of Morpholino Oligos. (from www.gene-tools.com) 
 
When the HGFa-ATG MO was microinjected at 1ng per embryo, smaller percentages 
of the phenotypes were observed in the HGFa-ATG morphants comparing with those 
microinjected at 10ng per embryo. Thus, the phenotypes observed in the HGFa-ATG 
morphants are MO dose-dependent. This suggests that the HGFa-ATG MO inhibition 
of the translation of hgfa mRNA may be dose-dependent. 
 
Since myoD expression is disrupted in hgfa morphants and fgf8 signalling is required 
for myoD expression in the somites (Groves et al., 2005), fgf8 expression was 
analyzed in hgfa morphants. At the 8-somite stage, the main phenotype observed was 
the reduction in fgf8 expression, together with a reduction in the number of somites 
(Fig.3.27). Thus, hgfa is required for normal fgf8 expression in the somites. 
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Since the continuously regressing posterior-to-anterior gradient of fgf8 plays a critical 
role in positioning the determination front for somites formation (Dubrulle et al., 2001; 
Dubrulle and Pourquie, 2004), and the knockdown of hgfa has shown to affect the 
expressions of myoD, fgf8 in this study, hgfa might plays a role in somitogenesis. 
 
However, it is puzzling that the hgfa morphants were able to continue survival, in 
spite of the severe developmental defects. There are a few possible reasons to explain 
this. One, there are other myogenic regulatory transcription factors (MRFs), such as 
myf5 and myogenin, involved in somitogenesis and myogenesis. These factors might 
be upregulated to compensate for the reduction and loss of myoD in the hgfa 
morphants. Two, other fgfs might also be involved in somitogenesis and could be co-
expressed with fgf8, especially the close homologues fgf17 and fgf17b. These fgfs 
could be upregulated to compensate for the loss of fgf8 in the hgfa morphants. In 
addition, some recovery of somitogenesis and myogenesis could be driven by later-
acting fgfs. Last but not least, it has been shown that a lack of fgf signalling does not 
lead to death of lateral somite cells, but rather, cause them to remain in a less 
differentiated state, i.e., similar to an immature somite (Groves et al., 2005). Hence, it 
is possible that other later-acting genes can induce these cells to undergo terminal 
differentiation. 
 
Since the knockdown of hgfa causes a reduction in both myoD and fgf8 expressions, 
and that fgf8 is expressed in the somites approximately 1 hour before the somatic 
expression of myoD (Reifers et al., 1998), it is possible that hgfa affects myoD 
expression through its effect on fgf8. This hypothesis is further supported by the study 
carried out by Groves (Groves et al., 2005). They have found that the lateral cells in 
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the posterior somite require fgf8 signalling to initiate the expression of myoD and 
consequently, to undergo terminal differentiation into fast muscle fibres. Furthermore, 
fgf8 expression within the somite is sufficient for myoD expression in the lateral 
somite. By exposing the embryos to SU5402, a drug that blocks the phosphorylation 
of fgf receptors and thus, prevents downstream signalling, myoD expression in the 
lateral somites is abolished (Groves et al., 2005). Hence, they have showed that fgf8 
signalling is required for myoD expression in the somites and further terminal 
differentiation. Thus, fgf8 drives lateral fast myogenesis in zebrafish. 
 
In another recent study done by Hamade et al. (Hamade et al., 2006), fgf8 is found to 
be a major relay factor in retinoic acid (RA)-mediated activation of myogenesis. The 
expression of fgf8 and myoD in the somites and/or PSM are regulated by RA. 
Localized synthesis of RA by aldh1a2 in the anterior PSM and in somites, activates 
fgf8 expression, which in turn, induces the expression of myogenic genes and fast 
muscle differentiation. Inhibition of RA signaling decreases both myoD expression 
and muscle differentiation. Therefore, RA and fgf8 are indicated as key regulators of 
myogenesis in zebrafish (Fig. 4.3). Hence, the RA synthesis by aldh1a2 was checked 
in hgfa morphants. And at the 12-somite stage, the phenotype observed was the 
reduction or asymmetry expression of aldh1a2 (Fig.3.29). Thus, hgfa is required for 
normal aldh1a2 expression in somites. Since knockdown of hgfa has been shown to 
affect the expressions of fgf8 and aldh1a2 in this study, it is hypothesized that hgfa 




Fig.4.3 Model of myoD regulation by RA and fgf8 signalling pathways and hgfa’s 
role during embryonic development. Schematic drawing of the posterior somites 
and the PSM of a 10-somite stage embryo. Arrows indicate relationships identified; 
dotted arrows represent possible relationships. Anterior presomitic mesoderm and 
somites are indicated by grey shading. aldh1a2 expressed in somites and anterior 
PSM synthesises RA, which in turn controls expression of fgf8 and possibly fgf17b in 
somites and anterior PSM. fgf8 and possibly fgf17b activate expression of myoD in 
somites. RA also activates fgf17b expression in adaxial cells, which in turn may 
control expression of myoD in these cells together with Shh. ac, adaxial cells; ant psm, 




4.6 hgfa influence angiogenesis in zebrafish embryos  
Using the Tg(fli:GFP), ISV and DLAV sprouting delay about 10 to 24 hours can be 
observed in hgfa morphant at dorsal part (Fig.3.31) and this delay is dependent on the 
level of hgfa knockdown (Fig.3.23). It is noted that the ISV sprouting route is 
different at the dorsal part and ventral part (Childs et al., 2002). At the ventral part, 
ISV sprouts between the somite bondary, while the dorsal part, ISV does not follow 
the somite boundary, where it runs directly to the DLAV by penetrating the somites 
(Fig.4.4). It is also speculated that during the ventral-to-dorsal migration, angioblasts 
encounter distinct signals, or different levels of a signal arrayed in a morphogenetic 
gradient that dictates the fate of the individual cell and the shape of the vessel (Childs 
et al., 2002). This is supported by our finding that in hgfa morphant, ISV sprouting is 
only affected at the dorsal part, not the ventral part. Based on hgfa’s expression in 
somites and role in somitogenesis or myogenesis, and the penetration of ISV through 
somites during the dorsal part sprouting, ISV and DLAV sprouting delay at dorsal 
part in hgfa morphant might be the consequence of somitogenesis or myogenesis 
disruption in hgfa morphant. 
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Fig.4.4 Model of the construction of a zebrafish ISV. An intersegmental vessel 
(ISV) is composed of three types of endothelial cells, distinguished by their 
morphologies. The dorsal connection to the DLAV is a T-shaped cell (blue); the 
ventral connection to the aorta is an inverted ‘T’ (red). The connecting cell (green) 
courses between the somites ventral to the notochord-neural tube interface, and 
appears not to follow the somite boundary dorsally, where it runs directly to the 
DLAV.(Childs et al., 2002) 
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4.7 hgfa plays a role in the left-right positioning of liver and pancreas 
Although hgfa’s expression in liver is not detectable in this study, the asymmetric 
position of liver was found to be shifted from left side to right side in hgfa morphants 
(Fig.3.32). Another asymmetrically positioned organ, pancreas, was later found to be 
shifted from right side to the left side in hgfa morphants (Fig 3.35). And the position 
of liver and pancreas can shift within a single hgfa morphant simultaneously (Fig 
3.37). 
 
Since hgfa expression is symmetrical and this knockdown effect is asymmetrical, it is 
very interesting to study how interfering symmetrical signal can induce asymmetrical 
effects. Recent studies about RA showed that the symmetry arrangement of the 
somitogenesis is not the default mode, but protected by the RA from the asymmetrical 
clues (Hornstein and Tabin, 2005; Kawakami et al., 2005; Vermot et al., 2005; 
Vermot and Pourquie, 2005). 
 
 
Fig.4.5 Maintaining symmetrical somitogenesis. A vertebrate embryo is shown 
from the back. a, The new papers1–3 show that, in wild-type embryos, a protective 
effect of retinoic acid (RA; pink field) masks the flow of left–right information (black 
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arrow) to enable the symmetrical bilateral formation of new somites (blue). b, 
Blocking RA production exposes somites to left–right signals and takes their 
generation out of synchrony. 
 
When separate the embryo into different pools basing on the curving trunk phenotype, 
the liver shifting ratio is higher in the curving trunk pool (45%) than the non-curving 
trunk pool (10%) (Fig.3.34). Together with the expression pattern of hgfa (not in liver 
or pancreas), shifting of those asymmetrical arranged organs may be the consequence 
of the disrupted somitogenesis. In this study, aldh1a2, which acts as a key enzyme in 
RA synthesis and converts retinal to retinoic acid, is disrupted in the hgfa morphants. 
RA has been proven to protect the symmetrical somitogenesis from the asymmetrical 
signals (Fig.4.5). It is speculated that RA may not only protect the symmetrical 
somitogenesis but also protect the asymmetrical organ which is beneath the somites 
(Fig.4.4). However, until now no reports has mentioned if RA will affect the 
asymmetrical organogenesis.  
 
Almost no study showed that how somitogenesis affect asymmetrical arranged organs, 
the mechanism remains unclear. Previous studies have shown that RA can protect the 
symmetry of somitogenesis through fgf8 (Hamade et al., 2006), however, didn’t 
mention about this protection form RA can also shield other asymmetrically 
positioned organs. This is a gap from the hgfa affecting the RA and symmetry of 
somitogenesis to hgfa affecting the liver and pancreas asymmetrical postion.  And this 
study may give the first indication that RA protection may shield asymmetrically 
positioned organs. To confirm this, studies were taken to determine whether the 
asymmetrically organs’ position are shifted in the RA deprived mutant using the 
DEAB. However, the results were not constant (data not included). 
 
176 
Another possible explanation is the MO delivery method. When using qRT-PCR 
analysis to check the gene knockdown level, within single batch of injected embryos, 
different pools have different knockdown level. This variation is probably due to that 
current MO delivery method may cause inconstant distribution of MO. I use 
microinjection to deliver MO into the embryo. The injection position is roughly at the 
york below the cell. The injection position may vary, which may lead to different take 
up of MO for the cell. Especially when injected at two cell stage, variation of injection 
position may cause the two cells within one single embryo taking different amount of 
morpholino, which may explain the one side myoD expression phenotype in hgfa 
morphant (Fig.3.25 C and D). So the limitation of morpholino delivery method may 
lead to that the knockdown level are not uniform at the spatial level, which might 
affect the asymmetrical clues. To verify the knock down effect at spatial level, MO 
targeting the first intron and first exon junction, which cause intron inclusion, can be 
used. The spatial distribution of intron inclusion knockdown products can be revealed 
by the probe targeting to the intron. 
The lack of hgfa expression in the liver and pancreas suggests that the liver and 
pancreas phenotypes observed in the hgfa morphants could be caused by a non-cell 





4.8 hgfb and its receptor c-met are essential for zebrafish liver 
development 
WISH of hgfb and its receptor c-met revealed their expressions at different locations 
at different developmental stages, which was consistent with previous studies showing 
that HGF and c-met signaling played a pivotal role in the regulation of growth and 
development (Birchmeier and Gherardi, 1998). As most importantly for the current 
study, hgfb and c-met were shown to be expressed in liver, with hgfb expressed at 
liver from 4dpf to 6dpf and c-met from 36hpf to 6dpf. In previous studies on HGF and 
its receptor c-met, the presence of HGF in day 19 rat liver (Defrances et al., 1992), the 
expression of HGF mRNA during human and rat fetal liver development (Selden et al., 
1990), and the expression of HGF’s receptor c-met during mouse and rat 
embryogenesis (Chan et al., 1988) all suggested the HGF helped to regulate fetal liver 
development. Therefore, hgfb and c-met expression in zebrafish liver found in this 
work also implied their role in zebrafish liver development. 
 
Primary hepatocytes are epithelial cells. Exchange of signals between the 
mesenchymal and epithelial cell compartments has long been recognized as a major 
driving force in epithelial growth, morphogenesis and differentiation (Birchmeier and 
Gherardi, 1998). Previous studies have already shown in mouse that c-met was 
expressed in epithelial cells in many organs, and HGF transcripts were produced by 
adjacent mesenchymal cells during development, and they interacted in a paracrine 
manner (Sonnenberg et al., 1993). In this study, hgfb’s expression in the liver 
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mesenchyme (Fig.3.18 V) and c-met’s expression in hepatocytes (Fig.3.19 R) also 
revealed their paracrine singling in liver development. 
 
From 4dpf onwards, smaller liver phenotype could be observed in hgfb morphants, c-
met morphants and double-knockdown morphants in a significantly higher percentage 
compared with controls. Together with the knockdown effect revealed by qRT-PCR 
and detection of the splicing interfered products by RT-PCR, the smaller liver 
phenotype was at first thought to be the direct and single effect of hgfb and c-met 
knockdown.  
 
Having observed the small liver phenotype in hgfb and c-met morphants, it was 
hypothesized that the reduction in liver size might be due to increased apoptosis rate 
or decreased proliferation rate of liver cells. Using BrdU as a proliferation marker, it 
was found that the proliferation rates in liver cells for both morphants and controls 
were similar, which were around 10% (Xiaorui Wang, NUS honors student 
2006/2007). This was an indication that hgfb and c-met knockdown had no effect on 
liver cell proliferation. However, this result was relatively preliminary and the extent 
of liver apoptosis has not been determined. Hence, no solid conclusion can be drawn 
up to now for the mechanism of reduced size of liver in hgfb/c-met morphants. In 
mouse HGF knockout mutants, the embryonic liver is reduced in size and shows 
extensive loss of hepatocytes, due to apoptotic cell death (Schmidt et al., 1995). 
Therefore, in the future work, it is necessary to check if the reduced size of liver in 
hgfb or c-met morphants is due to increased apoptosis of liver cells. 
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4.9. Comparison of HGF/c-Met functions in vertebrates 
The expressions and functions of HGF and c-Met are highly consevered among 
different species. HGF and c-Met are co-expressed and playing roles in many organs 
and tisuues, such as nervous system, muscle, liver etc. However, there are some 
differences of HGF and c-Met roles between different species. One example is the 
HGF and c-met’s role in hematopoiesis. In Xenopus, strong signals of HGF as well as 
c-met were detected early in the developing ventral mesoderm, which later gives rise 
to the ventral blood island (Koibuchi et al., 2004). In all vertebrate development, 
blood cell formation occurs in two successive waves, which are termed primitive and 
definitive hematopoiesis, based on the time of initiation, site of development, cell 
morphology, globin content, and potential to differentiate (Zon, 1995). Primitive 
hematopoiesis occurs first and gives rise to predominantly erythrocytes (primitive red 
blood cells). This phenomenon is then followed by definitive hematopoiesis, which 
leads to the production of all the blood lineages that are required throughout the life 
span of a vertebrate. Blocking of HGF signaling pathway in Xenopus embryos 
resulted in a marked decrease in the number of circulating blood cells and a 
significant reduction (or absence) of stem cell leukemia (SCL), α-globin, and GATA-
1 expression, but not GATA-2 expression, in the ventral blood island (VBI) where 
primitive red blood cells are exclusively produced. In contrast, no significant 
difference was observed in the levels of expression of early definitive blood markers, 
SCL,GATA-2, and GATA-3 in the dorsolateral plate (DLP) where definitive blood 
cells arise predominantly (Koibuchi et al., 2004). Koibuchi’s study (Koibuchi et al., 
2004) demonstrated that HGF is a specific regulator of primitive hematopoiesis rather 
than definitive hematopoiesis in Xenopus, which is different from mouse mutants. 
Another unique expression of HGF is the zebrafish hgfb’s expression in swimblader 
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which was first revealed in this study. This unique expression of HGF may shed light 






Chapter 5. Conclusions  
In this work, the roles of HGF and its receptor c-Met in zebrafish embryonic 
development were investigated. Full-length cDNAs of two zebrafish hgfs and its 
receptor c-met were cloned. The zebrafish hgfs were named as hgfa and hgfb. 
Expression analysis revealed distinctive expression pattern between hgfa and hgfb. 
hgfa is mainly expressed in somite from 7-somite stage to 30 hpf, pectoral fin from 30 
hpf to 48 hpf and ear from 30 hpf to 48 hpf, while hgfb is expressed in liver from 4 
dpf to 6 dpf, pronephric duct opening from 12-somite stage to 4 dpf and swim bladder 
from 36 hpf to 4 dpf. Their receptor c-met is detected in liver from 48 hpf to 6 dpf, 
pectoral fin from 48 hpf to 3 dpf, pronephric duct from 1-somite stage to 24 hpf, head 
from 1-somite stage to 12-somite stage, pancreas at 4 dpf and motor neuron from 18 
hpf to 24 hpf. The co-expression of hgfa and c-met in pectoral fin at 48 hpf, hgfb and 
c-met in liver from 4 dpf to 6 dpf, hgfb in the pronephric duct opening and c-met in 
proneprhic duct 12-somite stage to 24 hpf, indicate their paracrine signaling in 
zebrafish embryonic development. 
  
The functional analysis of hgfa by morpholino antisense oligonucleotide knockdown 
demonstrates its role in somitogensis and myogenesis, consistent with HGF’s role in 
muscle and limb development in other verterates. Although hgfa is not expressed in 
liver, suppression of hgfa expression lead to the shift of liver position from left to 
right side of the body. Two phenotypes in hgfa morphants, curving trunk and liver 
position shifting, are proven to be correlated. RA (retinoic acid) has been proven to 
protect the symmetric somitogenesis from the asymmetrical clues. In this study, 
aldh1a2 (RA synthesis enzyme) is disrupted in hgfa morphants. This gives the thought 
that RA might protect not only the symmetric somitognesis but also the asymmetric 
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organogenesis. However, deprivation of RA by DEAB can not generate the stable 
liver shifting phenotype. Given the one side missing of myoD expression, another 
possibility was coming into mind that the shifting of liver in hgfa morphants may not 
only require the knock down of hgfa but also the different knock down level at the 
spatial level which may be due to the limitation of the morpholino delivery method. 
When microinjecting into embryos older than one-cell stage, the uniform distribution 
of morpholino in each cell is not guaranteed. This would also explain why the liver 
shifting phenotype is not hgfa knockdown level dependent. The splicing morpholino 
make it possible to verify the different knock down level at the spatial level. This 
future work might be important to reveal the mechanism for liver shifting in hgfa 
morphant. Angiogenesis is also disrupted when hgfa was knocked-down as evidenced 
by the interruption of dorsal intersegmental vessel sprouting in hgfa morphants. 
Whether this is a direct effect on vessel formation or a secondary effect of 
somitogenesis disruption in hgfa morphants is unclear at this moment.  
 
The functional analysis of hgfb and c-met in liver development demonstrate their 
specific roles in liver growth, but not liver budding. The smaller liver phenotype in 
hgfb and c-met morphants is depedent on the extent of gene expression knockdown. 
There are two possible mechanisms for this smaller liver phenotype: one is the 
reduced cell proliferation, another is the accelerated cell apoptosis. Preliminary results 
showed that cell proliferation is not affected in hgfb and c-met morphants. Further 
confirmation of the proliferation results as well as analysis of the liver cell apoptosis 
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